data_2mla_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mla _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.755 0 CA-C-O 121.03 0.239 . . . . 0.0 113.023 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 3' ' ' ILE . 19.2 pt -125.05 160.85 29.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -80.49 63.64 5.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.668 0.747 . . . . 0.0 109.965 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 22.0 t -140.08 160.81 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.671 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.49 ' N ' HG13 ' A' ' 5' ' ' VAL . 98.4 mttt -113.43 128.73 56.55 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.943 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.8 t -66.2 97.0 0.36 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.063 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.414 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 75.3 mmtt -90.39 -34.4 15.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 171.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -148.89 134.55 18.75 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.467 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 25.6 p -72.71 86.97 1.24 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.789 0.804 . . . . 0.0 110.692 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.1 -25.43 1.43 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.211 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.414 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 34.2 tt0 -67.62 -29.91 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.16 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 60.8 m -63.37 -12.74 32.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.414 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.49 HD21 ' H ' ' A' ' 25' ' ' GLY . 3.9 mm? -67.17 -37.51 83.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.931 0.396 . . . . 0.0 110.938 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 95.5 mttt -59.8 -51.67 79.21 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.004 -175.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 73.9 Cg_endo -78.62 -14.6 14.15 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.539 1.492 . . . . 0.0 112.494 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 11.0 t -75.44 -33.41 60.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.033 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 6.5 ptpp? -66.61 -20.67 66.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.947 0.403 . . . . 0.0 109.971 175.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -84.4 -19.64 33.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.04 -27.06 33.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.966 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.06 17.06 48.81 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.963 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.482 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 25.4 mmt -98.66 177.21 5.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.393 0.14 . . . . 0.0 111.119 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 6.3 ttp180 -78.21 -71.55 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.991 -173.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.62 173.52 8.46 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 175.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -133.12 103.26 0.5 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -90.81 164.06 14.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.115 0.483 . . . . 0.0 110.419 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 10' ' ' SER . 1.5 m -85.67 129.06 34.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.36 0.6 . . . . 0.0 111.184 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.542 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -118.15 179.0 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.589 177.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.542 ' N ' HG21 ' A' ' 28' ' ' ILE . 6.6 p30 -45.46 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.014 0.911 . . . . 0.0 112.844 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.46 -11.25 5.55 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.406 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HB2' HG22 ' A' ' 28' ' ' ILE . 97.4 mttt -121.24 177.49 5.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.307 0.554 . . . . 0.0 111.328 -172.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.548 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 62.9 m -107.31 119.04 38.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.28 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -113.0 127.91 56.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.786 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 63.7 m -91.76 155.35 18.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.327 0.584 . . . . 0.0 111.733 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.46 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 58.0 m -105.05 124.74 35.63 Favored Pre-proline 0 N--CA 1.44 -0.95 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.011 173.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.28 176.97 8.22 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.035 1.823 . . . . 0.0 111.328 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 pttm . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.599 176.579 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.764 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 3' ' ' ILE . 15.3 pt -111.91 153.77 13.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.107 0.479 . . . . 0.0 110.637 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.27 64.64 4.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.303 -177.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 46.1 t -130.94 138.02 54.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.578 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 9.9 mtmp? -77.46 111.55 13.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 26.1 t -73.64 106.3 5.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.473 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -88.76 -34.46 17.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -149.89 146.72 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.584 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.1 p -62.47 -39.37 93.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.96 0.409 . . . . 0.0 110.391 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.37 -23.92 68.75 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.397 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -70.53 -40.26 73.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 0.0 109.836 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 81.8 m -69.56 -16.81 63.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.89 -174.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -66.35 -34.1 77.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.032 0.444 . . . . 0.0 110.826 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.5 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 92.8 mttt -61.3 -53.16 65.3 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.791 -174.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 72.5 Cg_endo -79.2 -17.14 11.91 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.62 1.547 . . . . 0.0 112.39 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.8 t -71.57 -29.97 65.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.278 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 23.1 pttm -65.4 -23.95 67.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 110.532 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -90.1 -13.09 36.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.535 0.684 . . . . 0.0 109.731 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.41 -10.55 56.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.063 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.08 23.79 73.38 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.998 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.573 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.3 mmt -104.71 177.87 4.72 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.247 -177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 3.2 ttp180 -84.21 -72.74 0.45 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.077 -174.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.86 -179.16 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.58 110.98 1.12 Allowed Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.491 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -90.21 154.72 19.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.8 t -95.89 105.18 17.17 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.282 0.563 . . . . 0.0 111.037 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.4 mp -102.17 153.78 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.407 ' N ' HG21 ' A' ' 28' ' ' ILE . 81.6 m-20 -46.24 90.75 0.0 OUTLIER 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.891 0.744 . . . . 0.0 112.467 -176.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 86.16 -9.66 68.95 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.373 -0.831 . . . . 0.0 113.458 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HB2' HG22 ' A' ' 28' ' ' ILE . 29.8 mtpp -121.02 135.42 55.21 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 117.726 0.763 . . . . 0.0 111.72 -175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 29.7 m -79.33 90.75 4.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.559 172.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.531 ' HB3' HD13 ' A' ' 28' ' ' ILE . 24.9 t70 -90.45 107.35 19.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.697 0.76 . . . . 0.0 110.901 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.6 m -81.47 149.98 28.51 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.532 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 26.3 m -92.07 128.63 44.67 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.141 174.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 5.1 Cg_exo -75.48 -173.04 1.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.817 1.678 . . . . 0.0 112.063 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.915 -177.631 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.9 pt -126.27 153.21 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.034 0.445 . . . . 0.0 110.851 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -80.73 42.05 0.6 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.615 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.7 t -110.59 146.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.072 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -81.66 138.92 35.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.234 0.54 . . . . 0.0 111.578 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 16.1 t -73.09 79.02 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.957 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -91.29 -47.92 7.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 172.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -150.74 142.8 24.03 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -66.21 -37.44 85.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.76 0.314 . . . . 0.0 110.985 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.1 -17.54 75.78 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.717 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.86 -41.09 26.99 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 75.2 m -62.83 -24.53 67.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.674 -176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.29 -35.66 80.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 0.0 111.565 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 61.8 mttp -64.51 -50.85 63.62 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -172.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 73.8 Cg_endo -78.53 -17.21 12.91 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.396 1.398 . . . . 0.0 112.355 176.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 39.6 t -73.58 -38.21 65.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.147 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 54.6 pttt -65.66 -21.85 66.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.312 0.577 . . . . 0.0 110.317 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -82.55 -16.74 47.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.672 0.748 . . . . 0.0 109.177 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.33 -11.11 53.02 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.18 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.542 ' O ' ' HE3' ' A' ' 37' ' ' LYS . . . 83.05 22.96 56.58 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.805 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.481 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.4 mmt -103.02 177.33 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.507 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.4 ttp180 -89.49 -68.23 0.79 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.02 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.507 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.35 172.91 9.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -139.85 107.22 0.53 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -86.89 154.35 20.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.191 0.52 . . . . 0.0 110.144 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.15 106.88 15.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.28 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.3 tp -106.87 177.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.04 -172.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -47.95 90.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.094 0.557 . . . . 0.0 111.499 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.41 -20.67 4.85 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.555 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 32.9 mmtp -123.47 178.78 5.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.363 0.582 . . . . 0.0 111.282 -170.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 80.2 m -108.48 113.57 26.71 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.28 117.3 32.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.999 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.468 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 65.3 m -91.02 150.69 21.34 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.501 0.667 . . . . 0.0 112.331 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.41 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 33.9 m -100.94 125.54 38.05 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.413 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -72.47 145.37 42.4 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.148 1.899 . . . . 0.0 112.024 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.542 ' HE3' ' O ' ' A' ' 21' ' ' GLY . 18.5 pttp . . . . . 0 C--O 1.249 1.042 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.246 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 112.768 -0.133 . . . . 0.0 112.768 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.469 HD12 ' SG ' ' A' ' 32' ' ' CYS . 28.5 pt -112.39 -178.89 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.774 0.321 . . . . 0.0 110.327 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -81.48 41.21 0.61 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.916 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.33 148.05 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.25 157.34 16.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.968 0.413 . . . . 0.0 110.906 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.9 t -77.92 77.49 4.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.326 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -90.59 -52.59 4.82 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.789 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 19.2 m80 -147.24 137.13 23.08 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.8 p -64.38 -39.11 93.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.878 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.75 -19.96 79.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.894 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 9' ' ' HIS . 17.4 tt0 -70.13 -26.31 63.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.225 0.536 . . . . 0.0 110.07 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.48 -11.17 59.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.394 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.0 mt -59.89 -48.97 79.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.931 0.396 . . . . 0.0 111.614 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -67.38 -57.59 10.28 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.41 -25.63 76.27 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 121.918 1.745 . . . . 0.0 112.781 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.419 ' SG ' ' HA3' ' A' ' 25' ' ' GLY . 97.7 m -76.58 -38.51 54.76 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.1 0.476 . . . . 0.0 110.668 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -65.4 -36.8 85.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.169 0.509 . . . . 0.0 110.701 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -76.2 -7.75 55.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.718 0.77 . . . . 0.0 109.541 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.3 5.27 50.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.378 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.99 26.81 54.9 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.731 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.485 ' SD ' ' HB2' ' A' ' 34' ' ' CYS . 37.4 mtt -123.65 175.71 6.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.561 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -88.17 -81.86 0.24 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.59 -174.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.561 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -110.88 -179.41 3.73 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -140.22 114.51 0.98 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.003 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -91.89 155.16 18.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.089 0.471 . . . . 0.0 109.968 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.22 105.68 17.97 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.6 tp -100.59 179.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -172.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' N ' HG21 ' A' ' 28' ' ' ILE . 38.0 m-20 -51.44 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.523 0.729 . . . . 0.0 112.21 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 83.01 -17.51 21.96 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.023 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HD2' ' C ' ' A' ' 30' ' ' GLY . 1.3 mptm? -121.22 -177.17 3.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.297 0.57 . . . . 0.0 111.217 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.469 ' SG ' HD12 ' A' ' 3' ' ' ILE . 37.0 t -111.67 111.67 22.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.818 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -103.38 113.88 27.72 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.454 0.645 . . . . 0.0 110.476 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 24.0 m -93.1 151.66 19.73 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.978 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.8 m -96.43 108.26 41.02 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.36 152.68 15.85 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.04 1.827 . . . . 0.0 111.479 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.133 176.685 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -126.99 160.44 35.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.021 0.439 . . . . 0.0 110.686 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.69 42.75 0.63 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.838 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.7 142.94 40.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 51.3 pttt -91.05 138.31 31.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.6 t -72.28 111.8 7.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.162 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HD2' HE22 ' A' ' 12' ' ' GLN . 96.4 mttt -91.53 -33.87 15.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -150.01 143.68 25.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p -75.71 76.98 2.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.833 0.825 . . . . 0.0 110.901 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.83 -28.16 0.59 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.815 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.526 HE22 ' HD2' ' A' ' 8' ' ' LYS . 13.6 tt0 -62.69 -28.4 69.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.325 0.583 . . . . 0.0 109.76 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 70.3 m -63.78 -9.27 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.934 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.458 HD21 ' H ' ' A' ' 25' ' ' GLY . 3.4 mm? -65.88 -37.04 85.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.864 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 98.6 mttt -60.05 -54.01 59.51 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.117 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 51.5 Cg_endo -74.3 -24.37 14.48 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.41 1.407 . . . . 0.0 112.386 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 20.7 t -73.38 -39.22 65.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.332 -175.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -69.88 -21.51 63.32 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.022 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -88.17 -0.84 57.56 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.637 0.732 . . . . 0.0 109.18 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.23 -16.52 19.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.936 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.0 7.97 60.73 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.994 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.473 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.0 mmt -96.79 178.53 5.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.375 -0.13 . . . . 0.0 110.678 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.462 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 20.8 ttp180 -87.61 -69.14 0.71 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.853 -174.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.465 ' HD1' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -124.68 167.75 14.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.458 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -131.8 107.71 0.75 Allowed Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HZ3' ' HB3' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -90.14 168.2 12.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.167 0.508 . . . . 0.0 110.5 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 t -84.75 122.14 28.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.889 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.52 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.2 tp -118.65 178.68 2.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.52 ' N ' HG21 ' A' ' 28' ' ' ILE . 5.5 m120 -48.85 86.35 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.979 0.799 . . . . 0.0 111.747 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.23 -18.07 4.53 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.436 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 34.1 mmtp -121.55 173.41 7.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.602 0.701 . . . . 0.0 111.838 -170.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 90.2 m -98.06 116.86 31.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.081 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -106.74 122.92 47.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.31 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 58.2 m -90.76 152.32 20.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.44 0.638 . . . . 0.0 112.138 -175.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.465 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 95.9 m -112.64 122.41 36.32 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.556 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.06 169.81 21.34 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.106 1.87 . . . . 0.0 112.058 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.9 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.583 HD12 ' SG ' ' A' ' 32' ' ' CYS . 17.2 pt -115.21 162.44 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.198 0.523 . . . . 0.0 110.662 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -75.31 11.3 1.25 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.059 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.408 HG12 ' HG3' ' A' ' 16' ' ' PRO . 22.1 t -91.6 140.48 16.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -86.5 131.56 34.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.929 0.395 . . . . 0.0 110.11 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 49.5 t -91.04 115.49 28.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.925 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -91.54 -35.95 13.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 171.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -145.1 151.76 39.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.552 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -61.84 -43.16 99.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.804 0.335 . . . . 0.0 111.342 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.34 -24.68 67.72 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.033 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.85 -28.19 50.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.975 0.417 . . . . 0.0 110.206 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.4 ' HB2' ' SG ' ' A' ' 7' ' ' CYS . 43.0 t -73.22 -25.65 60.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.617 0.722 . . . . 0.0 109.401 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.442 HD21 ' H ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -67.93 -29.55 68.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.464 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 47.7 mmtm -66.3 -53.84 28.99 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 86.3 Cg_endo -81.08 -17.64 9.21 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.338 1.359 . . . . 0.0 111.839 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 48.6 t -75.46 -39.33 58.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.294 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HZ2' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.58 -32.19 73.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.801 0.334 . . . . 0.0 110.631 -179.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 19.6 pttp -86.11 -13.99 45.56 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.839 0.828 . . . . 0.0 109.186 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 17' ' ' CYS . . . -74.14 -14.19 60.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.199 174.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.69 9.79 64.0 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.956 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.404 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.5 mmt -94.5 -178.11 4.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.442 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.531 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 6.4 ttp180 -90.19 -73.12 0.53 Allowed 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.87 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.531 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -123.93 172.6 8.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.442 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -136.9 112.92 0.98 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -91.82 155.93 17.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.04 109.64 17.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.157 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.425 HG21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -96.71 165.64 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.425 ' N ' HG21 ' A' ' 28' ' ' ILE . 24.5 m-80 -59.29 83.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.548 0.53 . . . . 0.0 111.394 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.35 -25.67 27.32 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.011 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HB2' HG22 ' A' ' 28' ' ' ILE . 14.3 mmmm -122.57 159.24 28.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.62 0.71 . . . . 0.0 112.326 -169.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.583 ' SG ' HD12 ' A' ' 3' ' ' ILE . 42.0 t -90.24 105.45 17.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.144 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -101.82 125.39 48.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.714 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.5 m -97.51 154.54 17.44 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.418 0.628 . . . . 0.0 112.182 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.445 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 33.9 m -105.4 131.07 22.09 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.772 172.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -81.53 159.65 19.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.201 1.934 . . . . 0.0 111.617 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.191 179.658 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 111.879 -0.489 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 pt -125.44 157.63 34.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.23 0.538 . . . . 0.0 110.705 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -79.55 48.32 0.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.759 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -130.45 139.91 50.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.072 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.78 132.64 34.54 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.35 85.57 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.128 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -92.17 105.63 17.81 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.2 m80 70.12 119.1 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.599 0.562 . . . . 0.0 109.823 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 p -70.79 77.54 0.62 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.785 0.802 . . . . 0.0 110.606 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.37 -23.33 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.625 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.62 -26.39 59.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.854 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 59.6 m -69.66 -11.39 60.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.399 -172.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.3 mt -65.95 -49.2 68.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.637 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 64.1 mttp -54.36 -58.97 11.46 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.472 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 45.6 Cg_endo -69.2 -19.84 38.24 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.565 1.51 . . . . 0.0 112.414 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 34.6 t -74.38 -29.99 61.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -63.36 -37.66 88.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.477 175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -76.71 1.82 16.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.641 0.734 . . . . 0.0 109.89 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.23 -7.7 17.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.104 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.02 22.31 78.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.308 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.634 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 22.4 mmt -98.12 -177.31 3.69 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.445 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 4.8 ttp180 -90.26 -73.25 0.53 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.709 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.532 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.15 174.63 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -127.33 104.27 0.69 Allowed Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 20.5 ptmt -89.03 153.35 21.07 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.955 0.407 . . . . 0.0 109.951 -177.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 t -80.28 118.18 21.71 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.292 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.61 HG21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -106.28 164.34 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 173.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.61 ' N ' HG21 ' A' ' 28' ' ' ILE . 8.0 m120 -57.2 85.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.41 0.624 . . . . 0.0 111.659 -176.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 -23.12 37.48 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.829 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -122.33 151.19 41.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.282 0.541 . . . . 0.0 110.996 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 88.1 m -85.75 113.47 21.95 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 172.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.571 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 27.8 t70 -109.35 123.09 48.75 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.429 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 75.9 m -89.6 154.37 20.03 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.574 0.702 . . . . 0.0 112.226 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 31.3 m -98.18 130.24 28.94 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.884 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 7.2 Cg_exo -69.07 152.75 72.84 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.719 1.613 . . . . 0.0 111.224 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.775 -0.631 . . . . 0.0 110.023 178.08 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.473 0 N-CA-C 113.849 0.299 . . . . 0.0 113.849 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 32' ' ' CYS . 33.2 pt -86.06 175.04 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 109.962 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -86.91 44.07 1.14 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.363 0.601 . . . . 0.0 111.003 -175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -131.58 149.98 33.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.524 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -99.74 138.19 37.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.24 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -70.11 86.38 0.56 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.951 0.405 . . . . 0.0 111.105 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.585 ' HE3' ' OE1' ' A' ' 12' ' ' GLN . 56.6 mtmt -91.83 -41.24 10.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 167.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -148.61 133.87 18.41 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.4 p -66.73 -36.26 82.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.762 0.315 . . . . 0.0 111.034 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.51 -19.24 76.13 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.492 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.585 ' OE1' ' HE3' ' A' ' 8' ' ' LYS . 34.7 tt0 -82.44 -23.19 34.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.897 0.379 . . . . 0.0 110.087 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 75.8 m -69.48 -18.92 63.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.327 0.584 . . . . 0.0 109.57 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.2 tp -75.54 -36.67 60.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.811 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 29.1 mmmt -54.1 -53.7 55.64 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.838 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 54.1 Cg_endo -78.38 -18.93 12.09 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.515 1.477 . . . . 0.0 111.921 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 11.7 t -65.39 -24.96 67.35 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.123 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 8.7 ptpp? -61.06 -30.44 70.33 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.818 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -90.15 -13.13 36.31 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.395 0.617 . . . . 0.0 109.737 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.67 56.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.46 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.09 29.9 66.1 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.145 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.57 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.4 mmt -107.23 -178.47 3.65 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.235 -175.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.443 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 20.9 ttp180 -89.64 -77.9 0.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.216 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -112.72 174.35 5.93 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -135.54 100.19 0.34 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -90.21 163.37 14.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.182 0.515 . . . . 0.0 110.342 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -87.24 122.21 30.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.904 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.47 HG22 ' HB2' ' A' ' 31' ' ' LYS . 1.0 OUTLIER -109.09 173.06 2.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.434 ' N ' HG21 ' A' ' 28' ' ' ILE . 42.3 m-80 -58.57 87.72 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.245 0.545 . . . . 0.0 111.422 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.09 -24.02 30.63 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.712 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HB2' HG22 ' A' ' 28' ' ' ILE . 47.6 mmtm -121.42 170.98 9.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.02 0.438 . . . . 0.0 111.266 -170.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.608 ' O ' HG12 ' A' ' 3' ' ' ILE . 85.7 m -98.19 120.35 38.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 168.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.408 ' HB3' HD13 ' A' ' 28' ' ' ILE . 22.7 t70 -109.42 124.16 50.55 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.843 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 80.8 m -92.46 151.63 20.11 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.158 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.428 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 91.3 m -97.63 118.45 64.16 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.181 175.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.66 144.37 31.47 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.103 1.869 . . . . 0.0 112.487 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp . . . . . 0 C--O 1.248 0.975 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.778 -178.696 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.468 HD12 ' SG ' ' A' ' 13' ' ' CYS . 12.3 pt -114.85 162.39 12.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.944 0.402 . . . . 0.0 110.736 -176.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.84 20.7 0.93 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.586 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.98 133.61 29.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.998 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -74.6 134.94 42.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.938 0.399 . . . . 0.0 110.144 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 t -68.16 101.59 1.19 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.433 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -91.59 -47.67 7.27 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -149.12 132.82 16.88 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.4 p -71.1 114.45 9.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.063 0.459 . . . . 0.0 110.529 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.93 -27.43 9.67 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.531 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -73.37 -22.11 60.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.377 0.608 . . . . 0.0 110.135 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.468 ' SG ' HD12 ' A' ' 3' ' ' ILE . 22.6 t -80.78 8.41 8.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.731 -175.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.487 HD21 ' H ' ' A' ' 25' ' ' GLY . 2.4 mm? -70.01 -28.28 65.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.155 0.502 . . . . 0.0 110.748 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 34.8 mmtp -67.78 -57.13 10.33 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.402 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 57.7 Cg_endo -71.09 -18.46 30.86 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.58 1.52 . . . . 0.0 112.795 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 36.1 t -79.79 -36.23 37.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.35 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -68.91 -25.14 64.44 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.306 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HZ3' ' HB3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -82.92 -17.8 42.39 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.974 0.893 . . . . 0.0 109.115 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.08 -8.6 58.43 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.109 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.94 5.06 81.45 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.084 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.508 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 23.0 mmt -94.95 177.45 5.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.641 0.257 . . . . 0.0 110.88 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.506 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 2.8 ttp180 -88.41 -73.41 0.5 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.292 -173.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -121.99 154.19 37.56 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.487 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -106.19 110.3 3.33 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.624 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -90.66 154.9 19.23 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.85 120.22 30.9 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.059 0.457 . . . . 0.0 110.818 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.2 tp -109.46 168.54 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.405 ' N ' HG21 ' A' ' 28' ' ' ILE . 1.3 t30 -44.23 98.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.832 0.825 . . . . 0.0 110.776 173.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.41 -27.11 2.15 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 114.797 -1.092 . . . . 0.0 114.031 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -120.85 -177.32 3.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.731 0.766 . . . . 0.0 111.038 -168.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.6 t -114.2 114.81 26.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.185 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.41 ' HB3' HD13 ' A' ' 28' ' ' ILE . 23.9 t70 -103.38 115.57 30.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.356 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -88.53 155.86 19.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.849 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 62.7 m -97.67 132.52 24.92 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.93 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -70.25 170.62 16.74 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.787 1.658 . . . . 0.0 112.378 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.582 176.452 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 5' ' ' VAL . 10.5 pt -116.39 163.26 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.77 33.54 0.14 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.281 0.562 . . . . 0.0 111.887 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.417 ' H ' ' C ' ' A' ' 3' ' ' ILE . 21.9 t -115.63 151.76 17.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.682 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 35.3 mtmm -109.52 145.23 36.63 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 t -69.17 95.13 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.697 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -92.43 -42.92 9.48 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 167.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -148.29 126.02 11.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.446 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 p -66.99 -21.87 65.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.081 0.467 . . . . 0.0 111.048 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.86 -35.67 44.4 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.413 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -71.0 -30.06 66.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.077 0.465 . . . . 0.0 110.213 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.9 t -62.04 -19.29 62.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.992 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.479 HD11 ' H ' ' A' ' 25' ' ' GLY . 6.8 mp -72.15 -31.94 66.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.343 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.498 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 29.6 mtpp -58.91 -56.58 34.62 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.078 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 72.8 Cg_endo -76.71 -17.17 16.12 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.336 1.358 . . . . 0.0 112.21 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 35.3 t -80.36 -34.74 36.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.279 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 64.8 pttt -67.83 -24.78 65.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.159 0.504 . . . . 0.0 109.921 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -83.11 -9.6 59.12 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.575 0.702 . . . . 0.0 109.35 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.44 -15.16 31.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.989 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.73 13.16 63.22 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.009 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.493 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.2 mmt -94.91 -178.13 4.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.606 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 7.1 ttp180 -90.26 -65.7 0.99 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.72 -176.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.606 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -129.59 166.91 18.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 109.966 175.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.479 ' H ' HD11 ' A' ' 14' ' ' LEU . . . -113.59 109.62 2.3 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -91.08 152.1 20.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.051 0.453 . . . . 0.0 110.162 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.7 m -82.94 114.72 21.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.724 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.577 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -107.21 176.18 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.766 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.577 ' N ' HG21 ' A' ' 28' ' ' ILE . 4.8 p30 -44.75 85.08 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.739 0.78 . . . . 0.0 112.684 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 82.38 -21.33 7.35 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.169 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 99.1 mttt -120.19 172.52 7.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.427 0.632 . . . . 0.0 112.359 -168.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.73 103.18 14.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.581 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -105.15 117.42 33.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.134 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.41 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.3 m -83.52 154.58 23.79 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.698 0.761 . . . . 0.0 112.617 -174.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.435 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 89.2 m -101.71 116.82 62.91 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.843 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 63.7 Cg_endo -69.67 152.71 69.82 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.332 2.021 . . . . 0.0 112.62 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.069 176.479 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.466 ' HA2' ' H ' ' A' ' 34' ' ' CYS . . . . . . . . 0 N--CA 1.446 -0.699 0 N-CA-C 112.338 -0.305 . . . . 0.0 112.338 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 32' ' ' CYS . 12.7 pt -128.8 157.7 41.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.961 0.41 . . . . 0.0 110.184 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.38 11.11 0.65 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.264 -177.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 3' ' ' ILE . 48.3 t -84.78 135.85 23.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -86.97 133.71 33.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.2 t -72.12 104.31 3.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.427 ' HZ3' ' HB3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -90.03 -39.15 13.12 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 172.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -148.29 138.54 22.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.916 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 p -62.95 -27.24 69.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.066 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.41 -32.66 41.87 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.816 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -69.2 -15.95 63.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.389 0.275 . . . . 0.0 111.594 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 77.5 m -77.39 -16.79 58.67 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -176.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.425 ' N ' HD13 ' A' ' 14' ' ' LEU . 11.1 mp -75.85 -37.48 58.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.766 0.317 . . . . 0.0 111.594 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -53.02 -55.37 34.27 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.687 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 73.9 Cg_endo -77.66 -16.61 14.72 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.439 1.426 . . . . 0.0 112.197 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 38.5 t -75.4 -37.4 60.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.322 -175.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.457 ' HZ1' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.76 -18.15 64.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.127 0.489 . . . . 0.0 110.13 178.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 16' ' ' PRO . 8.0 mtmp? -85.86 -14.29 45.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.634 0.731 . . . . 0.0 109.196 177.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.79 -7.62 57.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.336 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.58 16.86 69.79 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.028 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.53 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 25.2 mmt -97.85 179.64 4.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.659 0.266 . . . . 0.0 110.47 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.458 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 4.5 ttp180 -90.74 -69.83 0.71 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.535 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.63 169.5 11.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -125.29 109.4 1.19 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 19.4 ptmt -90.25 156.78 18.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.5 t -83.66 114.61 21.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.074 0.464 . . . . 0.0 110.242 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.49 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -103.33 170.71 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.396 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.49 ' N ' HG21 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -38.41 -43.94 0.87 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -167.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.17 -0.48 1.65 Allowed Glycine 0 C--N 1.318 -0.419 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.596 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.484 ' H ' HG22 ' A' ' 28' ' ' ILE . 96.2 mttt -123.79 166.91 14.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.762 -172.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.43 ' O ' HG12 ' A' ' 3' ' ' ILE . 98.3 m -90.97 100.71 13.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 169.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.617 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 18.5 t70 -95.06 118.9 32.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.694 -177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 69.6 m -88.5 153.41 21.17 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.638 0.732 . . . . 0.0 112.611 -172.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.424 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 52.6 m -109.34 118.4 50.94 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.946 171.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 18.0 Cg_exo -69.35 -177.74 1.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.884 2.389 . . . . 0.0 112.317 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.245 0.839 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.205 177.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.87 153.03 18.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 117.217 0.509 . . . . 0.0 110.55 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . 0.53 ' C ' HD21 ' A' ' 4' ' ' ASN . 0.1 OUTLIER -77.39 71.0 3.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.421 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 17.0 t -146.38 136.09 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -88.47 134.41 33.86 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.3 t -73.08 91.03 1.57 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.131 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -82.68 -34.02 27.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -147.5 148.59 31.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.983 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 p -67.17 -34.4 77.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.183 0.516 . . . . 0.0 110.129 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.94 -12.63 81.14 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.623 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -84.1 -15.74 46.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.63 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 62.7 m -90.54 -17.33 27.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.022 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.557 HD21 ' H ' ' A' ' 25' ' ' GLY . 87.9 mt -74.18 -51.51 15.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.178 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 58.5 mttp -52.52 -53.51 52.78 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.847 -175.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 49.1 Cg_endo -73.39 -15.9 24.84 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.525 1.483 . . . . 0.0 112.88 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 14.4 t -78.69 -36.35 43.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.946 0.403 . . . . 0.0 111.234 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -69.79 -21.52 63.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.24 0.543 . . . . 0.0 109.932 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -83.84 -11.93 56.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.712 0.768 . . . . 0.0 109.044 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.87 -14.59 27.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.068 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.07 17.74 64.44 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.063 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.563 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 23.8 mmt -96.64 170.72 9.01 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.985 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 4.7 ttp180 -76.2 -68.46 0.58 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.602 -173.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.525 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -128.18 154.07 46.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 174.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.557 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -109.95 97.25 1.0 Allowed Glycine 0 C--N 1.309 -0.927 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -90.33 160.59 16.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.147 0.498 . . . . 0.0 110.694 -175.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.3 t -83.85 118.28 23.86 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.031 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.501 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.6 tp -110.46 -178.02 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.501 ' N ' HG21 ' A' ' 28' ' ' ILE . 43.9 m-80 -48.93 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.143 0.497 . . . . 0.0 111.901 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.04 -10.95 2.88 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.77 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.4 ' O ' HG22 ' A' ' 28' ' ' ILE . 30.4 ttpt -123.18 161.96 23.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.192 0.496 . . . . 0.0 111.584 -168.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 68.1 m -91.57 102.15 14.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.44 0.638 . . . . 0.0 110.45 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -99.81 127.29 45.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.505 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.0 m -96.88 149.34 21.98 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.448 0.642 . . . . 0.0 111.653 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.449 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 57.2 m -102.28 116.96 62.21 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.521 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.62 167.14 27.3 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.346 2.031 . . . . 0.0 111.43 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.4 mttp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.096 178.42 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.416 HD13 ' SG ' ' A' ' 34' ' ' CYS . 18.0 pt -118.51 164.08 15.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.172 0.51 . . . . 0.0 110.627 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -74.47 13.3 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.847 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 3' ' ' ILE . 30.4 t -95.05 133.86 34.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.559 -176.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.29 149.38 26.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 t -73.2 81.22 1.31 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.055 0.455 . . . . 0.0 110.211 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.43 -40.38 26.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.321 0.581 . . . . 0.0 110.11 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.662 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 6.9 p-80 -169.61 123.85 0.79 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.251 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.2 p -63.27 99.87 0.21 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.692 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.23 -30.01 1.34 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.662 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 24.8 tt0 -60.84 -34.5 74.67 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.943 0.402 . . . . 0.0 111.702 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 97.4 m -69.59 -9.5 54.32 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -168.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.51 -38.99 75.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.037 0.446 . . . . 0.0 110.667 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 75.0 mmtt -70.22 -56.25 7.17 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.207 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 50.8 Cg_endo -71.02 -29.28 18.11 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.585 1.523 . . . . 0.0 113.414 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 43.2 t -75.09 -36.12 61.74 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.319 -0.238 . . . . 0.0 111.546 -174.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -63.98 -23.17 67.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 109.903 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -83.09 -14.52 53.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.344 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.85 -12.34 48.16 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.844 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.73 19.55 53.7 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.474 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.624 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 43.8 mtt -116.17 173.63 6.48 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.3 ttp180 -84.28 -76.06 0.32 Allowed 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.538 -170.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -123.12 178.21 5.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -133.33 115.12 1.48 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 12.6 ptmm? -91.22 166.88 12.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.975 0.417 . . . . 0.0 110.047 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.55 135.4 35.58 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.448 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.3 tp -123.26 173.23 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.448 ' N ' HG21 ' A' ' 28' ' ' ILE . 10.0 p30 -36.91 -44.58 0.51 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -166.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.19 -6.31 1.23 Allowed Glycine 0 C--N 1.317 -0.509 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.824 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -122.37 -165.86 1.34 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.947 0.403 . . . . 0.0 110.386 -168.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.3 t -118.27 125.92 51.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.953 175.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 22.0 t70 -111.51 123.98 51.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.197 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.51 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 21.7 m -87.66 155.88 19.73 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.642 0.734 . . . . 0.0 112.717 -173.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.443 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 89.4 m -107.27 128.69 25.52 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.712 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.33 -176.07 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.234 1.956 . . . . 0.0 112.03 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.4 pttm . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.834 -179.26 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . 0.531 ' HA2' ' H ' ' A' ' 34' ' ' CYS . . . . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 5' ' ' VAL . 7.4 pt -128.04 163.07 32.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.817 0.341 . . . . 0.0 110.277 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -70.24 4.18 2.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.105 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 14.1 t -84.93 138.18 19.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.17 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -90.18 139.26 30.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.27 104.83 4.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.576 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.417 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 62.8 mttp -91.73 -43.83 9.34 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 167.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -144.51 152.79 41.09 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.45 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 3.2 p -60.99 -50.73 72.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.996 0.362 . . . . 0.0 111.817 -175.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.47 -13.72 65.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.476 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.417 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 23.5 tt0 -70.69 -31.01 67.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.353 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 81.9 m -78.81 -21.31 47.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.604 -175.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.569 HD21 ' H ' ' A' ' 25' ' ' GLY . 1.3 mm? -64.94 -35.37 80.96 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.98 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 60.8 mtpt -60.21 -60.76 9.58 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.345 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.42 ' CD ' ' HB2' ' A' ' 15' ' ' LYS . 50.9 Cg_endo -71.44 -16.99 30.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.075 1.85 . . . . 0.0 112.678 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 15.4 t -70.75 -34.08 71.47 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.374 -174.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 23.5 pttm -63.82 -25.95 68.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.398 . . . . 0.0 110.48 176.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -88.69 -14.34 37.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.338 0.59 . . . . 0.0 109.543 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.21 45.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.2 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.91 15.46 48.84 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.66 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.503 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.3 mmt -99.67 -179.39 4.17 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.623 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.475 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 5.8 ttp180 -90.26 -65.78 0.99 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.496 -175.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.475 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.27 162.4 23.8 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 174.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.569 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -126.71 94.95 0.43 Allowed Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -90.87 159.35 16.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.366 0.603 . . . . 0.0 110.99 -174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -83.64 113.73 21.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.423 -177.193 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.611 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -106.36 169.94 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.611 ' N ' HG21 ' A' ' 28' ' ' ILE . 4.7 p30 -43.3 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.934 0.873 . . . . 0.0 113.173 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 80.06 -14.32 21.44 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.566 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HZ1' ' HB2' ' A' ' 31' ' ' LYS . 4.4 ttmp? -121.64 144.94 48.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.517 0.659 . . . . 0.0 111.541 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 62.2 m -79.42 99.34 7.14 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.367 173.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.413 ' HB3' HD13 ' A' ' 28' ' ' ILE . 24.7 t70 -99.49 118.19 35.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.4 0.619 . . . . 0.0 110.75 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.531 ' H ' ' HA2' ' A' ' 2' ' ' GLY . 62.1 m -93.08 149.93 20.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.684 -176.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.446 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 98.7 m -111.56 126.14 29.11 Favored Pre-proline 0 N--CA 1.439 -0.985 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.225 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.71 -168.03 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.398 2.065 . . . . 0.0 112.26 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.7 mttp . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.627 -0.702 . . . . 0.0 109.898 179.75 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -105.24 -179.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.055 0.455 . . . . 0.0 110.836 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -83.56 42.68 0.85 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.624 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.64 152.38 36.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.248 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -95.65 147.54 23.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.79 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 41.8 t -78.3 57.23 1.85 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.854 -174.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -93.4 104.88 17.0 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.7 m80 67.9 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.762 0.664 . . . . 0.0 110.73 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 p -60.74 -28.16 68.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.07 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.4 -20.52 76.96 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.523 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -76.98 -33.12 57.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.573 0.225 . . . . 0.0 110.831 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 74.7 m -65.78 -18.22 65.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.579 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.465 HD21 ' H ' ' A' ' 25' ' ' GLY . 1.1 mm? -64.84 -36.41 84.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.682 0.277 . . . . 0.0 111.245 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 4.8 mptp? -65.76 -56.71 16.63 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.08 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.01 -19.07 30.62 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.329 1.353 . . . . 0.0 112.701 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.5 m -76.38 -38.66 55.41 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.45 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 49.0 pttt -69.5 -26.75 64.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 95.3 mttt -75.67 -23.42 56.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.7 58.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.358 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.56 11.81 76.7 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.305 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.69 ' SD ' ' HA ' ' A' ' 36' ' ' PRO . 23.5 mmt -95.65 175.67 6.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.389 0.137 . . . . 0.0 111.117 -177.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 14.9 ttp180 -80.7 -71.49 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.24 -173.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -119.67 -176.88 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.169 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.465 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -136.17 102.81 0.42 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.388 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -85.26 156.31 21.0 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -96.16 109.71 22.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.2 tp -104.3 177.98 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.665 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -53.2 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.001 0.52 . . . . 0.0 111.63 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.91 -18.06 28.56 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.162 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 66.3 mttm -122.94 179.47 4.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.09 0.445 . . . . 0.0 110.564 -172.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.3 m -107.0 120.27 41.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -103.31 107.87 18.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.687 0.756 . . . . 0.0 110.381 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.9 m -81.09 142.07 33.68 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.357 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 m -88.98 121.05 69.99 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.69 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 17.7 Cg_endo -75.04 120.56 6.1 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.998 1.799 . . . . 0.0 112.38 -175.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.594 ' OXT' ' HD2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.814 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-O 120.939 0.188 . . . . 0.0 113.434 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.495 HD13 ' SG ' ' A' ' 34' ' ' CYS . 33.9 pt -120.17 167.62 13.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.53 67.56 7.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.955 0.407 . . . . 0.0 109.92 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -148.36 135.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -86.9 138.47 31.52 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 t -67.69 101.96 1.12 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.343 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.66 -50.74 5.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -149.65 135.16 18.4 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.5 p -62.17 -33.62 74.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.35 -31.58 61.01 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.967 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -76.72 -20.31 56.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HB3' ' HA3' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -69.0 -13.58 62.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.413 -177.125 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.402 ' N ' HD13 ' A' ' 14' ' ' LEU . 11.0 mp -67.79 -35.43 78.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.947 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 97.7 mttt -57.07 -54.16 57.58 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.526 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 46.7 Cg_endo -74.49 -25.43 13.0 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.034 1.156 . . . . 0.0 112.844 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 m -76.23 -31.56 58.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 19.6 ptpt -68.41 -25.42 65.03 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -85.91 -11.09 54.08 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.269 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.2 -1.41 56.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.088 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.17 74.35 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.197 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.441 ' SD ' ' HA ' ' A' ' 36' ' ' PRO . 25.3 mmt -110.05 178.32 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.858 -0.201 . . . . 0.0 110.946 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.478 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 19.8 ttp180 -81.87 -70.04 0.57 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.169 -173.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.99 -177.23 3.78 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 13' ' ' CYS . . . -126.72 107.91 0.95 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.872 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -91.9 157.05 17.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 m -90.05 129.69 36.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.216 0.532 . . . . 0.0 110.655 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.443 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.3 tp -119.42 -179.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.113 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.443 ' N ' HG21 ' A' ' 28' ' ' ILE . 38.9 m-20 -47.68 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.396 0.678 . . . . 0.0 112.133 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.49 -15.36 4.64 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.183 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -120.76 -173.66 2.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.231 0.515 . . . . 0.0 110.825 -172.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.3 t -115.49 121.34 42.4 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.8 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -112.24 115.91 29.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.4 0.619 . . . . 0.0 110.338 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.495 ' SG ' HD13 ' A' ' 3' ' ' ILE . 36.5 m -79.85 143.87 33.96 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.633 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.9 m -82.52 120.02 75.88 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.441 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 30.1 Cg_endo -79.73 131.75 9.4 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.122 1.881 . . . . 0.0 111.872 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.6 pttt . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.515 -178.919 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -130.7 171.54 17.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.471 0.653 . . . . 0.0 111.936 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.23 37.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.605 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.53 144.89 22.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.345 -177.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -91.24 141.58 28.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.046 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.9 t -72.26 94.1 1.54 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.33 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.14 -47.65 7.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.532 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 7.1 p-80 -166.17 147.33 6.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.636 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.7 p -51.01 -46.58 61.58 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -171.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.95 -19.66 56.69 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.447 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.532 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 26.1 tt0 -74.68 -43.87 53.05 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 66.4 m -68.93 -15.48 63.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.38 -173.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.54 HD21 ' H ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -62.45 -41.0 98.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.001 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.34 -54.97 13.29 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.12 -18.4 30.8 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.327 1.351 . . . . 0.0 112.815 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 m -80.26 -39.62 28.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.585 0.231 . . . . 0.0 111.329 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -72.15 -23.0 61.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.084 0.468 . . . . 0.0 110.039 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -89.22 -5.94 57.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.59 0.709 . . . . 0.0 109.421 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.2 -5.81 51.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.267 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.73 14.87 62.45 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.847 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.7 mmt -104.84 179.6 4.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 2.6 ttp180 -82.59 -74.6 0.34 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.994 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -122.63 -179.94 4.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.54 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -131.47 111.03 1.03 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.963 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -91.1 153.67 19.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.898 0.38 . . . . 0.0 110.014 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -91.26 111.63 23.2 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 29' ' ' ASN . 2.4 tp -115.57 -179.12 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.027 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.427 ' N ' HG21 ' A' ' 28' ' ' ILE . 21.6 m-80 -44.37 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.87 0.868 . . . . 0.0 112.621 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.94 -8.23 3.68 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.392 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HG2' ' N ' ' A' ' 32' ' ' CYS . 36.9 ttmt -122.9 167.4 13.6 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 122.559 -0.377 . . . . 0.0 110.001 -173.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.478 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 91.1 m -100.66 112.63 25.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.023 0.439 . . . . 0.0 109.895 169.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -96.43 109.11 21.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.62 0.724 . . . . 0.0 110.065 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 32.1 m -80.54 143.22 33.42 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.539 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.6 m -88.16 132.41 39.71 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -69.18 166.48 26.74 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.474 1.449 . . . . 0.0 110.828 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.489 -177.578 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -104.26 174.35 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.139 0.495 . . . . 0.0 110.606 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -76.23 7.91 3.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.302 -172.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.0 139.52 19.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.841 -173.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -83.32 142.98 30.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.517 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 5.7 t -79.18 101.55 8.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.777 -176.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -91.94 -57.07 2.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 168.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -147.01 156.45 43.05 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -62.46 -38.09 88.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.829 0.347 . . . . 0.0 110.752 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.79 -27.41 64.17 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.604 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -73.16 -44.97 59.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 0.0 110.243 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.96 -16.3 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.41 -172.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.56 HD21 ' H ' ' A' ' 25' ' ' GLY . 82.5 mt -56.94 -49.74 74.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.424 0.631 . . . . 0.0 111.3 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.552 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 22.3 ttmm -60.17 -54.8 51.68 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.317 -172.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 52.1 Cg_endo -73.96 -20.79 19.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.148 1.232 . . . . 0.0 113.077 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 m -77.6 -34.35 53.47 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 64.2 pttt -68.6 -25.59 64.95 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -86.05 -6.34 59.05 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.498 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.0 4.86 50.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.322 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.96 22.67 71.05 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.105 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.556 ' SD ' ' HB2' ' A' ' 34' ' ' CYS . 46.1 mtt -116.61 175.82 5.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.169 -176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.542 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 8.1 ttp180 -75.41 -72.36 0.31 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.139 0.274 . . . . 0.0 111.653 -170.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.542 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.3 -176.61 3.63 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.09 0.471 . . . . 0.0 110.137 177.125 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.56 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -123.58 115.58 2.66 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.708 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.514 ' HZ2' ' HB2' ' A' ' 26' ' ' LYS . 4.1 ttmp? -90.95 156.85 17.66 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.76 109.9 22.03 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.905 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -95.01 164.33 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.166 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.462 ' N ' HG21 ' A' ' 28' ' ' ILE . 8.1 p30 -39.06 -36.96 0.34 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.25 -14.79 1.05 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.025 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 28' ' ' ILE . 68.2 mttm -123.81 167.31 14.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.781 0.324 . . . . 0.0 111.277 -169.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.6 m -91.16 111.91 23.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.429 0.633 . . . . 0.0 110.525 173.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -85.53 158.52 20.13 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.556 ' HB2' ' SD ' ' A' ' 22' ' ' MET . 16.5 m -131.98 137.52 47.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.412 ' HB ' ' CD1' ' A' ' 24' ' ' PHE . 28.8 m -88.0 123.01 69.68 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.37 176.58 9.06 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.714 1.609 . . . . 0.0 111.498 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.004 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.019 0.233 . . . . 0.0 113.575 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.424 HD12 ' SG ' ' A' ' 32' ' ' CYS . 21.3 pt -110.02 171.61 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -81.28 45.18 0.83 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.986 0.422 . . . . 0.0 111.729 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.95 144.29 36.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.992 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -92.97 146.55 23.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.678 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 46.0 t -77.02 78.29 3.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.14 0.495 . . . . 0.0 111.276 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 52.7 mtpt -91.35 -50.21 5.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -143.9 136.6 27.15 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.0 p -66.69 -34.96 79.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.353 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.78 -18.2 79.48 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.586 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.441 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 61.1 tt0 -82.78 -31.14 28.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -19.64 65.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.474 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.528 HD21 ' H ' ' A' ' 25' ' ' GLY . 81.2 mt -61.14 -48.68 80.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.437 0.637 . . . . 0.0 110.737 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 56.3 mtpt -53.18 -56.71 21.29 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.322 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 57.9 Cg_endo -72.32 -28.93 14.58 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.304 1.336 . . . . 0.0 112.867 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.0 m -72.06 -36.87 69.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 65.1 pttt -67.45 -26.06 66.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.029 0.443 . . . . 0.0 109.867 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -79.88 -18.52 50.48 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.495 0.664 . . . . 0.0 109.327 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.06 9.16 23.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.068 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.94 19.25 80.03 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.008 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.1 mmt -97.89 175.34 6.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.75 0.309 . . . . 0.0 111.47 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.533 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 3.5 ttp180 -81.82 -66.06 0.94 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.164 -176.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -131.01 -177.51 4.41 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.528 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -125.14 116.65 2.76 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -91.91 146.46 23.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.249 0.547 . . . . 0.0 110.174 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.73 111.9 23.68 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.407 HG21 ' N ' ' A' ' 29' ' ' ASN . 2.2 tp -108.55 178.71 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.089 -171.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.407 ' N ' HG21 ' A' ' 28' ' ' ILE . 30.7 m-80 -49.63 87.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.065 0.546 . . . . 0.0 111.891 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.18 -15.93 8.1 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.254 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 74.9 mmtt -121.92 174.07 7.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.059 0.43 . . . . 0.0 110.988 -171.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . 0.424 ' SG ' HD12 ' A' ' 3' ' ' ILE . 14.2 t -111.35 112.09 23.6 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -115.7 118.98 34.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.413 0.625 . . . . 0.0 109.845 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 27.8 m -79.44 165.84 22.63 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.168 -172.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.437 ' HB ' ' CD1' ' A' ' 24' ' ' PHE . 10.6 m -105.37 109.5 63.28 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.5 153.21 78.83 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.6 1.533 . . . . 0.0 111.137 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.902 177.205 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 16' ' ' PRO . 16.3 pt -122.89 176.07 5.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.145 0.497 . . . . 0.0 111.235 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -87.46 35.12 0.71 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.812 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.04 132.88 62.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-O 120.872 0.367 . . . . 0.0 110.279 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -80.69 126.81 31.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.994 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 t -67.35 93.8 0.35 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.272 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.29 -41.25 11.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.155 0.503 . . . . 0.0 110.371 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -144.12 135.86 26.06 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -174.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . 37.2 p -70.81 94.22 1.03 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.626 0.727 . . . . 0.0 110.282 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.64 -25.76 2.27 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -67.24 -25.44 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.299 0.571 . . . . 0.0 110.118 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.6 m -84.02 -9.26 58.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.453 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.582 HD21 ' H ' ' A' ' 25' ' ' GLY . 94.4 mt -61.47 -54.16 46.96 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 111.362 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 55.8 mtmt -59.57 -53.98 60.42 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.755 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.455 ' HB2' HD11 ' A' ' 3' ' ' ILE . 20.1 Cg_endo -63.88 -24.45 67.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.214 1.276 . . . . 0.0 112.755 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -78.94 -37.92 38.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 13.8 ptmm? -71.11 -26.13 62.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.093 0.473 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 9.0 mtmp? -85.36 -5.2 59.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.703 0.763 . . . . 0.0 109.15 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.31 0.55 57.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.083 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.424 ' O ' ' HE2' ' A' ' 37' ' ' LYS . . . 80.65 19.13 68.96 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.014 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mmt -102.74 -175.8 2.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.46 0.171 . . . . 0.0 110.66 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.53 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 16.1 ttp180 -84.93 -71.23 0.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.678 0.275 . . . . 0.0 110.588 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.53 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -128.07 -179.37 4.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.582 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -131.49 104.54 0.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.605 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -91.35 158.81 16.33 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -92.15 114.75 27.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.037 0.446 . . . . 0.0 110.146 178.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.435 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.0 OUTLIER -99.81 162.86 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.426 ' N ' HG21 ' A' ' 28' ' ' ILE . 32.4 m-80 -58.33 87.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.397 0.618 . . . . 0.0 111.07 -177.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.48 -31.85 8.17 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.02 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HB2' HG22 ' A' ' 28' ' ' ILE . 49.8 mtmt -121.8 147.6 45.74 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.362 -0.493 . . . . 0.0 111.882 -168.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.0 m -80.13 102.98 9.7 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 168.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.435 ' HB3' HD13 ' A' ' 28' ' ' ILE . 34.1 t70 -102.83 129.86 49.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.647 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.7 m -98.62 145.03 27.27 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.095 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 m -85.74 125.68 68.29 Favored Pre-proline 0 N--CA 1.446 -0.641 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -71.89 141.64 37.4 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.815 1.677 . . . . 0.0 111.264 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.424 ' HE2' ' O ' ' A' ' 21' ' ' GLY . 52.5 pttt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.496 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 77.6 t . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.567 0.222 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.35 124.39 0.26 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.023 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.407 HD13 HG21 ' A' ' 3' ' ' ILE . 19.2 pt -125.05 160.85 29.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -80.49 63.64 5.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.668 0.747 . . . . 0.0 109.965 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.548 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 22.0 t -140.08 160.81 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.671 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.49 ' N ' HG13 ' A' ' 5' ' ' VAL . 98.4 mttt -113.43 128.73 56.55 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.943 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.8 t -66.2 97.0 0.36 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.063 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.414 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 75.3 mmtt -90.39 -34.4 15.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 171.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -148.89 134.55 18.75 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.467 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 25.6 p -72.71 86.97 1.24 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.789 0.804 . . . . 0.0 110.692 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.1 -25.43 1.43 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.211 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.414 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 34.2 tt0 -67.62 -29.91 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.16 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.588 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 60.8 m -63.37 -12.74 32.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.414 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.49 HD21 ' H ' ' A' ' 25' ' ' GLY . 3.9 mm? -67.17 -37.51 83.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.931 0.396 . . . . 0.0 110.938 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 95.5 mttt -59.8 -51.67 79.21 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.004 -175.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.461 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 73.9 Cg_endo -78.62 -14.6 14.15 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.539 1.492 . . . . 0.0 112.494 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.588 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 11.0 t -75.44 -33.41 60.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.033 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.471 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 6.5 ptpp? -66.61 -20.67 66.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.947 0.403 . . . . 0.0 109.971 175.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -84.4 -19.64 33.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.04 -27.06 33.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.966 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.06 17.06 48.81 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.963 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.482 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 25.4 mmt -98.66 177.21 5.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.393 0.14 . . . . 0.0 111.119 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.499 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 6.3 ttp180 -78.21 -71.55 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.991 -173.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.499 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.62 173.52 8.46 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 175.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -133.12 103.26 0.5 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -90.81 164.06 14.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.115 0.483 . . . . 0.0 110.419 -177.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.467 ' SG ' ' HA ' ' A' ' 10' ' ' SER . 1.5 m -85.67 129.06 34.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.36 0.6 . . . . 0.0 111.184 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.542 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -118.15 179.0 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.589 177.838 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.542 ' N ' HG21 ' A' ' 28' ' ' ILE . 6.6 p30 -45.46 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.014 0.911 . . . . 0.0 112.844 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.46 -11.25 5.55 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.406 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.436 ' HB2' HG22 ' A' ' 28' ' ' ILE . 97.4 mttt -121.24 177.49 5.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.307 0.554 . . . . 0.0 111.328 -172.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.548 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 62.9 m -107.31 119.04 38.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.28 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -113.0 127.91 56.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.786 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 63.7 m -91.76 155.35 18.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.327 0.584 . . . . 0.0 111.733 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.46 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 58.0 m -105.05 124.74 35.63 Favored Pre-proline 0 N--CA 1.44 -0.95 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.011 173.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.28 176.97 8.22 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.035 1.823 . . . . 0.0 111.328 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 pttm . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.599 176.579 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.602 0.239 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 127.04 147.76 6.79 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 3' ' ' ILE . 15.3 pt -111.91 153.77 13.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.107 0.479 . . . . 0.0 110.637 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.27 64.64 4.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.303 -177.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.502 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 46.1 t -130.94 138.02 54.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.578 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 9.9 mtmp? -77.46 111.55 13.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 26.1 t -73.64 106.3 5.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.473 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -88.76 -34.46 17.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -149.89 146.72 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.584 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.1 p -62.47 -39.37 93.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.96 0.409 . . . . 0.0 110.391 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.37 -23.92 68.75 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.397 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -70.53 -40.26 73.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 0.0 109.836 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 81.8 m -69.56 -16.81 63.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.89 -174.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -66.35 -34.1 77.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.032 0.444 . . . . 0.0 110.826 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.5 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 92.8 mttt -61.3 -53.16 65.3 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.791 -174.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.5 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 72.5 Cg_endo -79.2 -17.14 11.91 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.62 1.547 . . . . 0.0 112.39 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.8 t -71.57 -29.97 65.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.278 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.494 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 23.1 pttm -65.4 -23.95 67.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 110.532 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -90.1 -13.09 36.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.535 0.684 . . . . 0.0 109.731 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.41 -10.55 56.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.063 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.08 23.79 73.38 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.998 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.573 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.3 mmt -104.71 177.87 4.72 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.247 -177.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 3.2 ttp180 -84.21 -72.74 0.45 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.077 -174.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.86 -179.16 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -129.58 110.98 1.12 Allowed Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.491 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -90.21 154.72 19.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.8 t -95.89 105.18 17.17 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.282 0.563 . . . . 0.0 111.037 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.531 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.4 mp -102.17 153.78 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' N ' HG21 ' A' ' 28' ' ' ILE . 81.6 m-20 -46.24 90.75 0.0 OUTLIER 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.891 0.744 . . . . 0.0 112.467 -176.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.582 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 86.16 -9.66 68.95 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.373 -0.831 . . . . 0.0 113.458 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.476 ' HB2' HG22 ' A' ' 28' ' ' ILE . 29.8 mtpp -121.02 135.42 55.21 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 117.726 0.763 . . . . 0.0 111.72 -175.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.502 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 29.7 m -79.33 90.75 4.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.559 172.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.531 ' HB3' HD13 ' A' ' 28' ' ' ILE . 24.9 t70 -90.45 107.35 19.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.697 0.76 . . . . 0.0 110.901 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 56.6 m -81.47 149.98 28.51 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.532 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 26.3 m -92.07 128.63 44.67 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.141 174.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 5.1 Cg_exo -75.48 -173.04 1.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.817 1.678 . . . . 0.0 112.063 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.915 -177.631 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.6 m . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.66 0.267 . . . . 0.0 110.687 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.93 160.42 8.53 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.622 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.9 pt -126.27 153.21 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.034 0.445 . . . . 0.0 110.851 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -80.73 42.05 0.6 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.615 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.7 t -110.59 146.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.072 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -81.66 138.92 35.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.234 0.54 . . . . 0.0 111.578 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 16.1 t -73.09 79.02 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.957 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -91.29 -47.92 7.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 172.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -150.74 142.8 24.03 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -66.21 -37.44 85.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.76 0.314 . . . . 0.0 110.985 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.1 -17.54 75.78 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.717 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.86 -41.09 26.99 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 75.2 m -62.83 -24.53 67.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.674 -176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.29 -35.66 80.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 0.0 111.565 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 61.8 mttp -64.51 -50.85 63.62 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -172.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 73.8 Cg_endo -78.53 -17.21 12.91 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.396 1.398 . . . . 0.0 112.355 176.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 39.6 t -73.58 -38.21 65.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.147 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 54.6 pttt -65.66 -21.85 66.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.312 0.577 . . . . 0.0 110.317 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -82.55 -16.74 47.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.672 0.748 . . . . 0.0 109.177 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.33 -11.11 53.02 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.18 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.542 ' O ' ' HE3' ' A' ' 37' ' ' LYS . . . 83.05 22.96 56.58 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.805 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.481 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.4 mmt -103.02 177.33 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.507 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.4 ttp180 -89.49 -68.23 0.79 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.02 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.507 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.35 172.91 9.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.341 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -139.85 107.22 0.53 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -86.89 154.35 20.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.191 0.52 . . . . 0.0 110.144 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.15 106.88 15.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.28 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.3 tp -106.87 177.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.04 -172.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -47.95 90.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.094 0.557 . . . . 0.0 111.499 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.41 -20.67 4.85 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.555 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 32.9 mmtp -123.47 178.78 5.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.363 0.582 . . . . 0.0 111.282 -170.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 80.2 m -108.48 113.57 26.71 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.28 117.3 32.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.999 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.468 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 65.3 m -91.02 150.69 21.34 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.501 0.667 . . . . 0.0 112.331 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.41 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 33.9 m -100.94 125.54 38.05 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.413 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -72.47 145.37 42.4 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.148 1.899 . . . . 0.0 112.024 -179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.542 ' HE3' ' O ' ' A' ' 21' ' ' GLY . 18.5 pttp . . . . . 0 C--O 1.249 1.042 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.246 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.727 0.298 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.52 135.98 12.65 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.768 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.469 HD12 ' SG ' ' A' ' 32' ' ' CYS . 28.5 pt -112.39 -178.89 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.774 0.321 . . . . 0.0 110.327 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -81.48 41.21 0.61 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.916 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.33 148.05 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.25 157.34 16.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.968 0.413 . . . . 0.0 110.906 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.9 t -77.92 77.49 4.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.326 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -90.59 -52.59 4.82 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.789 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.478 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 19.2 m80 -147.24 137.13 23.08 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.8 p -64.38 -39.11 93.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.878 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.75 -19.96 79.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.894 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.478 ' HB2' ' HB2' ' A' ' 9' ' ' HIS . 17.4 tt0 -70.13 -26.31 63.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.225 0.536 . . . . 0.0 110.07 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.48 -11.17 59.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.394 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.0 mt -59.89 -48.97 79.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.931 0.396 . . . . 0.0 111.614 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.2 mttm -67.38 -57.59 10.28 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -62.41 -25.63 76.27 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 121.918 1.745 . . . . 0.0 112.781 -174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.419 ' SG ' ' HA3' ' A' ' 25' ' ' GLY . 97.7 m -76.58 -38.51 54.76 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.1 0.476 . . . . 0.0 110.668 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -65.4 -36.8 85.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.169 0.509 . . . . 0.0 110.701 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -76.2 -7.75 55.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.718 0.77 . . . . 0.0 109.541 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.3 5.27 50.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.378 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.99 26.81 54.9 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.731 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.485 ' SD ' ' HB2' ' A' ' 34' ' ' CYS . 37.4 mtt -123.65 175.71 6.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.561 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -88.17 -81.86 0.24 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.59 -174.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.561 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -110.88 -179.41 3.73 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -140.22 114.51 0.98 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.003 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -91.89 155.16 18.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.089 0.471 . . . . 0.0 109.968 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.22 105.68 17.97 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.468 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.6 tp -100.59 179.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -172.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' N ' HG21 ' A' ' 28' ' ' ILE . 38.0 m-20 -51.44 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.523 0.729 . . . . 0.0 112.21 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 83.01 -17.51 21.96 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.023 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HD2' ' C ' ' A' ' 30' ' ' GLY . 1.3 mptm? -121.22 -177.17 3.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.297 0.57 . . . . 0.0 111.217 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.469 ' SG ' HD12 ' A' ' 3' ' ' ILE . 37.0 t -111.67 111.67 22.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.818 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -103.38 113.88 27.72 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.454 0.645 . . . . 0.0 110.476 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 24.0 m -93.1 151.66 19.73 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.978 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.8 m -96.43 108.26 41.02 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.36 152.68 15.85 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.04 1.827 . . . . 0.0 111.479 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.133 176.685 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.047 0.451 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.98 175.23 24.98 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.964 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -126.99 160.44 35.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.021 0.439 . . . . 0.0 110.686 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.69 42.75 0.63 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.838 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.7 142.94 40.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 51.3 pttt -91.05 138.31 31.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.6 t -72.28 111.8 7.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.162 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.526 ' HD2' HE22 ' A' ' 12' ' ' GLN . 96.4 mttt -91.53 -33.87 15.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.6 m80 -150.01 143.68 25.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p -75.71 76.98 2.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.833 0.825 . . . . 0.0 110.901 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.83 -28.16 0.59 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.815 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.526 HE22 ' HD2' ' A' ' 8' ' ' LYS . 13.6 tt0 -62.69 -28.4 69.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.325 0.583 . . . . 0.0 109.76 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 70.3 m -63.78 -9.27 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.934 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.458 HD21 ' H ' ' A' ' 25' ' ' GLY . 3.4 mm? -65.88 -37.04 85.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.864 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 98.6 mttt -60.05 -54.01 59.51 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.117 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 51.5 Cg_endo -74.3 -24.37 14.48 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.41 1.407 . . . . 0.0 112.386 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 20.7 t -73.38 -39.22 65.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.332 -175.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -69.88 -21.51 63.32 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.022 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -88.17 -0.84 57.56 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.637 0.732 . . . . 0.0 109.18 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.23 -16.52 19.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.936 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.0 7.97 60.73 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.994 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.473 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.0 mmt -96.79 178.53 5.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.375 -0.13 . . . . 0.0 110.678 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.462 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 20.8 ttp180 -87.61 -69.14 0.71 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.853 -174.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.465 ' HD1' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -124.68 167.75 14.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.458 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -131.8 107.71 0.75 Allowed Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HZ3' ' HB3' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -90.14 168.2 12.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.167 0.508 . . . . 0.0 110.5 -177.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 t -84.75 122.14 28.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.889 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.52 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.2 tp -118.65 178.68 2.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.52 ' N ' HG21 ' A' ' 28' ' ' ILE . 5.5 m120 -48.85 86.35 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.979 0.799 . . . . 0.0 111.747 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.23 -18.07 4.53 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.436 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.496 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 34.1 mmtp -121.55 173.41 7.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.602 0.701 . . . . 0.0 111.838 -170.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 90.2 m -98.06 116.86 31.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.081 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -106.74 122.92 47.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.31 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.452 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 58.2 m -90.76 152.32 20.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.44 0.638 . . . . 0.0 112.138 -175.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.465 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 95.9 m -112.64 122.41 36.32 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.556 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.06 169.81 21.34 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.106 1.87 . . . . 0.0 112.058 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.424 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.9 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 121.004 0.431 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.5 164.83 14.02 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.583 HD12 ' SG ' ' A' ' 32' ' ' CYS . 17.2 pt -115.21 162.44 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.198 0.523 . . . . 0.0 110.662 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -75.31 11.3 1.25 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.059 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.408 HG12 ' HG3' ' A' ' 16' ' ' PRO . 22.1 t -91.6 140.48 16.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -86.5 131.56 34.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.929 0.395 . . . . 0.0 110.11 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 49.5 t -91.04 115.49 28.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.925 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -91.54 -35.95 13.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 171.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -145.1 151.76 39.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.552 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -61.84 -43.16 99.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.804 0.335 . . . . 0.0 111.342 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.34 -24.68 67.72 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.033 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.85 -28.19 50.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.975 0.417 . . . . 0.0 110.206 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.4 ' HB2' ' SG ' ' A' ' 7' ' ' CYS . 43.0 t -73.22 -25.65 60.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.617 0.722 . . . . 0.0 109.401 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.442 HD21 ' H ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -67.93 -29.55 68.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.464 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.457 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 47.7 mmtm -66.3 -53.84 28.99 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 86.3 Cg_endo -81.08 -17.64 9.21 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.338 1.359 . . . . 0.0 111.839 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.404 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 48.6 t -75.46 -39.33 58.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.294 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HZ2' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.58 -32.19 73.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.801 0.334 . . . . 0.0 110.631 -179.437 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 19.6 pttp -86.11 -13.99 45.56 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.839 0.828 . . . . 0.0 109.186 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.401 ' HB1' ' O ' ' A' ' 17' ' ' CYS . . . -74.14 -14.19 60.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.199 174.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.69 9.79 64.0 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.956 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.404 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.5 mmt -94.5 -178.11 4.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.442 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.531 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 6.4 ttp180 -90.19 -73.12 0.53 Allowed 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.87 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.531 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -123.93 172.6 8.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.311 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -136.9 112.92 0.98 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -91.82 155.93 17.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.04 109.64 17.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.157 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.425 HG21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -96.71 165.64 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.425 ' N ' HG21 ' A' ' 28' ' ' ILE . 24.5 m-80 -59.29 83.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.548 0.53 . . . . 0.0 111.394 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.35 -25.67 27.32 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.011 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' HB2' HG22 ' A' ' 28' ' ' ILE . 14.3 mmmm -122.57 159.24 28.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.62 0.71 . . . . 0.0 112.326 -169.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.583 ' SG ' HD12 ' A' ' 3' ' ' ILE . 42.0 t -90.24 105.45 17.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.144 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -101.82 125.39 48.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.714 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.5 m -97.51 154.54 17.44 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.418 0.628 . . . . 0.0 112.182 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.445 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 33.9 m -105.4 131.07 22.09 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.772 172.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -81.53 159.65 19.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.201 1.934 . . . . 0.0 111.617 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.191 179.658 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 17.4 m . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.85 0.357 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.89 169.61 33.92 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.879 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 pt -125.44 157.63 34.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.23 0.538 . . . . 0.0 110.705 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -79.55 48.32 0.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.759 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -130.45 139.91 50.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.072 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.78 132.64 34.54 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.35 85.57 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.128 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 32.0 mtmm -92.17 105.63 17.81 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.2 m80 70.12 119.1 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.599 0.562 . . . . 0.0 109.823 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 p -70.79 77.54 0.62 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.785 0.802 . . . . 0.0 110.606 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.37 -23.33 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.625 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -74.62 -26.39 59.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.854 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 59.6 m -69.66 -11.39 60.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.399 -172.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.3 mt -65.95 -49.2 68.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.637 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.437 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 64.1 mttp -54.36 -58.97 11.46 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.472 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 45.6 Cg_endo -69.2 -19.84 38.24 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.565 1.51 . . . . 0.0 112.414 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.634 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 34.6 t -74.38 -29.99 61.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -63.36 -37.66 88.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.477 175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -76.71 1.82 16.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.641 0.734 . . . . 0.0 109.89 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.23 -7.7 17.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.104 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.02 22.31 78.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.308 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.634 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 22.4 mmt -98.12 -177.31 3.69 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.445 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 4.8 ttp180 -90.26 -73.25 0.53 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.709 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.532 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.15 174.63 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -127.33 104.27 0.69 Allowed Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 20.5 ptmt -89.03 153.35 21.07 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.955 0.407 . . . . 0.0 109.951 -177.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 t -80.28 118.18 21.71 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.292 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.61 HG21 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -106.28 164.34 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 173.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.61 ' N ' HG21 ' A' ' 28' ' ' ILE . 8.0 m120 -57.2 85.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.41 0.624 . . . . 0.0 111.659 -176.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 -23.12 37.48 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.829 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -122.33 151.19 41.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.282 0.541 . . . . 0.0 110.996 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 88.1 m -85.75 113.47 21.95 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 172.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.571 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 27.8 t70 -109.35 123.09 48.75 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 1' ' ' VAL . 75.9 m -89.6 154.37 20.03 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.574 0.702 . . . . 0.0 112.226 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.401 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 31.3 m -98.18 130.24 28.94 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.884 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 7.2 Cg_exo -69.07 152.75 72.84 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.719 1.613 . . . . 0.0 111.224 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.775 -0.631 . . . . 0.0 110.023 178.08 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 119.787 -0.149 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 52.6 91.32 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 O-C-N 123.197 0.31 . . . . 0.0 113.849 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 32' ' ' CYS . 33.2 pt -86.06 175.04 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 109.962 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -86.91 44.07 1.14 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.363 0.601 . . . . 0.0 111.003 -175.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -131.58 149.98 33.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.524 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -99.74 138.19 37.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.24 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -70.11 86.38 0.56 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.951 0.405 . . . . 0.0 111.105 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.585 ' HE3' ' OE1' ' A' ' 12' ' ' GLN . 56.6 mtmt -91.83 -41.24 10.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 167.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 27.4 m80 -148.61 133.87 18.41 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.4 p -66.73 -36.26 82.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.762 0.315 . . . . 0.0 111.034 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.51 -19.24 76.13 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.492 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.585 ' OE1' ' HE3' ' A' ' 8' ' ' LYS . 34.7 tt0 -82.44 -23.19 34.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.897 0.379 . . . . 0.0 110.087 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.576 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 75.8 m -69.48 -18.92 63.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.327 0.584 . . . . 0.0 109.57 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.2 tp -75.54 -36.67 60.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.811 -179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.526 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 29.1 mmmt -54.1 -53.7 55.64 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.838 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 54.1 Cg_endo -78.38 -18.93 12.09 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.515 1.477 . . . . 0.0 111.921 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 11.7 t -65.39 -24.96 67.35 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.123 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 8.7 ptpp? -61.06 -30.44 70.33 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.818 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -90.15 -13.13 36.31 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.395 0.617 . . . . 0.0 109.737 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.67 56.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.46 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.09 29.9 66.1 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.145 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.57 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.4 mmt -107.23 -178.47 3.65 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.235 -175.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.443 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 20.9 ttp180 -89.64 -77.9 0.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.216 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.443 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -112.72 174.35 5.93 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.159 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -135.54 100.19 0.34 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -90.21 163.37 14.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.182 0.515 . . . . 0.0 110.342 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -87.24 122.21 30.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.904 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.47 HG22 ' HB2' ' A' ' 31' ' ' LYS . 1.0 OUTLIER -109.09 173.06 2.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.434 ' N ' HG21 ' A' ' 28' ' ' ILE . 42.3 m-80 -58.57 87.72 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.245 0.545 . . . . 0.0 111.422 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.09 -24.02 30.63 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.712 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.47 ' HB2' HG22 ' A' ' 28' ' ' ILE . 47.6 mmtm -121.42 170.98 9.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.02 0.438 . . . . 0.0 111.266 -170.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.608 ' O ' HG12 ' A' ' 3' ' ' ILE . 85.7 m -98.19 120.35 38.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 168.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.408 ' HB3' HD13 ' A' ' 28' ' ' ILE . 22.7 t70 -109.42 124.16 50.55 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.843 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.472 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 80.8 m -92.46 151.63 20.11 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.158 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.428 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 91.3 m -97.63 118.45 64.16 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.181 175.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.66 144.37 31.47 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.103 1.869 . . . . 0.0 112.487 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp . . . . . 0 C--O 1.248 0.975 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.778 -178.696 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.922 0.391 . . . . 0.0 111.351 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.9 155.88 30.72 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.356 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.468 HD12 ' SG ' ' A' ' 13' ' ' CYS . 12.3 pt -114.85 162.39 12.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.944 0.402 . . . . 0.0 110.736 -176.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.84 20.7 0.93 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.586 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.98 133.61 29.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.998 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -74.6 134.94 42.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.938 0.399 . . . . 0.0 110.144 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 t -68.16 101.59 1.19 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.433 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -91.59 -47.67 7.27 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -149.12 132.82 16.88 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.4 p -71.1 114.45 9.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.063 0.459 . . . . 0.0 110.529 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.93 -27.43 9.67 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.531 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -73.37 -22.11 60.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.377 0.608 . . . . 0.0 110.135 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.468 ' SG ' HD12 ' A' ' 3' ' ' ILE . 22.6 t -80.78 8.41 8.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.731 -175.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.487 HD21 ' H ' ' A' ' 25' ' ' GLY . 2.4 mm? -70.01 -28.28 65.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.155 0.502 . . . . 0.0 110.748 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 34.8 mmtp -67.78 -57.13 10.33 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.402 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 57.7 Cg_endo -71.09 -18.46 30.86 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.58 1.52 . . . . 0.0 112.795 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.508 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 36.1 t -79.79 -36.23 37.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.35 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -68.91 -25.14 64.44 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.306 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HZ3' ' HB3' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -82.92 -17.8 42.39 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.974 0.893 . . . . 0.0 109.115 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.08 -8.6 58.43 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.109 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.94 5.06 81.45 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.084 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.508 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 23.0 mmt -94.95 177.45 5.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.641 0.257 . . . . 0.0 110.88 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.506 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 2.8 ttp180 -88.41 -73.41 0.5 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.292 -173.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.506 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -121.99 154.19 37.56 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.392 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.487 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -106.19 110.3 3.33 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.624 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -90.66 154.9 19.23 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.85 120.22 30.9 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.059 0.457 . . . . 0.0 110.818 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.41 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.2 tp -109.46 168.54 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.405 ' N ' HG21 ' A' ' 28' ' ' ILE . 1.3 t30 -44.23 98.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.832 0.825 . . . . 0.0 110.776 173.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.41 -27.11 2.15 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 114.797 -1.092 . . . . 0.0 114.031 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -120.85 -177.32 3.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.731 0.766 . . . . 0.0 111.038 -168.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.6 t -114.2 114.81 26.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.185 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.41 ' HB3' HD13 ' A' ' 28' ' ' ILE . 23.9 t70 -103.38 115.57 30.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.356 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -88.53 155.86 19.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.849 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 62.7 m -97.67 132.52 24.92 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.93 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -70.25 170.62 16.74 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.787 1.658 . . . . 0.0 112.378 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.582 176.452 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.0 140.67 5.74 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.843 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.417 ' C ' ' H ' ' A' ' 5' ' ' VAL . 10.5 pt -116.39 163.26 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.77 33.54 0.14 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.281 0.562 . . . . 0.0 111.887 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.417 ' H ' ' C ' ' A' ' 3' ' ' ILE . 21.9 t -115.63 151.76 17.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.682 -176.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 35.3 mtmm -109.52 145.23 36.63 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 t -69.17 95.13 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.697 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -92.43 -42.92 9.48 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 167.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -148.29 126.02 11.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.446 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 p -66.99 -21.87 65.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.081 0.467 . . . . 0.0 111.048 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.86 -35.67 44.4 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.413 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -71.0 -30.06 66.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.077 0.465 . . . . 0.0 110.213 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.9 t -62.04 -19.29 62.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.992 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.479 HD11 ' H ' ' A' ' 25' ' ' GLY . 6.8 mp -72.15 -31.94 66.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.343 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.498 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 29.6 mtpp -58.91 -56.58 34.62 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.078 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.498 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 72.8 Cg_endo -76.71 -17.17 16.12 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.336 1.358 . . . . 0.0 112.21 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 35.3 t -80.36 -34.74 36.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.279 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 64.8 pttt -67.83 -24.78 65.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.159 0.504 . . . . 0.0 109.921 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -83.11 -9.6 59.12 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.575 0.702 . . . . 0.0 109.35 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.44 -15.16 31.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.989 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.73 13.16 63.22 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.009 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.493 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.2 mmt -94.91 -178.13 4.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.606 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 7.1 ttp180 -90.26 -65.7 0.99 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.72 -176.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.606 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -129.59 166.91 18.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 109.966 175.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.479 ' H ' HD11 ' A' ' 14' ' ' LEU . . . -113.59 109.62 2.3 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -91.08 152.1 20.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.051 0.453 . . . . 0.0 110.162 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.7 m -82.94 114.72 21.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.724 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.577 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -107.21 176.18 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.766 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.577 ' N ' HG21 ' A' ' 28' ' ' ILE . 4.8 p30 -44.75 85.08 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.739 0.78 . . . . 0.0 112.684 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 82.38 -21.33 7.35 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.169 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 99.1 mttt -120.19 172.52 7.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.427 0.632 . . . . 0.0 112.359 -168.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.73 103.18 14.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.581 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -105.15 117.42 33.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.134 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.41 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.3 m -83.52 154.58 23.79 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.698 0.761 . . . . 0.0 112.617 -174.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.435 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 89.2 m -101.71 116.82 62.91 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.843 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.429 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 63.7 Cg_endo -69.67 152.71 69.82 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.332 2.021 . . . . 0.0 112.62 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.069 176.479 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.528 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 30.9 m . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.697 0.284 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.466 ' HA2' ' H ' ' A' ' 34' ' ' CYS . . . -94.09 -177.69 39.1 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.338 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 32' ' ' CYS . 12.7 pt -128.8 157.7 41.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.961 0.41 . . . . 0.0 110.184 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -72.38 11.11 0.65 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.264 -177.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.402 ' H ' ' C ' ' A' ' 3' ' ' ILE . 48.3 t -84.78 135.85 23.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 46.2 mtpt -86.97 133.71 33.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.2 t -72.12 104.31 3.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.427 ' HZ3' ' HB3' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -90.03 -39.15 13.12 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 172.223 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -148.29 138.54 22.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.916 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 p -62.95 -27.24 69.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.066 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.41 -32.66 41.87 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.816 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -69.2 -15.95 63.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.389 0.275 . . . . 0.0 111.594 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.532 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 77.5 m -77.39 -16.79 58.67 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -176.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.425 ' N ' HD13 ' A' ' 14' ' ' LEU . 11.1 mp -75.85 -37.48 58.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.766 0.317 . . . . 0.0 111.594 -179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -53.02 -55.37 34.27 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.687 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.434 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 73.9 Cg_endo -77.66 -16.61 14.72 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.439 1.426 . . . . 0.0 112.197 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 38.5 t -75.4 -37.4 60.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.322 -175.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.457 ' HZ1' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.76 -18.15 64.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.127 0.489 . . . . 0.0 110.13 178.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.434 ' HE3' ' HA ' ' A' ' 16' ' ' PRO . 8.0 mtmp? -85.86 -14.29 45.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.634 0.731 . . . . 0.0 109.196 177.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.79 -7.62 57.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.336 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.58 16.86 69.79 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.028 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.53 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 25.2 mmt -97.85 179.64 4.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.659 0.266 . . . . 0.0 110.47 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.458 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 4.5 ttp180 -90.74 -69.83 0.71 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.535 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.458 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.63 169.5 11.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.83 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -125.29 109.4 1.19 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 19.4 ptmt -90.25 156.78 18.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.5 t -83.66 114.61 21.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.074 0.464 . . . . 0.0 110.242 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.49 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -103.33 170.71 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.396 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.49 ' N ' HG21 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -38.41 -43.94 0.87 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -167.462 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.17 -0.48 1.65 Allowed Glycine 0 C--N 1.318 -0.419 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.596 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.484 ' H ' HG22 ' A' ' 28' ' ' ILE . 96.2 mttt -123.79 166.91 14.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.762 -172.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.43 ' O ' HG12 ' A' ' 3' ' ' ILE . 98.3 m -90.97 100.71 13.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 169.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.617 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 18.5 t70 -95.06 118.9 32.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.694 -177.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 1' ' ' VAL . 69.6 m -88.5 153.41 21.17 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.638 0.732 . . . . 0.0 112.611 -172.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.424 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 52.6 m -109.34 118.4 50.94 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.946 171.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 18.0 Cg_exo -69.35 -177.74 1.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.884 2.389 . . . . 0.0 112.317 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.245 0.839 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.205 177.877 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.762 0.315 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.43 162.47 9.25 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.87 153.03 18.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 117.217 0.509 . . . . 0.0 110.55 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . 0.53 ' C ' HD21 ' A' ' 4' ' ' ASN . 0.1 OUTLIER -77.39 71.0 3.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.421 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.501 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 17.0 t -146.38 136.09 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -88.47 134.41 33.86 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.3 t -73.08 91.03 1.57 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.131 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -82.68 -34.02 27.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.6 m80 -147.5 148.59 31.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.983 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 p -67.17 -34.4 77.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.183 0.516 . . . . 0.0 110.129 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.94 -12.63 81.14 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.623 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -84.1 -15.74 46.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.63 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 62.7 m -90.54 -17.33 27.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.022 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.557 HD21 ' H ' ' A' ' 25' ' ' GLY . 87.9 mt -74.18 -51.51 15.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.178 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 58.5 mttp -52.52 -53.51 52.78 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.847 -175.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.424 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 49.1 Cg_endo -73.39 -15.9 24.84 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.525 1.483 . . . . 0.0 112.88 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.63 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 14.4 t -78.69 -36.35 43.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.946 0.403 . . . . 0.0 111.234 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -69.79 -21.52 63.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.24 0.543 . . . . 0.0 109.932 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -83.84 -11.93 56.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.712 0.768 . . . . 0.0 109.044 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.87 -14.59 27.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.068 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.07 17.74 64.44 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.063 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.563 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 23.8 mmt -96.64 170.72 9.01 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.985 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 4.7 ttp180 -76.2 -68.46 0.58 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.602 -173.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.525 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -128.18 154.07 46.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 174.465 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.557 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -109.95 97.25 1.0 Allowed Glycine 0 C--N 1.309 -0.927 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -90.33 160.59 16.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.147 0.498 . . . . 0.0 110.694 -175.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.3 t -83.85 118.28 23.86 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.031 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.501 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.6 tp -110.46 -178.02 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.501 ' N ' HG21 ' A' ' 28' ' ' ILE . 43.9 m-80 -48.93 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.143 0.497 . . . . 0.0 111.901 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.04 -10.95 2.88 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.77 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.4 ' O ' HG22 ' A' ' 28' ' ' ILE . 30.4 ttpt -123.18 161.96 23.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.192 0.496 . . . . 0.0 111.584 -168.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.501 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 68.1 m -91.57 102.15 14.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.44 0.638 . . . . 0.0 110.45 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -99.81 127.29 45.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.505 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.0 m -96.88 149.34 21.98 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.448 0.642 . . . . 0.0 111.653 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.449 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 57.2 m -102.28 116.96 62.21 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.521 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.62 167.14 27.3 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.346 2.031 . . . . 0.0 111.43 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.4 mttp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.096 178.42 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.035 0.445 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.74 145.3 17.64 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.567 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.416 HD13 ' SG ' ' A' ' 34' ' ' CYS . 18.0 pt -118.51 164.08 15.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.172 0.51 . . . . 0.0 110.627 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -74.47 13.3 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.847 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.409 ' H ' ' C ' ' A' ' 3' ' ' ILE . 30.4 t -95.05 133.86 34.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.559 -176.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.29 149.38 26.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 t -73.2 81.22 1.31 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.055 0.455 . . . . 0.0 110.211 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.43 -40.38 26.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.321 0.581 . . . . 0.0 110.11 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.662 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 6.9 p-80 -169.61 123.85 0.79 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.251 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.2 p -63.27 99.87 0.21 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.692 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.23 -30.01 1.34 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.662 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 24.8 tt0 -60.84 -34.5 74.67 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.943 0.402 . . . . 0.0 111.702 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 97.4 m -69.59 -9.5 54.32 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -168.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.51 -38.99 75.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.037 0.446 . . . . 0.0 110.667 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.476 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 75.0 mmtt -70.22 -56.25 7.17 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.207 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.476 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 50.8 Cg_endo -71.02 -29.28 18.11 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.585 1.523 . . . . 0.0 113.414 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.624 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 43.2 t -75.09 -36.12 61.74 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.319 -0.238 . . . . 0.0 111.546 -174.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -63.98 -23.17 67.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 109.903 175.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -83.09 -14.52 53.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.344 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.85 -12.34 48.16 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.844 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.73 19.55 53.7 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.474 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.624 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 43.8 mtt -116.17 173.63 6.48 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.3 ttp180 -84.28 -76.06 0.32 Allowed 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.538 -170.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -123.12 178.21 5.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -133.33 115.12 1.48 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 12.6 ptmm? -91.22 166.88 12.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.975 0.417 . . . . 0.0 110.047 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.55 135.4 35.58 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.448 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.3 tp -123.26 173.23 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.448 ' N ' HG21 ' A' ' 28' ' ' ILE . 10.0 p30 -36.91 -44.58 0.51 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -166.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.19 -6.31 1.23 Allowed Glycine 0 C--N 1.317 -0.509 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.824 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -122.37 -165.86 1.34 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.947 0.403 . . . . 0.0 110.386 -168.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.3 t -118.27 125.92 51.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.953 175.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 22.0 t70 -111.51 123.98 51.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.197 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.51 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 21.7 m -87.66 155.88 19.73 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.642 0.734 . . . . 0.0 112.717 -173.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.443 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 89.4 m -107.27 128.69 25.52 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.712 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.33 -176.07 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.234 1.956 . . . . 0.0 112.03 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.4 pttm . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.834 -179.26 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.731 0.301 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.531 ' HA2' ' H ' ' A' ' 34' ' ' CYS . . . -83.83 -176.57 51.3 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.075 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.406 ' C ' ' H ' ' A' ' 5' ' ' VAL . 7.4 pt -128.04 163.07 32.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.817 0.341 . . . . 0.0 110.277 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -70.24 4.18 2.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.105 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 14.1 t -84.93 138.18 19.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.17 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -90.18 139.26 30.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.27 104.83 4.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.576 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.417 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 62.8 mttp -91.73 -43.83 9.34 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 167.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -144.51 152.79 41.09 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.45 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 3.2 p -60.99 -50.73 72.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.996 0.362 . . . . 0.0 111.817 -175.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.47 -13.72 65.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.476 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.417 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 23.5 tt0 -70.69 -31.01 67.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.353 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.52 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 81.9 m -78.81 -21.31 47.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.604 -175.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.569 HD21 ' H ' ' A' ' 25' ' ' GLY . 1.3 mm? -64.94 -35.37 80.96 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.98 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 60.8 mtpt -60.21 -60.76 9.58 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.345 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.42 ' CD ' ' HB2' ' A' ' 15' ' ' LYS . 50.9 Cg_endo -71.44 -16.99 30.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.075 1.85 . . . . 0.0 112.678 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 15.4 t -70.75 -34.08 71.47 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.374 -174.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.571 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 23.5 pttm -63.82 -25.95 68.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.398 . . . . 0.0 110.48 176.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -88.69 -14.34 37.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.338 0.59 . . . . 0.0 109.543 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.21 45.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.2 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.91 15.46 48.84 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.66 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.503 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.3 mmt -99.67 -179.39 4.17 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.623 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.475 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 5.8 ttp180 -90.26 -65.78 0.99 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.496 -175.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.475 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.27 162.4 23.8 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 174.375 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.569 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -126.71 94.95 0.43 Allowed Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -90.87 159.35 16.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.366 0.603 . . . . 0.0 110.99 -174.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -83.64 113.73 21.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.423 -177.193 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.611 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -106.36 169.94 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.748 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.611 ' N ' HG21 ' A' ' 28' ' ' ILE . 4.7 p30 -43.3 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.934 0.873 . . . . 0.0 113.173 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 80.06 -14.32 21.44 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.566 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HZ1' ' HB2' ' A' ' 31' ' ' LYS . 4.4 ttmp? -121.64 144.94 48.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.517 0.659 . . . . 0.0 111.541 -171.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 62.2 m -79.42 99.34 7.14 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.367 173.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.413 ' HB3' HD13 ' A' ' 28' ' ' ILE . 24.7 t70 -99.49 118.19 35.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.4 0.619 . . . . 0.0 110.75 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.531 ' H ' ' HA2' ' A' ' 2' ' ' GLY . 62.1 m -93.08 149.93 20.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.684 -176.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.446 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 98.7 m -111.56 126.14 29.11 Favored Pre-proline 0 N--CA 1.439 -0.985 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.225 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.71 -168.03 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.398 2.065 . . . . 0.0 112.26 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.7 mttp . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.627 -0.702 . . . . 0.0 109.898 179.75 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.82 126.6 9.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.411 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -105.24 -179.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.055 0.455 . . . . 0.0 110.836 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -83.56 42.68 0.85 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.624 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.64 152.38 36.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.248 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -95.65 147.54 23.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.79 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 41.8 t -78.3 57.23 1.85 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.854 -174.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -93.4 104.88 17.0 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.7 m80 67.9 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.762 0.664 . . . . 0.0 110.73 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 p -60.74 -28.16 68.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.07 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.4 -20.52 76.96 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.523 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -76.98 -33.12 57.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.573 0.225 . . . . 0.0 110.831 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 74.7 m -65.78 -18.22 65.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.579 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.465 HD21 ' H ' ' A' ' 25' ' ' GLY . 1.1 mm? -64.84 -36.41 84.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.682 0.277 . . . . 0.0 111.245 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 4.8 mptp? -65.76 -56.71 16.63 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.08 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -71.01 -19.07 30.62 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.329 1.353 . . . . 0.0 112.701 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.5 m -76.38 -38.66 55.41 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.45 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 49.0 pttt -69.5 -26.75 64.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 95.3 mttt -75.67 -23.42 56.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.7 58.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.358 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.56 11.81 76.7 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.305 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.69 ' SD ' ' HA ' ' A' ' 36' ' ' PRO . 23.5 mmt -95.65 175.67 6.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.389 0.137 . . . . 0.0 111.117 -177.132 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.457 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 14.9 ttp180 -80.7 -71.49 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.24 -173.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.457 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -119.67 -176.88 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.169 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.465 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -136.17 102.81 0.42 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.388 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -85.26 156.31 21.0 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -96.16 109.71 22.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.2 tp -104.3 177.98 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.665 -172.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -53.2 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.001 0.52 . . . . 0.0 111.63 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.91 -18.06 28.56 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.162 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.5 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 66.3 mttm -122.94 179.47 4.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.09 0.445 . . . . 0.0 110.564 -172.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.3 m -107.0 120.27 41.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -103.31 107.87 18.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.687 0.756 . . . . 0.0 110.381 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.9 m -81.09 142.07 33.68 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.357 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 m -88.98 121.05 69.99 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.69 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 17.7 Cg_endo -75.04 120.56 6.1 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.998 1.799 . . . . 0.0 112.38 -175.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.594 ' OXT' ' HD2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.814 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.44 118.43 0.03 OUTLIER Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.086 -0.578 . . . . 0.0 113.434 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.495 HD13 ' SG ' ' A' ' 34' ' ' CYS . 33.9 pt -120.17 167.62 13.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.53 67.56 7.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.955 0.407 . . . . 0.0 109.92 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -148.36 135.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -86.9 138.47 31.52 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 t -67.69 101.96 1.12 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.343 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.66 -50.74 5.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -149.65 135.16 18.4 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.5 p -62.17 -33.62 74.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.35 -31.58 61.01 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.967 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -76.72 -20.31 56.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.445 ' HB3' ' HA3' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -69.0 -13.58 62.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.413 -177.125 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.402 ' N ' HD13 ' A' ' 14' ' ' LEU . 11.0 mp -67.79 -35.43 78.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.947 178.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 97.7 mttt -57.07 -54.16 57.58 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.526 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 46.7 Cg_endo -74.49 -25.43 13.0 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.034 1.156 . . . . 0.0 112.844 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 m -76.23 -31.56 58.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.506 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 19.6 ptpt -68.41 -25.42 65.03 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -85.91 -11.09 54.08 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.269 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.2 -1.41 56.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.088 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.17 74.35 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.197 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.441 ' SD ' ' HA ' ' A' ' 36' ' ' PRO . 25.3 mmt -110.05 178.32 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.858 -0.201 . . . . 0.0 110.946 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.478 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 19.8 ttp180 -81.87 -70.04 0.57 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.169 -173.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.478 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.99 -177.23 3.78 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.445 ' HA3' ' HB3' ' A' ' 13' ' ' CYS . . . -126.72 107.91 0.95 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.872 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -91.9 157.05 17.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 m -90.05 129.69 36.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.216 0.532 . . . . 0.0 110.655 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.443 HG21 ' N ' ' A' ' 29' ' ' ASN . 1.3 tp -119.42 -179.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.113 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.443 ' N ' HG21 ' A' ' 28' ' ' ILE . 38.9 m-20 -47.68 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.396 0.678 . . . . 0.0 112.133 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.49 -15.36 4.64 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.183 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 48.0 mtmt -120.76 -173.66 2.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.231 0.515 . . . . 0.0 110.825 -172.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.3 t -115.49 121.34 42.4 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.8 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -112.24 115.91 29.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.4 0.619 . . . . 0.0 110.338 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.495 ' SG ' HD13 ' A' ' 3' ' ' ILE . 36.5 m -79.85 143.87 33.96 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.633 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.9 m -82.52 120.02 75.88 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.441 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 30.1 Cg_endo -79.73 131.75 9.4 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.122 1.881 . . . . 0.0 111.872 -177.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.6 pttt . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.515 -178.919 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.6 m . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.795 0.331 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.44 157.3 7.1 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.1 pt -130.7 171.54 17.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.471 0.653 . . . . 0.0 111.936 -176.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.23 37.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.605 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.53 144.89 22.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.345 -177.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -91.24 141.58 28.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.046 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.9 t -72.26 94.1 1.54 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.33 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.14 -47.65 7.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.532 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 7.1 p-80 -166.17 147.33 6.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.636 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.7 p -51.01 -46.58 61.58 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -171.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.95 -19.66 56.69 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.447 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.532 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 26.1 tt0 -74.68 -43.87 53.05 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 66.4 m -68.93 -15.48 63.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.38 -173.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.54 HD21 ' H ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -62.45 -41.0 98.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.001 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -68.34 -54.97 13.29 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.12 -18.4 30.8 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.327 1.351 . . . . 0.0 112.815 -178.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 m -80.26 -39.62 28.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.585 0.231 . . . . 0.0 111.329 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -72.15 -23.0 61.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.084 0.468 . . . . 0.0 110.039 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -89.22 -5.94 57.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.59 0.709 . . . . 0.0 109.421 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.2 -5.81 51.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.267 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.73 14.87 62.45 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.847 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.7 mmt -104.84 179.6 4.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 2.6 ttp180 -82.59 -74.6 0.34 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.994 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -122.63 -179.94 4.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.386 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.54 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -131.47 111.03 1.03 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.963 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -91.1 153.67 19.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.898 0.38 . . . . 0.0 110.014 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -91.26 111.63 23.2 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.427 HG21 ' N ' ' A' ' 29' ' ' ASN . 2.4 tp -115.57 -179.12 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.027 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.427 ' N ' HG21 ' A' ' 28' ' ' ILE . 21.6 m-80 -44.37 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.87 0.868 . . . . 0.0 112.621 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.94 -8.23 3.68 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.392 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' HG2' ' N ' ' A' ' 32' ' ' CYS . 36.9 ttmt -122.9 167.4 13.6 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 122.559 -0.377 . . . . 0.0 110.001 -173.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.478 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 91.1 m -100.66 112.63 25.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.023 0.439 . . . . 0.0 109.895 169.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -96.43 109.11 21.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.62 0.724 . . . . 0.0 110.065 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 32.1 m -80.54 143.22 33.42 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.539 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.6 m -88.16 132.41 39.71 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -69.18 166.48 26.74 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.474 1.449 . . . . 0.0 110.828 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.489 -177.578 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.649 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 13.2 m . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.79 0.329 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.18 87.17 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.864 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.5 pt -104.26 174.35 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.139 0.495 . . . . 0.0 110.606 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -76.23 7.91 3.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.302 -172.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.0 139.52 19.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.841 -173.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -83.32 142.98 30.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.517 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 5.7 t -79.18 101.55 8.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.777 -176.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -91.94 -57.07 2.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 168.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -147.01 156.45 43.05 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -62.46 -38.09 88.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.829 0.347 . . . . 0.0 110.752 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.79 -27.41 64.17 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.604 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -73.16 -44.97 59.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 0.0 110.243 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.96 -16.3 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.41 -172.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.56 HD21 ' H ' ' A' ' 25' ' ' GLY . 82.5 mt -56.94 -49.74 74.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.424 0.631 . . . . 0.0 111.3 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.552 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 22.3 ttmm -60.17 -54.8 51.68 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.317 -172.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 52.1 Cg_endo -73.96 -20.79 19.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.148 1.232 . . . . 0.0 113.077 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 m -77.6 -34.35 53.47 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 64.2 pttt -68.6 -25.59 64.95 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -86.05 -6.34 59.05 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.498 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.0 4.86 50.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.322 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.96 22.67 71.05 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.105 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.556 ' SD ' ' HB2' ' A' ' 34' ' ' CYS . 46.1 mtt -116.61 175.82 5.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.169 -176.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.542 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 8.1 ttp180 -75.41 -72.36 0.31 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.139 0.274 . . . . 0.0 111.653 -170.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.542 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.3 -176.61 3.63 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.09 0.471 . . . . 0.0 110.137 177.125 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.56 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -123.58 115.58 2.66 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.708 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.514 ' HZ2' ' HB2' ' A' ' 26' ' ' LYS . 4.1 ttmp? -90.95 156.85 17.66 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.76 109.9 22.03 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.905 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.516 HG22 ' H ' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -95.01 164.33 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.166 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.462 ' N ' HG21 ' A' ' 28' ' ' ILE . 8.1 p30 -39.06 -36.96 0.34 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.25 -14.79 1.05 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.025 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.516 ' H ' HG22 ' A' ' 28' ' ' ILE . 68.2 mttm -123.81 167.31 14.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.781 0.324 . . . . 0.0 111.277 -169.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 99.6 m -91.16 111.91 23.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.429 0.633 . . . . 0.0 110.525 173.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.649 ' OD1' ' HA ' ' A' ' 1' ' ' VAL . 8.0 t70 -85.53 158.52 20.13 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.556 ' HB2' ' SD ' ' A' ' 22' ' ' MET . 16.5 m -131.98 137.52 47.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.412 ' HB ' ' CD1' ' A' ' 24' ' ' PHE . 28.8 m -88.0 123.01 69.68 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.37 176.58 9.06 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.714 1.609 . . . . 0.0 111.498 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.004 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 121.102 0.477 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -57.91 141.37 45.13 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.575 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.424 HD12 ' SG ' ' A' ' 32' ' ' CYS . 21.3 pt -110.02 171.61 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -81.28 45.18 0.83 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.986 0.422 . . . . 0.0 111.729 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.95 144.29 36.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.992 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -92.97 146.55 23.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.678 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 46.0 t -77.02 78.29 3.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.14 0.495 . . . . 0.0 111.276 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 52.7 mtpt -91.35 -50.21 5.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -143.9 136.6 27.15 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.0 p -66.69 -34.96 79.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.353 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.78 -18.2 79.48 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.586 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.441 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 61.1 tt0 -82.78 -31.14 28.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -19.64 65.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.474 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.528 HD21 ' H ' ' A' ' 25' ' ' GLY . 81.2 mt -61.14 -48.68 80.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.437 0.637 . . . . 0.0 110.737 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 56.3 mtpt -53.18 -56.71 21.29 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.322 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 57.9 Cg_endo -72.32 -28.93 14.58 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.304 1.336 . . . . 0.0 112.867 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.0 m -72.06 -36.87 69.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -176.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 65.1 pttt -67.45 -26.06 66.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.029 0.443 . . . . 0.0 109.867 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -79.88 -18.52 50.48 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.495 0.664 . . . . 0.0 109.327 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.06 9.16 23.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.068 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.94 19.25 80.03 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.008 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.1 mmt -97.89 175.34 6.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.75 0.309 . . . . 0.0 111.47 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.533 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 3.5 ttp180 -81.82 -66.06 0.94 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.164 -176.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.533 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -131.01 -177.51 4.41 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.528 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -125.14 116.65 2.76 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -91.91 146.46 23.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.249 0.547 . . . . 0.0 110.174 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.73 111.9 23.68 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.407 HG21 ' N ' ' A' ' 29' ' ' ASN . 2.2 tp -108.55 178.71 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.089 -171.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' N ' HG21 ' A' ' 28' ' ' ILE . 30.7 m-80 -49.63 87.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.065 0.546 . . . . 0.0 111.891 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.18 -15.93 8.1 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.254 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 74.9 mmtt -121.92 174.07 7.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.059 0.43 . . . . 0.0 110.988 -171.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . 0.424 ' SG ' HD12 ' A' ' 3' ' ' ILE . 14.2 t -111.35 112.09 23.6 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -115.7 118.98 34.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.413 0.625 . . . . 0.0 109.845 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 27.8 m -79.44 165.84 22.63 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.168 -172.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.437 ' HB ' ' CD1' ' A' ' 24' ' ' PHE . 10.6 m -105.37 109.5 63.28 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.5 153.21 78.83 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.6 1.533 . . . . 0.0 111.137 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.902 177.205 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 121.048 0.451 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.48 164.85 19.05 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 16' ' ' PRO . 16.3 pt -122.89 176.07 5.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.145 0.497 . . . . 0.0 111.235 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -87.46 35.12 0.71 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.812 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 t -115.04 132.88 62.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-O 120.872 0.367 . . . . 0.0 110.279 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -80.69 126.81 31.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.994 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 t -67.35 93.8 0.35 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.272 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.29 -41.25 11.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.155 0.503 . . . . 0.0 110.371 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -144.12 135.86 26.06 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -174.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.448 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . 37.2 p -70.81 94.22 1.03 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.626 0.727 . . . . 0.0 110.282 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.64 -25.76 2.27 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -67.24 -25.44 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.299 0.571 . . . . 0.0 110.118 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.6 m -84.02 -9.26 58.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.453 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.582 HD21 ' H ' ' A' ' 25' ' ' GLY . 94.4 mt -61.47 -54.16 46.96 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 111.362 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.619 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 55.8 mtmt -59.57 -53.98 60.42 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.755 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.455 ' HB2' HD11 ' A' ' 3' ' ' ILE . 20.1 Cg_endo -63.88 -24.45 67.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.214 1.276 . . . . 0.0 112.755 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -78.94 -37.92 38.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.619 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 13.8 ptmm? -71.11 -26.13 62.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.093 0.473 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 9.0 mtmp? -85.36 -5.2 59.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.703 0.763 . . . . 0.0 109.15 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.31 0.55 57.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.083 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.424 ' O ' ' HE2' ' A' ' 37' ' ' LYS . . . 80.65 19.13 68.96 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.014 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mmt -102.74 -175.8 2.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.46 0.171 . . . . 0.0 110.66 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.53 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 16.1 ttp180 -84.93 -71.23 0.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.678 0.275 . . . . 0.0 110.588 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.53 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -128.07 -179.37 4.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.192 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.582 ' H ' HD21 ' A' ' 14' ' ' LEU . . . -131.49 104.54 0.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.605 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -91.35 158.81 16.33 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -92.15 114.75 27.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.037 0.446 . . . . 0.0 110.146 178.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.435 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.0 OUTLIER -99.81 162.86 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.089 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.426 ' N ' HG21 ' A' ' 28' ' ' ILE . 32.4 m-80 -58.33 87.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.397 0.618 . . . . 0.0 111.07 -177.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.48 -31.85 8.17 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.02 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HB2' HG22 ' A' ' 28' ' ' ILE . 49.8 mtmt -121.8 147.6 45.74 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.362 -0.493 . . . . 0.0 111.882 -168.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 41.0 m -80.13 102.98 9.7 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 168.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.435 ' HB3' HD13 ' A' ' 28' ' ' ILE . 34.1 t70 -102.83 129.86 49.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.647 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.7 m -98.62 145.03 27.27 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.095 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 m -85.74 125.68 68.29 Favored Pre-proline 0 N--CA 1.446 -0.641 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -71.89 141.64 37.4 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.815 1.677 . . . . 0.0 111.264 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.424 ' HE2' ' O ' ' A' ' 21' ' ' GLY . 52.5 pttt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.496 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.755 0 CA-C-O 121.03 0.239 . . . . 0.0 113.023 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 pt -125.05 160.85 29.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -80.49 63.64 5.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.668 0.747 . . . . 0.0 109.965 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 22.0 t -140.08 160.81 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.671 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.45 ' N ' HG12 ' A' ' 5' ' ' VAL . 98.4 mttt -113.43 128.73 56.55 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.943 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.8 t -66.2 97.0 0.36 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.063 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 75.3 mmtt -90.39 -34.4 15.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 171.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -148.89 134.55 18.75 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.457 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 25.6 p -72.71 86.97 1.24 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.789 0.804 . . . . 0.0 110.692 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.1 -25.43 1.43 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.211 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 34.2 tt0 -67.62 -29.91 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.16 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 60.8 m -63.37 -12.74 32.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.414 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.441 HD22 ' H ' ' A' ' 25' ' ' GLY . 3.9 mm? -67.17 -37.51 83.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.931 0.396 . . . . 0.0 110.938 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 95.5 mttt -59.8 -51.67 79.21 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.004 -175.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 73.9 Cg_endo -78.62 -14.6 14.15 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.539 1.492 . . . . 0.0 112.494 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 11.0 t -75.44 -33.41 60.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.033 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 6.5 ptpp? -66.61 -20.67 66.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.947 0.403 . . . . 0.0 109.971 175.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -84.4 -19.64 33.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.04 -27.06 33.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.966 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.06 17.06 48.81 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.963 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.498 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 25.4 mmt -98.66 177.21 5.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.393 0.14 . . . . 0.0 111.119 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.511 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 6.3 ttp180 -78.21 -71.55 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.991 -173.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.511 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.62 173.52 8.46 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 175.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -133.12 103.26 0.5 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 62.7 pttt -90.81 164.06 14.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.115 0.483 . . . . 0.0 110.419 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 10' ' ' SER . 1.5 m -85.67 129.06 34.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.36 0.6 . . . . 0.0 111.184 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -118.15 179.0 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.589 177.838 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.552 ' N ' HG23 ' A' ' 28' ' ' ILE . 6.6 p30 -45.46 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.014 0.911 . . . . 0.0 112.844 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.46 -11.25 5.55 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.406 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HB2' HG22 ' A' ' 28' ' ' ILE . 97.4 mttt -121.24 177.49 5.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.307 0.554 . . . . 0.0 111.328 -172.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.578 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 62.9 m -107.31 119.04 38.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.28 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 20.0 t70 -113.0 127.91 56.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.786 175.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 63.7 m -91.76 155.35 18.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.327 0.584 . . . . 0.0 111.733 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.488 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 58.0 m -105.05 124.74 35.63 Favored Pre-proline 0 N--CA 1.44 -0.95 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.011 173.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.28 176.97 8.22 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.035 1.823 . . . . 0.0 111.328 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 pttm . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.599 176.579 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.764 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.3 pt -111.91 153.77 13.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.107 0.479 . . . . 0.0 110.637 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -79.27 64.64 4.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.303 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 46.1 t -130.94 138.02 54.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.578 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 9.9 mtmp? -77.46 111.55 13.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 26.1 t -73.64 106.3 5.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.473 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -88.76 -34.46 17.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -149.89 146.72 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.584 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.1 p -62.47 -39.37 93.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.96 0.409 . . . . 0.0 110.391 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.37 -23.92 68.75 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.397 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -70.53 -40.26 73.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 0.0 109.836 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 81.8 m -69.56 -16.81 63.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.89 -174.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -66.35 -34.1 77.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.032 0.444 . . . . 0.0 110.826 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 92.8 mttt -61.3 -53.16 65.3 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.791 -174.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 72.5 Cg_endo -79.2 -17.14 11.91 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.62 1.547 . . . . 0.0 112.39 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.8 t -71.57 -29.97 65.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.278 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 23.1 pttm -65.4 -23.95 67.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 110.532 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -90.1 -13.09 36.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.535 0.684 . . . . 0.0 109.731 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.41 -10.55 56.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.063 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.08 23.79 73.38 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.998 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.59 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.3 mmt -104.71 177.87 4.72 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.247 -177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.2 ttp180 -84.21 -72.74 0.45 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.077 -174.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.86 -179.16 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.619 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -129.58 110.98 1.12 Allowed Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.491 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -90.21 154.72 19.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.8 t -95.89 105.18 17.17 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.282 0.563 . . . . 0.0 111.037 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.4 mp -102.17 153.78 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -46.24 90.75 0.0 OUTLIER 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.891 0.744 . . . . 0.0 112.467 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 86.16 -9.66 68.95 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.373 -0.831 . . . . 0.0 113.458 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -121.02 135.42 55.21 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 117.726 0.763 . . . . 0.0 111.72 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.506 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 29.7 m -79.33 90.75 4.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.559 172.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.524 ' HB3' HD13 ' A' ' 28' ' ' ILE . 24.9 t70 -90.45 107.35 19.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.697 0.76 . . . . 0.0 110.901 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.6 m -81.47 149.98 28.51 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.532 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 26.3 m -92.07 128.63 44.67 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.141 174.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 5.1 Cg_exo -75.48 -173.04 1.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.817 1.678 . . . . 0.0 112.063 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.915 -177.631 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.9 pt -126.27 153.21 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.034 0.445 . . . . 0.0 110.851 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -80.73 42.05 0.6 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.615 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.7 t -110.59 146.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.072 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -81.66 138.92 35.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.234 0.54 . . . . 0.0 111.578 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 16.1 t -73.09 79.02 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.957 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -91.29 -47.92 7.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 172.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -150.74 142.8 24.03 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -66.21 -37.44 85.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.76 0.314 . . . . 0.0 110.985 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.1 -17.54 75.78 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.717 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.86 -41.09 26.99 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 75.2 m -62.83 -24.53 67.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.674 -176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.29 -35.66 80.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 0.0 111.565 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 61.8 mttp -64.51 -50.85 63.62 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -172.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 73.8 Cg_endo -78.53 -17.21 12.91 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.396 1.398 . . . . 0.0 112.355 176.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 39.6 t -73.58 -38.21 65.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.147 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 54.6 pttt -65.66 -21.85 66.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.312 0.577 . . . . 0.0 110.317 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -82.55 -16.74 47.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.672 0.748 . . . . 0.0 109.177 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.33 -11.11 53.02 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.18 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.546 ' O ' ' HE3' ' A' ' 37' ' ' LYS . . . 83.05 22.96 56.58 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.805 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.493 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.4 mmt -103.02 177.33 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.518 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.4 ttp180 -89.49 -68.23 0.79 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.02 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.518 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.35 172.91 9.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.341 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -139.85 107.22 0.53 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -86.89 154.35 20.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.191 0.52 . . . . 0.0 110.144 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.15 106.88 15.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.28 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 28' ' ' ILE . 2.3 tp -106.87 177.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.04 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -47.95 90.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.094 0.557 . . . . 0.0 111.499 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.41 -20.67 4.85 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.555 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 32.9 mmtp -123.47 178.78 5.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.363 0.582 . . . . 0.0 111.282 -170.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 80.2 m -108.48 113.57 26.71 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.28 117.3 32.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.999 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 65.3 m -91.02 150.69 21.34 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.501 0.667 . . . . 0.0 112.331 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.422 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 33.9 m -100.94 125.54 38.05 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.413 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 3.9 Cg_exo -72.47 145.37 42.4 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.148 1.899 . . . . 0.0 112.024 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HE3' ' O ' ' A' ' 21' ' ' GLY . 18.5 pttp . . . . . 0 C--O 1.249 1.042 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.246 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 112.768 -0.133 . . . . 0.0 112.768 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.446 HD11 ' SG ' ' A' ' 32' ' ' CYS . 28.5 pt -112.39 -178.89 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.774 0.321 . . . . 0.0 110.327 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -81.48 41.21 0.61 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.916 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.33 148.05 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.25 157.34 16.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.968 0.413 . . . . 0.0 110.906 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.9 t -77.92 77.49 4.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.326 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -90.59 -52.59 4.82 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.789 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 19.2 m80 -147.24 137.13 23.08 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.8 p -64.38 -39.11 93.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.878 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.75 -19.96 79.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.894 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 9' ' ' HIS . 17.4 tt0 -70.13 -26.31 63.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.225 0.536 . . . . 0.0 110.07 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.48 -11.17 59.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.394 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.0 mt -59.89 -48.97 79.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.931 0.396 . . . . 0.0 111.614 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 52.2 mttm -67.38 -57.59 10.28 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -175.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 27.4 Cg_endo -62.41 -25.63 76.27 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 121.918 1.745 . . . . 0.0 112.781 -174.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' HA3' ' A' ' 25' ' ' GLY . 97.7 m -76.58 -38.51 54.76 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.1 0.476 . . . . 0.0 110.668 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -65.4 -36.8 85.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.169 0.509 . . . . 0.0 110.701 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 33.9 mmtp -76.2 -7.75 55.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.718 0.77 . . . . 0.0 109.541 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.3 5.27 50.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.378 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.99 26.81 54.9 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.731 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' A' ' 34' ' ' CYS . 37.4 mtt -123.65 175.71 6.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -88.17 -81.86 0.24 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.59 -174.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -110.88 -179.41 3.73 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -140.22 114.51 0.98 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.003 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -91.89 155.16 18.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.089 0.471 . . . . 0.0 109.968 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.22 105.68 17.97 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.6 tp -100.59 179.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -172.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.512 ' N ' HG23 ' A' ' 28' ' ' ILE . 38.0 m-20 -51.44 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.523 0.729 . . . . 0.0 112.21 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.422 ' C ' ' HD2' ' A' ' 31' ' ' LYS . . . 83.01 -17.51 21.96 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.023 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 30' ' ' GLY . 1.3 mptm? -121.22 -177.17 3.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.297 0.57 . . . . 0.0 111.217 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 3' ' ' ILE . 37.0 t -111.67 111.67 22.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.818 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -103.38 113.88 27.72 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.454 0.645 . . . . 0.0 110.476 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 24.0 m -93.1 151.66 19.73 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.978 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.8 m -96.43 108.26 41.02 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.36 152.68 15.85 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.04 1.827 . . . . 0.0 111.479 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.133 176.685 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -126.99 160.44 35.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.021 0.439 . . . . 0.0 110.686 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.69 42.75 0.63 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.838 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.7 142.94 40.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 51.3 pttt -91.05 138.31 31.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.6 t -72.28 111.8 7.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.162 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HD2' HE22 ' A' ' 12' ' ' GLN . 96.4 mttt -91.53 -33.87 15.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 54.6 m80 -150.01 143.68 25.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p -75.71 76.98 2.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.833 0.825 . . . . 0.0 110.901 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.83 -28.16 0.59 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.815 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.582 HE22 ' HD2' ' A' ' 8' ' ' LYS . 13.6 tt0 -62.69 -28.4 69.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.325 0.583 . . . . 0.0 109.76 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 70.3 m -63.78 -9.27 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.934 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.453 HD22 ' H ' ' A' ' 25' ' ' GLY . 3.4 mm? -65.88 -37.04 85.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.864 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.495 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 98.6 mttt -60.05 -54.01 59.51 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.117 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 51.5 Cg_endo -74.3 -24.37 14.48 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.41 1.407 . . . . 0.0 112.386 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 20.7 t -73.38 -39.22 65.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.332 -175.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -69.88 -21.51 63.32 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.022 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -88.17 -0.84 57.56 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.637 0.732 . . . . 0.0 109.18 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.23 -16.52 19.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.936 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.0 7.97 60.73 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.994 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.488 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.0 mmt -96.79 178.53 5.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.375 -0.13 . . . . 0.0 110.678 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.477 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 20.8 ttp180 -87.61 -69.14 0.71 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.853 -174.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.497 ' HD1' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -124.68 167.75 14.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -131.8 107.71 0.75 Allowed Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.14 168.2 12.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.167 0.508 . . . . 0.0 110.5 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 t -84.75 122.14 28.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.889 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.2 tp -118.65 178.68 2.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.549 ' N ' HG23 ' A' ' 28' ' ' ILE . 19.3 m-20 -48.85 86.35 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.979 0.799 . . . . 0.0 111.747 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.23 -18.07 4.53 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.436 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 34.1 mmtp -121.55 173.41 7.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.602 0.701 . . . . 0.0 111.838 -170.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 90.2 m -98.06 116.86 31.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.081 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -106.74 122.92 47.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.31 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 58.2 m -90.76 152.32 20.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.44 0.638 . . . . 0.0 112.138 -175.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.497 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 95.9 m -112.64 122.41 36.32 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.556 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.06 169.81 21.34 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.106 1.87 . . . . 0.0 112.058 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.9 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.581 HD11 ' SG ' ' A' ' 32' ' ' CYS . 17.2 pt -115.21 162.44 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.198 0.523 . . . . 0.0 110.662 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -75.31 11.3 1.25 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.059 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.455 HG11 ' HG3' ' A' ' 16' ' ' PRO . 22.1 t -91.6 140.48 16.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -86.5 131.56 34.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.929 0.395 . . . . 0.0 110.11 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 49.5 t -91.04 115.49 28.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.925 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -91.54 -35.95 13.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 171.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -145.1 151.76 39.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.552 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -61.84 -43.16 99.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.804 0.335 . . . . 0.0 111.342 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.34 -24.68 67.72 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.033 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.85 -28.19 50.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.975 0.417 . . . . 0.0 110.206 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 7' ' ' CYS . 43.0 t -73.22 -25.65 60.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.617 0.722 . . . . 0.0 109.401 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -67.93 -29.55 68.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.464 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 47.7 mmtm -66.3 -53.84 28.99 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 86.3 Cg_endo -81.08 -17.64 9.21 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.338 1.359 . . . . 0.0 111.839 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 48.6 t -75.46 -39.33 58.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.294 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.58 -32.19 73.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.801 0.334 . . . . 0.0 110.631 -179.437 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 19.6 pttp -86.11 -13.99 45.56 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.839 0.828 . . . . 0.0 109.186 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.14 -14.19 60.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.199 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.69 9.79 64.0 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.956 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.414 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.5 mmt -94.5 -178.11 4.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.442 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 6.4 ttp180 -90.19 -73.12 0.53 Allowed 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.87 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.543 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -123.93 172.6 8.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.311 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -136.9 112.92 0.98 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -91.82 155.93 17.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.04 109.64 17.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.157 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -96.71 165.64 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.402 ' N ' HG23 ' A' ' 28' ' ' ILE . 24.5 m-80 -59.29 83.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.548 0.53 . . . . 0.0 111.394 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.35 -25.67 27.32 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.011 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.47 ' H ' HG22 ' A' ' 28' ' ' ILE . 14.3 mmmm -122.57 159.24 28.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.62 0.71 . . . . 0.0 112.326 -169.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 3' ' ' ILE . 42.0 t -90.24 105.45 17.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.144 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -101.82 125.39 48.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.714 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.5 m -97.51 154.54 17.44 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.418 0.628 . . . . 0.0 112.182 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.463 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 33.9 m -105.4 131.07 22.09 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.772 172.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -81.53 159.65 19.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.201 1.934 . . . . 0.0 111.617 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.191 179.658 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 111.879 -0.489 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 pt -125.44 157.63 34.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.23 0.538 . . . . 0.0 110.705 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -79.55 48.32 0.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.759 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -130.45 139.91 50.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.072 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.78 132.64 34.54 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.35 85.57 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.128 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 32.0 mtmm -92.17 105.63 17.81 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.2 m80 70.12 119.1 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.599 0.562 . . . . 0.0 109.823 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 p -70.79 77.54 0.62 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.785 0.802 . . . . 0.0 110.606 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.37 -23.33 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.625 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 54.2 tt0 -74.62 -26.39 59.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.854 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 59.6 m -69.66 -11.39 60.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.399 -172.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.3 mt -65.95 -49.2 68.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.637 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 64.1 mttp -54.36 -58.97 11.46 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.472 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 45.6 Cg_endo -69.2 -19.84 38.24 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.565 1.51 . . . . 0.0 112.414 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 34.6 t -74.38 -29.99 61.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -63.36 -37.66 88.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.477 175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -76.71 1.82 16.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.641 0.734 . . . . 0.0 109.89 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.23 -7.7 17.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.104 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.02 22.31 78.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.308 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.642 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 22.4 mmt -98.12 -177.31 3.69 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.445 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 4.8 ttp180 -90.26 -73.25 0.53 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.709 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.531 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.15 174.63 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -127.33 104.27 0.69 Allowed Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 20.5 ptmt -89.03 153.35 21.07 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.955 0.407 . . . . 0.0 109.951 -177.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 t -80.28 118.18 21.71 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.292 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -106.28 164.34 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 173.214 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.411 ' N ' HG23 ' A' ' 28' ' ' ILE . 35.8 m-20 -57.2 85.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.41 0.624 . . . . 0.0 111.659 -176.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 -23.12 37.48 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.829 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -122.33 151.19 41.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.282 0.541 . . . . 0.0 110.996 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 88.1 m -85.75 113.47 21.95 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 172.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.59 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 27.8 t70 -109.35 123.09 48.75 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.447 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 75.9 m -89.6 154.37 20.03 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.574 0.702 . . . . 0.0 112.226 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 31.3 m -98.18 130.24 28.94 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.884 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 7.2 Cg_exo -69.07 152.75 72.84 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.719 1.613 . . . . 0.0 111.224 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.775 -0.631 . . . . 0.0 110.023 178.08 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.473 0 N-CA-C 113.849 0.299 . . . . 0.0 113.849 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 32' ' ' CYS . 33.2 pt -86.06 175.04 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 109.962 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -86.91 44.07 1.14 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.363 0.601 . . . . 0.0 111.003 -175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -131.58 149.98 33.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.524 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -99.74 138.19 37.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.24 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -70.11 86.38 0.56 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.951 0.405 . . . . 0.0 111.105 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HE3' ' OE1' ' A' ' 12' ' ' GLN . 56.6 mtmt -91.83 -41.24 10.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 167.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 12' ' ' GLN . 27.4 m80 -148.61 133.87 18.41 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.4 p -66.73 -36.26 82.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.762 0.315 . . . . 0.0 111.034 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.51 -19.24 76.13 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.492 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.604 ' OE1' ' HE3' ' A' ' 8' ' ' LYS . 34.7 tt0 -82.44 -23.19 34.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.897 0.379 . . . . 0.0 110.087 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.597 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 75.8 m -69.48 -18.92 63.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.327 0.584 . . . . 0.0 109.57 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' A' ' 24' ' ' PHE . 4.2 tp -75.54 -36.67 60.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.811 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 29.1 mmmt -54.1 -53.7 55.64 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.838 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 54.1 Cg_endo -78.38 -18.93 12.09 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.515 1.477 . . . . 0.0 111.921 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 11.7 t -65.39 -24.96 67.35 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.123 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 8.7 ptpp? -61.06 -30.44 70.33 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.818 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -90.15 -13.13 36.31 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.395 0.617 . . . . 0.0 109.737 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.67 56.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.46 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.09 29.9 66.1 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.145 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.583 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.4 mmt -107.23 -178.47 3.65 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.235 -175.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.452 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 20.9 ttp180 -89.64 -77.9 0.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.216 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.452 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -112.72 174.35 5.93 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.159 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -135.54 100.19 0.34 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -90.21 163.37 14.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.182 0.515 . . . . 0.0 110.342 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -87.24 122.21 30.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.904 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.533 HG22 ' HB2' ' A' ' 31' ' ' LYS . 1.0 OUTLIER -109.09 173.06 2.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 28' ' ' ILE . 42.3 m-80 -58.57 87.72 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.245 0.545 . . . . 0.0 111.422 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.09 -24.02 30.63 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.712 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HB2' HG22 ' A' ' 28' ' ' ILE . 47.6 mmtm -121.42 170.98 9.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.02 0.438 . . . . 0.0 111.266 -170.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.625 ' O ' HG12 ' A' ' 3' ' ' ILE . 85.7 m -98.19 120.35 38.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 168.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' HB3' HD13 ' A' ' 28' ' ' ILE . 22.7 t70 -109.42 124.16 50.55 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.843 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.496 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 80.8 m -92.46 151.63 20.11 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.158 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.448 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 91.3 m -97.63 118.45 64.16 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.181 175.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.66 144.37 31.47 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.103 1.869 . . . . 0.0 112.487 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp . . . . . 0 C--O 1.248 0.975 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.778 -178.696 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.523 HD11 ' SG ' ' A' ' 13' ' ' CYS . 12.3 pt -114.85 162.39 12.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.944 0.402 . . . . 0.0 110.736 -176.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -81.84 20.7 0.93 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.586 -175.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.98 133.61 29.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.998 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -74.6 134.94 42.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.938 0.399 . . . . 0.0 110.144 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 t -68.16 101.59 1.19 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.433 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -91.59 -47.67 7.27 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -149.12 132.82 16.88 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.4 p -71.1 114.45 9.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.063 0.459 . . . . 0.0 110.529 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.93 -27.43 9.67 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.531 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -73.37 -22.11 60.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.377 0.608 . . . . 0.0 110.135 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' HD11 ' A' ' 3' ' ' ILE . 22.6 t -80.78 8.41 8.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.731 -175.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.477 HD22 ' H ' ' A' ' 25' ' ' GLY . 2.4 mm? -70.01 -28.28 65.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.155 0.502 . . . . 0.0 110.748 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 34.8 mmtp -67.78 -57.13 10.33 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.402 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 57.7 Cg_endo -71.09 -18.46 30.86 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.58 1.52 . . . . 0.0 112.795 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 36.1 t -79.79 -36.23 37.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.35 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -68.91 -25.14 64.44 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.306 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -82.92 -17.8 42.39 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.974 0.893 . . . . 0.0 109.115 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.08 -8.6 58.43 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.109 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.94 5.06 81.45 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.084 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.52 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 23.0 mmt -94.95 177.45 5.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.641 0.257 . . . . 0.0 110.88 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 2.8 ttp180 -88.41 -73.41 0.5 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.292 -173.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -121.99 154.19 37.56 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.392 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.477 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -106.19 110.3 3.33 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.624 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -90.66 154.9 19.23 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.85 120.22 30.9 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.059 0.457 . . . . 0.0 110.818 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.2 tp -109.46 168.54 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.422 ' N ' HG23 ' A' ' 28' ' ' ILE . 1.3 t30 -44.23 98.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.832 0.825 . . . . 0.0 110.776 173.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.41 -27.11 2.15 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 114.797 -1.092 . . . . 0.0 114.031 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 28' ' ' ILE . 74.8 mmtt -120.85 -177.32 3.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.731 0.766 . . . . 0.0 111.038 -168.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.6 t -114.2 114.81 26.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.185 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.457 ' HB3' HD13 ' A' ' 28' ' ' ILE . 23.9 t70 -103.38 115.57 30.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.356 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -88.53 155.86 19.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.849 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 62.7 m -97.67 132.52 24.92 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.93 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -70.25 170.62 16.74 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.787 1.658 . . . . 0.0 112.378 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.582 176.452 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -116.39 163.26 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -76.77 33.54 0.14 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.281 0.562 . . . . 0.0 111.887 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.63 151.76 17.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.682 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 35.3 mtmm -109.52 145.23 36.63 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 t -69.17 95.13 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.697 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -92.43 -42.92 9.48 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 167.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -148.29 126.02 11.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.446 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 p -66.99 -21.87 65.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.081 0.467 . . . . 0.0 111.048 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.86 -35.67 44.4 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.413 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -71.0 -30.06 66.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.077 0.465 . . . . 0.0 110.213 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.9 t -62.04 -19.29 62.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.992 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.508 HD12 ' H ' ' A' ' 25' ' ' GLY . 6.8 mp -72.15 -31.94 66.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.343 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.538 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 29.6 mtpp -58.91 -56.58 34.62 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.078 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 72.8 Cg_endo -76.71 -17.17 16.12 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.336 1.358 . . . . 0.0 112.21 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 35.3 t -80.36 -34.74 36.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.279 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 64.8 pttt -67.83 -24.78 65.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.159 0.504 . . . . 0.0 109.921 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -83.11 -9.6 59.12 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.575 0.702 . . . . 0.0 109.35 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.44 -15.16 31.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.989 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.73 13.16 63.22 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.009 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.506 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.2 mmt -94.91 -178.13 4.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.613 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 7.1 ttp180 -90.26 -65.7 0.99 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.72 -176.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.613 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -129.59 166.91 18.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 109.966 175.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' H ' HD12 ' A' ' 14' ' ' LEU . . . -113.59 109.62 2.3 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -91.08 152.1 20.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.051 0.453 . . . . 0.0 110.162 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.7 m -82.94 114.72 21.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.724 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -107.21 176.18 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.766 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.555 ' N ' HG23 ' A' ' 28' ' ' ILE . 4.8 p30 -44.75 85.08 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.739 0.78 . . . . 0.0 112.684 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 82.38 -21.33 7.35 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.169 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 99.1 mttt -120.19 172.52 7.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.427 0.632 . . . . 0.0 112.359 -168.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.73 103.18 14.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.581 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -105.15 117.42 33.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.134 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.3 m -83.52 154.58 23.79 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.698 0.761 . . . . 0.0 112.617 -174.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.46 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 89.2 m -101.71 116.82 62.91 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.843 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -69.67 152.71 69.82 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.332 2.021 . . . . 0.0 112.62 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.069 176.479 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.514 ' HA2' ' H ' ' A' ' 34' ' ' CYS . . . . . . . . 0 N--CA 1.446 -0.699 0 N-CA-C 112.338 -0.305 . . . . 0.0 112.338 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 32' ' ' CYS . 12.7 pt -128.8 157.7 41.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.961 0.41 . . . . 0.0 110.184 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -72.38 11.11 0.65 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.264 -177.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.78 135.85 23.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 46.2 mtpt -86.97 133.71 33.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.2 t -72.12 104.31 3.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -39.15 13.12 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 172.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -148.29 138.54 22.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.916 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 p -62.95 -27.24 69.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.066 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.41 -32.66 41.87 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.816 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -69.2 -15.95 63.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.389 0.275 . . . . 0.0 111.594 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 77.5 m -77.39 -16.79 58.67 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -176.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.85 -37.48 58.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.766 0.317 . . . . 0.0 111.594 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -53.02 -55.37 34.27 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.687 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 73.9 Cg_endo -77.66 -16.61 14.72 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.439 1.426 . . . . 0.0 112.197 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 38.5 t -75.4 -37.4 60.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.322 -175.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.454 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.76 -18.15 64.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.127 0.489 . . . . 0.0 110.13 178.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 16' ' ' PRO . 8.0 mtmp? -85.86 -14.29 45.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.634 0.731 . . . . 0.0 109.196 177.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.79 -7.62 57.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.336 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.58 16.86 69.79 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.028 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.541 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 25.2 mmt -97.85 179.64 4.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.659 0.266 . . . . 0.0 110.47 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 4.5 ttp180 -90.74 -69.83 0.71 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.535 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.472 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.63 169.5 11.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.83 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -125.29 109.4 1.19 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 19.4 ptmt -90.25 156.78 18.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.5 t -83.66 114.61 21.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.074 0.464 . . . . 0.0 110.242 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.606 HG22 ' H ' ' A' ' 31' ' ' LYS . 1.0 OUTLIER -103.33 170.71 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.396 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.467 ' N ' HG23 ' A' ' 28' ' ' ILE . 10.9 m-20 -38.41 -43.94 0.87 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -167.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.17 -0.48 1.65 Allowed Glycine 0 C--N 1.318 -0.419 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.596 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.606 ' H ' HG22 ' A' ' 28' ' ' ILE . 96.2 mttt -123.79 166.91 14.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.762 -172.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.452 ' O ' HG12 ' A' ' 3' ' ' ILE . 98.3 m -90.97 100.71 13.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 169.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.633 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 18.5 t70 -95.06 118.9 32.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.694 -177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.514 ' H ' ' HA2' ' A' ' 2' ' ' GLY . 69.6 m -88.5 153.41 21.17 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.638 0.732 . . . . 0.0 112.611 -172.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.449 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 52.6 m -109.34 118.4 50.94 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.946 171.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 18.0 Cg_exo -69.35 -177.74 1.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.884 2.389 . . . . 0.0 112.317 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.245 0.839 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.205 177.877 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.87 153.03 18.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 117.217 0.509 . . . . 0.0 110.55 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -77.39 71.0 3.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.421 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 17.0 t -146.38 136.09 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -88.47 134.41 33.86 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.3 t -73.08 91.03 1.57 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.131 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -82.68 -34.02 27.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 28.6 m80 -147.5 148.59 31.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.983 177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 p -67.17 -34.4 77.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.183 0.516 . . . . 0.0 110.129 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.94 -12.63 81.14 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.623 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 9' ' ' HIS . 20.6 tt0 -84.1 -15.74 46.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.653 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 62.7 m -90.54 -17.33 27.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.022 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.666 HD23 ' H ' ' A' ' 25' ' ' GLY . 87.9 mt -74.18 -51.51 15.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.178 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 58.5 mttp -52.52 -53.51 52.78 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.847 -175.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 49.1 Cg_endo -73.39 -15.9 24.84 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.525 1.483 . . . . 0.0 112.88 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.653 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 14.4 t -78.69 -36.35 43.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.946 0.403 . . . . 0.0 111.234 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -69.79 -21.52 63.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.24 0.543 . . . . 0.0 109.932 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -83.84 -11.93 56.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.712 0.768 . . . . 0.0 109.044 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.87 -14.59 27.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.068 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.07 17.74 64.44 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.063 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.578 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 23.8 mmt -96.64 170.72 9.01 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.985 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 4.7 ttp180 -76.2 -68.46 0.58 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.602 -173.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.525 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -128.18 154.07 46.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 174.465 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.666 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -109.95 97.25 1.0 Allowed Glycine 0 C--N 1.309 -0.927 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -90.33 160.59 16.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.147 0.498 . . . . 0.0 110.694 -175.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.3 t -83.85 118.28 23.86 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.031 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.6 tp -110.46 -178.02 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.504 ' N ' HG23 ' A' ' 28' ' ' ILE . 43.9 m-80 -48.93 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.143 0.497 . . . . 0.0 111.901 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.04 -10.95 2.88 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.77 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 28' ' ' ILE . 30.4 ttpt -123.18 161.96 23.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.192 0.496 . . . . 0.0 111.584 -168.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.531 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 68.1 m -91.57 102.15 14.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.44 0.638 . . . . 0.0 110.45 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -99.81 127.29 45.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.505 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.0 m -96.88 149.34 21.98 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.448 0.642 . . . . 0.0 111.653 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.472 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 57.2 m -102.28 116.96 62.21 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.521 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.62 167.14 27.3 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.346 2.031 . . . . 0.0 111.43 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.4 mttp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.096 178.42 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.428 HD13 ' SG ' ' A' ' 34' ' ' CYS . 18.0 pt -118.51 164.08 15.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.172 0.51 . . . . 0.0 110.627 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -74.47 13.3 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.847 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.4 t -95.05 133.86 34.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.559 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.29 149.38 26.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 t -73.2 81.22 1.31 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.055 0.455 . . . . 0.0 110.211 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.43 -40.38 26.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.321 0.581 . . . . 0.0 110.11 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.679 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 6.9 p-80 -169.61 123.85 0.79 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.251 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.2 p -63.27 99.87 0.21 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.692 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.23 -30.01 1.34 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.679 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 24.8 tt0 -60.84 -34.5 74.67 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.943 0.402 . . . . 0.0 111.702 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 97.4 m -69.59 -9.5 54.32 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -168.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.51 -38.99 75.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.037 0.446 . . . . 0.0 110.667 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.516 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 75.0 mmtt -70.22 -56.25 7.17 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.207 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 50.8 Cg_endo -71.02 -29.28 18.11 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.585 1.523 . . . . 0.0 113.414 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 43.2 t -75.09 -36.12 61.74 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.319 -0.238 . . . . 0.0 111.546 -174.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 60.5 pttt -63.98 -23.17 67.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 109.903 175.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -83.09 -14.52 53.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.344 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.85 -12.34 48.16 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.844 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.73 19.55 53.7 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.474 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.636 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 43.8 mtt -116.17 173.63 6.48 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.3 ttp180 -84.28 -76.06 0.32 Allowed 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.538 -170.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.519 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -123.12 178.21 5.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.681 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -133.33 115.12 1.48 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 12.6 ptmm? -91.22 166.88 12.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.975 0.417 . . . . 0.0 110.047 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.55 135.4 35.58 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 31' ' ' LYS . 1.3 tp -123.26 173.23 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.451 ' N ' HG23 ' A' ' 28' ' ' ILE . 10.0 p30 -36.91 -44.58 0.51 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -166.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.19 -6.31 1.23 Allowed Glycine 0 C--N 1.317 -0.509 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.824 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.474 ' H ' HG22 ' A' ' 28' ' ' ILE . 34.3 mmtp -122.37 -165.86 1.34 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.947 0.403 . . . . 0.0 110.386 -168.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.3 t -118.27 125.92 51.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.953 175.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.459 ' HB3' HD13 ' A' ' 28' ' ' ILE . 22.0 t70 -111.51 123.98 51.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.197 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.539 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 21.7 m -87.66 155.88 19.73 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.642 0.734 . . . . 0.0 112.717 -173.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.467 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 89.4 m -107.27 128.69 25.52 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.712 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.33 -176.07 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.234 1.956 . . . . 0.0 112.03 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.4 pttm . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.834 -179.26 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.57 ' HA2' ' H ' ' A' ' 34' ' ' CYS . . . . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.04 163.07 32.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.817 0.341 . . . . 0.0 110.277 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -70.24 4.18 2.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.105 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 14.1 t -84.93 138.18 19.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.17 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -90.18 139.26 30.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.27 104.83 4.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.576 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 62.8 mttp -91.73 -43.83 9.34 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 167.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -144.51 152.79 41.09 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.447 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 3.2 p -60.99 -50.73 72.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.996 0.362 . . . . 0.0 111.817 -175.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.47 -13.72 65.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.476 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 23.5 tt0 -70.69 -31.01 67.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.353 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 81.9 m -78.81 -21.31 47.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.604 -175.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.529 HD22 ' H ' ' A' ' 25' ' ' GLY . 1.3 mm? -64.94 -35.37 80.96 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.98 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 60.8 mtpt -60.21 -60.76 9.58 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.345 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 50.9 Cg_endo -71.44 -16.99 30.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.075 1.85 . . . . 0.0 112.678 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 15.4 t -70.75 -34.08 71.47 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.374 -174.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 23.5 pttm -63.82 -25.95 68.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.398 . . . . 0.0 110.48 176.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -88.69 -14.34 37.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.338 0.59 . . . . 0.0 109.543 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.21 45.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.2 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.91 15.46 48.84 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.66 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.518 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.3 mmt -99.67 -179.39 4.17 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.623 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.486 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 5.8 ttp180 -90.26 -65.78 0.99 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.496 -175.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.27 162.4 23.8 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 174.375 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -126.71 94.95 0.43 Allowed Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HZ3' HD11 ' A' ' 28' ' ' ILE . 21.1 pttp -90.87 159.35 16.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.366 0.603 . . . . 0.0 110.99 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -83.64 113.73 21.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.423 -177.193 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -106.36 169.94 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.748 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' N ' HG23 ' A' ' 28' ' ' ILE . 4.7 p30 -43.3 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.934 0.873 . . . . 0.0 113.173 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 80.06 -14.32 21.44 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.566 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -121.64 144.94 48.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.517 0.659 . . . . 0.0 111.541 -171.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.448 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 62.2 m -79.42 99.34 7.14 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.367 173.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' HB3' HD13 ' A' ' 28' ' ' ILE . 24.7 t70 -99.49 118.19 35.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.4 0.619 . . . . 0.0 110.75 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.57 ' H ' ' HA2' ' A' ' 2' ' ' GLY . 62.1 m -93.08 149.93 20.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.684 -176.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.474 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 98.7 m -111.56 126.14 29.11 Favored Pre-proline 0 N--CA 1.439 -0.985 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.225 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.71 -168.03 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.398 2.065 . . . . 0.0 112.26 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.7 mttp . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.627 -0.702 . . . . 0.0 109.898 179.75 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -105.24 -179.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.055 0.455 . . . . 0.0 110.836 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -83.56 42.68 0.85 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.624 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.64 152.38 36.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.248 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -95.65 147.54 23.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.79 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 41.8 t -78.3 57.23 1.85 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.854 -174.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -93.4 104.88 17.0 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.7 m80 67.9 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.762 0.664 . . . . 0.0 110.73 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 p -60.74 -28.16 68.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.07 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.4 -20.52 76.96 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.523 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -76.98 -33.12 57.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.573 0.225 . . . . 0.0 110.831 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 74.7 m -65.78 -18.22 65.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.579 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 25' ' ' GLY . 1.1 mm? -64.84 -36.41 84.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.682 0.277 . . . . 0.0 111.245 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 4.8 mptp? -65.76 -56.71 16.63 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.08 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 39.8 Cg_endo -71.01 -19.07 30.62 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.329 1.353 . . . . 0.0 112.701 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.5 m -76.38 -38.66 55.41 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.45 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 49.0 pttt -69.5 -26.75 64.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 95.3 mttt -75.67 -23.42 56.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.7 58.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.358 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.56 11.81 76.7 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.305 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.655 ' SD ' ' HA ' ' A' ' 36' ' ' PRO . 23.5 mmt -95.65 175.67 6.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.389 0.137 . . . . 0.0 111.117 -177.132 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 14.9 ttp180 -80.7 -71.49 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.24 -173.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.468 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -119.67 -176.88 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.169 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.459 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -136.17 102.81 0.42 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.388 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -85.26 156.31 21.0 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -96.16 109.71 22.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.407 HG23 ' N ' ' A' ' 29' ' ' ASN . 2.2 tp -104.3 177.98 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.665 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.407 ' N ' HG23 ' A' ' 28' ' ' ILE . 9.6 m-80 -53.2 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.001 0.52 . . . . 0.0 111.63 -177.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.91 -18.06 28.56 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.162 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 66.3 mttm -122.94 179.47 4.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.09 0.445 . . . . 0.0 110.564 -172.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.3 m -107.0 120.27 41.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -103.31 107.87 18.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.687 0.756 . . . . 0.0 110.381 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.9 m -81.09 142.07 33.68 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.357 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 m -88.98 121.05 69.99 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.655 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 17.7 Cg_endo -75.04 120.56 6.1 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.998 1.799 . . . . 0.0 112.38 -175.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.602 ' OXT' ' HD2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.814 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-O 120.939 0.188 . . . . 0.0 113.434 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.577 HD13 ' SG ' ' A' ' 34' ' ' CYS . 33.9 pt -120.17 167.62 13.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.53 67.56 7.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.955 0.407 . . . . 0.0 109.92 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -148.36 135.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -86.9 138.47 31.52 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 t -67.69 101.96 1.12 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.343 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.66 -50.74 5.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -149.65 135.16 18.4 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.5 p -62.17 -33.62 74.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.35 -31.58 61.01 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.967 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -76.72 -20.31 56.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' HA3' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -69.0 -13.58 62.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.413 -177.125 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.79 -35.43 78.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.947 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 97.7 mttt -57.07 -54.16 57.58 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.526 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 46.7 Cg_endo -74.49 -25.43 13.0 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.034 1.156 . . . . 0.0 112.844 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 m -76.23 -31.56 58.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 19.6 ptpt -68.41 -25.42 65.03 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -85.91 -11.09 54.08 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.269 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.2 -1.41 56.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.088 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.17 74.35 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.197 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.404 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 25.3 mmt -110.05 178.32 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.858 -0.201 . . . . 0.0 110.946 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.49 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 19.8 ttp180 -81.87 -70.04 0.57 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.169 -173.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.49 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.99 -177.23 3.78 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' A' ' 13' ' ' CYS . . . -126.72 107.91 0.95 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.872 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -91.9 157.05 17.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 m -90.05 129.69 36.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.216 0.532 . . . . 0.0 110.655 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.3 tp -119.42 -179.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.113 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.518 ' N ' HG23 ' A' ' 28' ' ' ILE . 38.9 m-20 -47.68 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.396 0.678 . . . . 0.0 112.133 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.49 -15.36 4.64 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.183 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HB2' HG22 ' A' ' 28' ' ' ILE . 48.0 mtmt -120.76 -173.66 2.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.231 0.515 . . . . 0.0 110.825 -172.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.3 t -115.49 121.34 42.4 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.8 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -112.24 115.91 29.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.4 0.619 . . . . 0.0 110.338 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.577 ' SG ' HD13 ' A' ' 3' ' ' ILE . 36.5 m -79.85 143.87 33.96 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.633 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.9 m -82.52 120.02 75.88 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -79.73 131.75 9.4 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.122 1.881 . . . . 0.0 111.872 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.6 pttt . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.515 -178.919 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 16' ' ' PRO . 18.1 pt -130.7 171.54 17.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.471 0.653 . . . . 0.0 111.936 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.23 37.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.605 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.53 144.89 22.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.345 -177.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -91.24 141.58 28.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.046 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.9 t -72.26 94.1 1.54 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.33 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.14 -47.65 7.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 7.1 p-80 -166.17 147.33 6.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.636 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.7 p -51.01 -46.58 61.58 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -171.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.95 -19.66 56.69 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.447 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.545 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 26.1 tt0 -74.68 -43.87 53.05 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 66.4 m -68.93 -15.48 63.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.38 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.597 HD22 ' H ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -62.45 -41.0 98.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.001 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 67.7 mttm -68.34 -54.97 13.29 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -174.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 56.5 Cg_endo -71.12 -18.4 30.8 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.327 1.351 . . . . 0.0 112.815 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 m -80.26 -39.62 28.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.585 0.231 . . . . 0.0 111.329 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -72.15 -23.0 61.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.084 0.468 . . . . 0.0 110.039 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -89.22 -5.94 57.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.59 0.709 . . . . 0.0 109.421 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.2 -5.81 51.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.267 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.73 14.87 62.45 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.847 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.7 mmt -104.84 179.6 4.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 2.6 ttp180 -82.59 -74.6 0.34 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.994 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -122.63 -179.94 4.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.386 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.597 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -131.47 111.03 1.03 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.963 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -91.1 153.67 19.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.898 0.38 . . . . 0.0 110.014 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -91.26 111.63 23.2 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 28' ' ' ILE . 2.4 tp -115.57 -179.12 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.027 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.424 ' N ' HG23 ' A' ' 28' ' ' ILE . 21.6 m-80 -44.37 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.87 0.868 . . . . 0.0 112.621 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.94 -8.23 3.68 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.392 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.483 ' HG2' ' N ' ' A' ' 32' ' ' CYS . 36.9 ttmt -122.9 167.4 13.6 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 122.559 -0.377 . . . . 0.0 110.001 -173.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.483 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 91.1 m -100.66 112.63 25.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.023 0.439 . . . . 0.0 109.895 169.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -96.43 109.11 21.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.62 0.724 . . . . 0.0 110.065 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 32.1 m -80.54 143.22 33.42 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.539 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.6 m -88.16 132.41 39.71 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -69.18 166.48 26.74 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.474 1.449 . . . . 0.0 110.828 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.489 -177.578 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 32' ' ' CYS . 28.5 pt -104.26 174.35 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.139 0.495 . . . . 0.0 110.606 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -76.23 7.91 3.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.302 -172.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.0 139.52 19.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.841 -173.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -83.32 142.98 30.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.517 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 5.7 t -79.18 101.55 8.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.777 -176.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -91.94 -57.07 2.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 168.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -147.01 156.45 43.05 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -62.46 -38.09 88.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.829 0.347 . . . . 0.0 110.752 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.79 -27.41 64.17 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.604 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -73.16 -44.97 59.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 0.0 110.243 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.96 -16.3 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.41 -172.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.696 HD23 ' H ' ' A' ' 25' ' ' GLY . 82.5 mt -56.94 -49.74 74.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.424 0.631 . . . . 0.0 111.3 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 22.3 ttmm -60.17 -54.8 51.68 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.317 -172.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 52.1 Cg_endo -73.96 -20.79 19.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.148 1.232 . . . . 0.0 113.077 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 m -77.6 -34.35 53.47 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 64.2 pttt -68.6 -25.59 64.95 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -86.05 -6.34 59.05 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.498 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.0 4.86 50.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.322 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.96 22.67 71.05 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.105 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 34' ' ' CYS . 46.1 mtt -116.61 175.82 5.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.169 -176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 8.1 ttp180 -75.41 -72.36 0.31 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.139 0.274 . . . . 0.0 111.653 -170.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.547 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.3 -176.61 3.63 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.09 0.471 . . . . 0.0 110.137 177.125 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.696 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -123.58 115.58 2.66 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.708 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -90.95 156.85 17.66 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.76 109.9 22.03 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.905 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.685 HG22 ' H ' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -95.01 164.33 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.166 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -39.06 -36.96 0.34 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.25 -14.79 1.05 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.025 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.685 ' H ' HG22 ' A' ' 28' ' ' ILE . 68.2 mttm -123.81 167.31 14.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.781 0.324 . . . . 0.0 111.277 -169.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.405 ' O ' HG12 ' A' ' 3' ' ' ILE . 99.6 m -91.16 111.91 23.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.429 0.633 . . . . 0.0 110.525 173.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -85.53 158.52 20.13 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.573 ' HB2' ' SD ' ' A' ' 22' ' ' MET . 16.5 m -131.98 137.52 47.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.427 ' HB ' ' CD1' ' A' ' 24' ' ' PHE . 28.8 m -88.0 123.01 69.68 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.37 176.58 9.06 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.714 1.609 . . . . 0.0 111.498 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.413 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.004 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.019 0.233 . . . . 0.0 113.575 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.44 HD11 ' SG ' ' A' ' 32' ' ' CYS . 21.3 pt -110.02 171.61 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -81.28 45.18 0.83 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.986 0.422 . . . . 0.0 111.729 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.95 144.29 36.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.992 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -92.97 146.55 23.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.678 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 46.0 t -77.02 78.29 3.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.14 0.495 . . . . 0.0 111.276 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 52.7 mtpt -91.35 -50.21 5.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -143.9 136.6 27.15 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.0 p -66.69 -34.96 79.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.353 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.78 -18.2 79.48 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.586 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.455 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 61.1 tt0 -82.78 -31.14 28.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -19.64 65.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.474 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 25' ' ' GLY . 81.2 mt -61.14 -48.68 80.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.437 0.637 . . . . 0.0 110.737 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 56.3 mtpt -53.18 -56.71 21.29 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.322 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 57.9 Cg_endo -72.32 -28.93 14.58 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.304 1.336 . . . . 0.0 112.867 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.0 m -72.06 -36.87 69.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 65.1 pttt -67.45 -26.06 66.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.029 0.443 . . . . 0.0 109.867 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -79.88 -18.52 50.48 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.495 0.664 . . . . 0.0 109.327 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.06 9.16 23.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.068 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.94 19.25 80.03 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.008 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.1 mmt -97.89 175.34 6.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.75 0.309 . . . . 0.0 111.47 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 3.5 ttp180 -81.82 -66.06 0.94 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.164 -176.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.532 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -131.01 -177.51 4.41 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.642 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -125.14 116.65 2.76 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -91.91 146.46 23.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.249 0.547 . . . . 0.0 110.174 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.73 111.9 23.68 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 28' ' ' ILE . 2.2 tp -108.55 178.71 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.089 -171.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.404 ' N ' HG23 ' A' ' 28' ' ' ILE . 30.7 m-80 -49.63 87.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.065 0.546 . . . . 0.0 111.891 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.18 -15.93 8.1 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.254 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 74.9 mmtt -121.92 174.07 7.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.059 0.43 . . . . 0.0 110.988 -171.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.44 ' SG ' HD11 ' A' ' 3' ' ' ILE . 14.2 t -111.35 112.09 23.6 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -115.7 118.98 34.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.413 0.625 . . . . 0.0 109.845 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 27.8 m -79.44 165.84 22.63 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.168 -172.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.452 ' HB ' ' CD1' ' A' ' 24' ' ' PHE . 10.6 m -105.37 109.5 63.28 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.5 153.21 78.83 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.6 1.533 . . . . 0.0 111.137 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.902 177.205 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 16' ' ' PRO . 16.3 pt -122.89 176.07 5.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.145 0.497 . . . . 0.0 111.235 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -87.46 35.12 0.71 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.812 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 22.0 t -115.04 132.88 62.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-O 120.872 0.367 . . . . 0.0 110.279 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -80.69 126.81 31.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.994 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 t -67.35 93.8 0.35 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.272 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.29 -41.25 11.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.155 0.503 . . . . 0.0 110.371 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -144.12 135.86 26.06 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -174.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.463 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . 37.2 p -70.81 94.22 1.03 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.626 0.727 . . . . 0.0 110.282 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.64 -25.76 2.27 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -67.24 -25.44 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.299 0.571 . . . . 0.0 110.118 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.6 m -84.02 -9.26 58.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.453 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 25' ' ' GLY . 94.4 mt -61.47 -54.16 46.96 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 111.362 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.636 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 55.8 mtmt -59.57 -53.98 60.42 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.755 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HB2' HD12 ' A' ' 3' ' ' ILE . 20.1 Cg_endo -63.88 -24.45 67.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.214 1.276 . . . . 0.0 112.755 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -78.94 -37.92 38.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 13.8 ptmm? -71.11 -26.13 62.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.093 0.473 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 9.0 mtmp? -85.36 -5.2 59.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.703 0.763 . . . . 0.0 109.15 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.31 0.55 57.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.083 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 37' ' ' LYS . . . 80.65 19.13 68.96 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.014 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mmt -102.74 -175.8 2.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.46 0.171 . . . . 0.0 110.66 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 16.1 ttp180 -84.93 -71.23 0.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.678 0.275 . . . . 0.0 110.588 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -128.07 -179.37 4.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.192 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.701 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -131.49 104.54 0.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.605 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -91.35 158.81 16.33 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -92.15 114.75 27.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.037 0.446 . . . . 0.0 110.146 178.587 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.46 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.0 OUTLIER -99.81 162.86 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.089 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -58.33 87.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.397 0.618 . . . . 0.0 111.07 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.48 -31.85 8.17 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.02 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.421 ' H ' HG22 ' A' ' 28' ' ' ILE . 49.8 mtmt -121.8 147.6 45.74 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.362 -0.493 . . . . 0.0 111.882 -168.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 41.0 m -80.13 102.98 9.7 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 168.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.46 ' HB3' HD13 ' A' ' 28' ' ' ILE . 34.1 t70 -102.83 129.86 49.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.647 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.7 m -98.62 145.03 27.27 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.095 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 m -85.74 125.68 68.29 Favored Pre-proline 0 N--CA 1.446 -0.641 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -71.89 141.64 37.4 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.815 1.677 . . . . 0.0 111.264 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 21' ' ' GLY . 52.5 pttt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.496 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 77.6 t . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.567 0.222 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.35 124.39 0.26 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.023 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 pt -125.05 160.85 29.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -80.49 63.64 5.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.668 0.747 . . . . 0.0 109.965 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 22.0 t -140.08 160.81 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.671 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.45 ' N ' HG12 ' A' ' 5' ' ' VAL . 98.4 mttt -113.43 128.73 56.55 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.943 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.8 t -66.2 97.0 0.36 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.063 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 75.3 mmtt -90.39 -34.4 15.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 171.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -148.89 134.55 18.75 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.457 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 25.6 p -72.71 86.97 1.24 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.789 0.804 . . . . 0.0 110.692 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.1 -25.43 1.43 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.211 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 34.2 tt0 -67.62 -29.91 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.16 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 60.8 m -63.37 -12.74 32.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.414 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.441 HD22 ' H ' ' A' ' 25' ' ' GLY . 3.9 mm? -67.17 -37.51 83.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.931 0.396 . . . . 0.0 110.938 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 95.5 mttt -59.8 -51.67 79.21 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.004 -175.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 73.9 Cg_endo -78.62 -14.6 14.15 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.539 1.492 . . . . 0.0 112.494 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 11.0 t -75.44 -33.41 60.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.033 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 6.5 ptpp? -66.61 -20.67 66.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.947 0.403 . . . . 0.0 109.971 175.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -84.4 -19.64 33.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.04 -27.06 33.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.966 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.06 17.06 48.81 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.963 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.498 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 25.4 mmt -98.66 177.21 5.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.393 0.14 . . . . 0.0 111.119 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.511 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 6.3 ttp180 -78.21 -71.55 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.991 -173.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.511 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.62 173.52 8.46 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 175.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -133.12 103.26 0.5 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 62.7 pttt -90.81 164.06 14.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.115 0.483 . . . . 0.0 110.419 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 10' ' ' SER . 1.5 m -85.67 129.06 34.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.36 0.6 . . . . 0.0 111.184 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -118.15 179.0 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.589 177.838 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.552 ' N ' HG23 ' A' ' 28' ' ' ILE . 6.6 p30 -45.46 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.014 0.911 . . . . 0.0 112.844 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.46 -11.25 5.55 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.406 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HB2' HG22 ' A' ' 28' ' ' ILE . 97.4 mttt -121.24 177.49 5.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.307 0.554 . . . . 0.0 111.328 -172.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.578 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 62.9 m -107.31 119.04 38.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.28 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 20.0 t70 -113.0 127.91 56.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.786 175.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 63.7 m -91.76 155.35 18.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.327 0.584 . . . . 0.0 111.733 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.488 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 58.0 m -105.05 124.74 35.63 Favored Pre-proline 0 N--CA 1.44 -0.95 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.011 173.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.28 176.97 8.22 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.035 1.823 . . . . 0.0 111.328 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 pttm . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.599 176.579 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.408 HG11 ' HG3' ' A' ' 36' ' ' PRO . 34.4 m . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.602 0.239 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 127.04 147.76 6.79 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.3 pt -111.91 153.77 13.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.107 0.479 . . . . 0.0 110.637 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -79.27 64.64 4.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.303 -177.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 46.1 t -130.94 138.02 54.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.578 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 9.9 mtmp? -77.46 111.55 13.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 26.1 t -73.64 106.3 5.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.473 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -88.76 -34.46 17.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -149.89 146.72 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.584 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.1 p -62.47 -39.37 93.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.96 0.409 . . . . 0.0 110.391 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.37 -23.92 68.75 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.397 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -70.53 -40.26 73.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 0.0 109.836 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 81.8 m -69.56 -16.81 63.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.89 -174.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -66.35 -34.1 77.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.032 0.444 . . . . 0.0 110.826 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 92.8 mttt -61.3 -53.16 65.3 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.791 -174.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 72.5 Cg_endo -79.2 -17.14 11.91 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.62 1.547 . . . . 0.0 112.39 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.8 t -71.57 -29.97 65.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.278 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 23.1 pttm -65.4 -23.95 67.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 110.532 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -90.1 -13.09 36.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.535 0.684 . . . . 0.0 109.731 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.41 -10.55 56.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.063 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.08 23.79 73.38 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.998 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.59 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.3 mmt -104.71 177.87 4.72 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.247 -177.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.2 ttp180 -84.21 -72.74 0.45 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.077 -174.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.86 -179.16 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -129.58 110.98 1.12 Allowed Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.491 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -90.21 154.72 19.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.8 t -95.89 105.18 17.17 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.282 0.563 . . . . 0.0 111.037 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.4 mp -102.17 153.78 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -46.24 90.75 0.0 OUTLIER 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.891 0.744 . . . . 0.0 112.467 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 86.16 -9.66 68.95 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.373 -0.831 . . . . 0.0 113.458 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -121.02 135.42 55.21 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 117.726 0.763 . . . . 0.0 111.72 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.506 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 29.7 m -79.33 90.75 4.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.559 172.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.524 ' HB3' HD13 ' A' ' 28' ' ' ILE . 24.9 t70 -90.45 107.35 19.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.697 0.76 . . . . 0.0 110.901 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.6 m -81.47 149.98 28.51 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.532 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 26.3 m -92.07 128.63 44.67 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.141 174.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 5.1 Cg_exo -75.48 -173.04 1.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.817 1.678 . . . . 0.0 112.063 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.915 -177.631 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.484 HG11 ' HG3' ' A' ' 36' ' ' PRO . 30.6 m . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.66 0.267 . . . . 0.0 110.687 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.93 160.42 8.53 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.622 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.9 pt -126.27 153.21 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.034 0.445 . . . . 0.0 110.851 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -80.73 42.05 0.6 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.615 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.7 t -110.59 146.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.072 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -81.66 138.92 35.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.234 0.54 . . . . 0.0 111.578 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 16.1 t -73.09 79.02 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.957 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -91.29 -47.92 7.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 172.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -150.74 142.8 24.03 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -66.21 -37.44 85.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.76 0.314 . . . . 0.0 110.985 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.1 -17.54 75.78 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.717 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.86 -41.09 26.99 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 75.2 m -62.83 -24.53 67.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.674 -176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.29 -35.66 80.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 0.0 111.565 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 61.8 mttp -64.51 -50.85 63.62 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -172.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 73.8 Cg_endo -78.53 -17.21 12.91 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.396 1.398 . . . . 0.0 112.355 176.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 39.6 t -73.58 -38.21 65.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.147 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 54.6 pttt -65.66 -21.85 66.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.312 0.577 . . . . 0.0 110.317 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -82.55 -16.74 47.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.672 0.748 . . . . 0.0 109.177 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.33 -11.11 53.02 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.18 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.546 ' O ' ' HE3' ' A' ' 37' ' ' LYS . . . 83.05 22.96 56.58 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.805 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.493 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.4 mmt -103.02 177.33 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.518 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.4 ttp180 -89.49 -68.23 0.79 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.02 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.518 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.35 172.91 9.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.341 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -139.85 107.22 0.53 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -86.89 154.35 20.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.191 0.52 . . . . 0.0 110.144 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.15 106.88 15.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.28 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 28' ' ' ILE . 2.3 tp -106.87 177.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.04 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -47.95 90.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.094 0.557 . . . . 0.0 111.499 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.41 -20.67 4.85 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.555 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 32.9 mmtp -123.47 178.78 5.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.363 0.582 . . . . 0.0 111.282 -170.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 80.2 m -108.48 113.57 26.71 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.28 117.3 32.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.999 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 65.3 m -91.02 150.69 21.34 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.501 0.667 . . . . 0.0 112.331 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.422 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 33.9 m -100.94 125.54 38.05 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.413 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HG3' HG11 ' A' ' 1' ' ' VAL . 3.9 Cg_exo -72.47 145.37 42.4 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.148 1.899 . . . . 0.0 112.024 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HE3' ' O ' ' A' ' 21' ' ' GLY . 18.5 pttp . . . . . 0 C--O 1.249 1.042 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.246 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.727 0.298 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.52 135.98 12.65 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.768 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.446 HD11 ' SG ' ' A' ' 32' ' ' CYS . 28.5 pt -112.39 -178.89 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.774 0.321 . . . . 0.0 110.327 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -81.48 41.21 0.61 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.916 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.33 148.05 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.25 157.34 16.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.968 0.413 . . . . 0.0 110.906 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.9 t -77.92 77.49 4.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.326 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -90.59 -52.59 4.82 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.789 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 19.2 m80 -147.24 137.13 23.08 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.8 p -64.38 -39.11 93.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.878 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.75 -19.96 79.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.894 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 9' ' ' HIS . 17.4 tt0 -70.13 -26.31 63.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.225 0.536 . . . . 0.0 110.07 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.48 -11.17 59.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.394 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.0 mt -59.89 -48.97 79.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.931 0.396 . . . . 0.0 111.614 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 52.2 mttm -67.38 -57.59 10.28 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -175.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 27.4 Cg_endo -62.41 -25.63 76.27 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 121.918 1.745 . . . . 0.0 112.781 -174.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' HA3' ' A' ' 25' ' ' GLY . 97.7 m -76.58 -38.51 54.76 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.1 0.476 . . . . 0.0 110.668 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -65.4 -36.8 85.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.169 0.509 . . . . 0.0 110.701 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 33.9 mmtp -76.2 -7.75 55.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.718 0.77 . . . . 0.0 109.541 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.3 5.27 50.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.378 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.99 26.81 54.9 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.731 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' A' ' 34' ' ' CYS . 37.4 mtt -123.65 175.71 6.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -88.17 -81.86 0.24 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.59 -174.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -110.88 -179.41 3.73 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -140.22 114.51 0.98 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.003 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -91.89 155.16 18.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.089 0.471 . . . . 0.0 109.968 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.22 105.68 17.97 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.6 tp -100.59 179.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -172.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.512 ' N ' HG23 ' A' ' 28' ' ' ILE . 38.0 m-20 -51.44 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.523 0.729 . . . . 0.0 112.21 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' C ' ' HD2' ' A' ' 31' ' ' LYS . . . 83.01 -17.51 21.96 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.023 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 30' ' ' GLY . 1.3 mptm? -121.22 -177.17 3.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.297 0.57 . . . . 0.0 111.217 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 3' ' ' ILE . 37.0 t -111.67 111.67 22.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.818 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -103.38 113.88 27.72 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.454 0.645 . . . . 0.0 110.476 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 24.0 m -93.1 151.66 19.73 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.978 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.8 m -96.43 108.26 41.02 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.36 152.68 15.85 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.04 1.827 . . . . 0.0 111.479 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.133 176.685 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.047 0.451 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.98 175.23 24.98 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.964 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -126.99 160.44 35.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.021 0.439 . . . . 0.0 110.686 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.69 42.75 0.63 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.838 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.7 142.94 40.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 51.3 pttt -91.05 138.31 31.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.6 t -72.28 111.8 7.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.162 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HD2' HE22 ' A' ' 12' ' ' GLN . 96.4 mttt -91.53 -33.87 15.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 54.6 m80 -150.01 143.68 25.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p -75.71 76.98 2.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.833 0.825 . . . . 0.0 110.901 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.83 -28.16 0.59 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.815 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.582 HE22 ' HD2' ' A' ' 8' ' ' LYS . 13.6 tt0 -62.69 -28.4 69.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.325 0.583 . . . . 0.0 109.76 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 70.3 m -63.78 -9.27 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.934 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.453 HD22 ' H ' ' A' ' 25' ' ' GLY . 3.4 mm? -65.88 -37.04 85.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.864 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.495 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 98.6 mttt -60.05 -54.01 59.51 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.117 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 51.5 Cg_endo -74.3 -24.37 14.48 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.41 1.407 . . . . 0.0 112.386 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 20.7 t -73.38 -39.22 65.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.332 -175.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -69.88 -21.51 63.32 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.022 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -88.17 -0.84 57.56 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.637 0.732 . . . . 0.0 109.18 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.23 -16.52 19.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.936 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.0 7.97 60.73 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.994 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.488 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.0 mmt -96.79 178.53 5.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.375 -0.13 . . . . 0.0 110.678 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.477 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 20.8 ttp180 -87.61 -69.14 0.71 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.853 -174.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.497 ' HD1' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -124.68 167.75 14.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -131.8 107.71 0.75 Allowed Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.14 168.2 12.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.167 0.508 . . . . 0.0 110.5 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 t -84.75 122.14 28.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.889 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.2 tp -118.65 178.68 2.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.549 ' N ' HG23 ' A' ' 28' ' ' ILE . 19.3 m-20 -48.85 86.35 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.979 0.799 . . . . 0.0 111.747 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.23 -18.07 4.53 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.436 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 34.1 mmtp -121.55 173.41 7.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.602 0.701 . . . . 0.0 111.838 -170.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 90.2 m -98.06 116.86 31.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.081 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -106.74 122.92 47.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.31 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 58.2 m -90.76 152.32 20.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.44 0.638 . . . . 0.0 112.138 -175.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.497 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 95.9 m -112.64 122.41 36.32 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.556 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.06 169.81 21.34 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.106 1.87 . . . . 0.0 112.058 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.9 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 121.004 0.431 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.5 164.83 14.02 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.581 HD11 ' SG ' ' A' ' 32' ' ' CYS . 17.2 pt -115.21 162.44 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.198 0.523 . . . . 0.0 110.662 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -75.31 11.3 1.25 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.059 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.455 HG11 ' HG3' ' A' ' 16' ' ' PRO . 22.1 t -91.6 140.48 16.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -86.5 131.56 34.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.929 0.395 . . . . 0.0 110.11 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 49.5 t -91.04 115.49 28.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.925 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -91.54 -35.95 13.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 171.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -145.1 151.76 39.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.552 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -61.84 -43.16 99.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.804 0.335 . . . . 0.0 111.342 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.34 -24.68 67.72 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.033 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.85 -28.19 50.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.975 0.417 . . . . 0.0 110.206 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 7' ' ' CYS . 43.0 t -73.22 -25.65 60.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.617 0.722 . . . . 0.0 109.401 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -67.93 -29.55 68.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.464 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 47.7 mmtm -66.3 -53.84 28.99 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 86.3 Cg_endo -81.08 -17.64 9.21 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.338 1.359 . . . . 0.0 111.839 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 48.6 t -75.46 -39.33 58.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.294 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.58 -32.19 73.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.801 0.334 . . . . 0.0 110.631 -179.437 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 19.6 pttp -86.11 -13.99 45.56 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.839 0.828 . . . . 0.0 109.186 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.14 -14.19 60.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.199 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.69 9.79 64.0 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.956 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.414 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.5 mmt -94.5 -178.11 4.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.442 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 6.4 ttp180 -90.19 -73.12 0.53 Allowed 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.87 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.543 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -123.93 172.6 8.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.311 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -136.9 112.92 0.98 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -91.82 155.93 17.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.04 109.64 17.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.157 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -96.71 165.64 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' N ' HG23 ' A' ' 28' ' ' ILE . 24.5 m-80 -59.29 83.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.548 0.53 . . . . 0.0 111.394 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.35 -25.67 27.32 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.011 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.47 ' H ' HG22 ' A' ' 28' ' ' ILE . 14.3 mmmm -122.57 159.24 28.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.62 0.71 . . . . 0.0 112.326 -169.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 3' ' ' ILE . 42.0 t -90.24 105.45 17.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.144 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -101.82 125.39 48.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.714 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.5 m -97.51 154.54 17.44 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.418 0.628 . . . . 0.0 112.182 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.463 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 33.9 m -105.4 131.07 22.09 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.772 172.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -81.53 159.65 19.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.201 1.934 . . . . 0.0 111.617 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.191 179.658 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 17.4 m . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.85 0.357 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.89 169.61 33.92 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.879 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 pt -125.44 157.63 34.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.23 0.538 . . . . 0.0 110.705 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -79.55 48.32 0.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.759 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -130.45 139.91 50.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.072 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.78 132.64 34.54 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.35 85.57 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.128 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 32.0 mtmm -92.17 105.63 17.81 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.2 m80 70.12 119.1 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.599 0.562 . . . . 0.0 109.823 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 p -70.79 77.54 0.62 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.785 0.802 . . . . 0.0 110.606 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.37 -23.33 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.625 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 54.2 tt0 -74.62 -26.39 59.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.854 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 59.6 m -69.66 -11.39 60.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.399 -172.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.3 mt -65.95 -49.2 68.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.637 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 64.1 mttp -54.36 -58.97 11.46 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.472 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 45.6 Cg_endo -69.2 -19.84 38.24 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.565 1.51 . . . . 0.0 112.414 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 34.6 t -74.38 -29.99 61.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -63.36 -37.66 88.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.477 175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -76.71 1.82 16.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.641 0.734 . . . . 0.0 109.89 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.23 -7.7 17.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.104 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.02 22.31 78.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.308 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.642 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 22.4 mmt -98.12 -177.31 3.69 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.445 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 4.8 ttp180 -90.26 -73.25 0.53 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.709 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.531 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.15 174.63 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -127.33 104.27 0.69 Allowed Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 20.5 ptmt -89.03 153.35 21.07 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.955 0.407 . . . . 0.0 109.951 -177.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 t -80.28 118.18 21.71 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.292 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -106.28 164.34 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 173.214 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.411 ' N ' HG23 ' A' ' 28' ' ' ILE . 35.8 m-20 -57.2 85.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.41 0.624 . . . . 0.0 111.659 -176.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 -23.12 37.48 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.829 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -122.33 151.19 41.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.282 0.541 . . . . 0.0 110.996 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 88.1 m -85.75 113.47 21.95 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 172.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.59 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 27.8 t70 -109.35 123.09 48.75 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 1' ' ' VAL . 75.9 m -89.6 154.37 20.03 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.574 0.702 . . . . 0.0 112.226 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 31.3 m -98.18 130.24 28.94 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.884 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 7.2 Cg_exo -69.07 152.75 72.84 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.719 1.613 . . . . 0.0 111.224 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.775 -0.631 . . . . 0.0 110.023 178.08 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.442 HG21 ' HB2' ' A' ' 34' ' ' CYS . 7.9 m . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 119.787 -0.149 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 52.6 91.32 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 O-C-N 123.197 0.31 . . . . 0.0 113.849 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 32' ' ' CYS . 33.2 pt -86.06 175.04 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 109.962 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -86.91 44.07 1.14 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.363 0.601 . . . . 0.0 111.003 -175.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -131.58 149.98 33.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.524 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -99.74 138.19 37.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.24 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -70.11 86.38 0.56 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.951 0.405 . . . . 0.0 111.105 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HE3' ' OE1' ' A' ' 12' ' ' GLN . 56.6 mtmt -91.83 -41.24 10.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 167.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 12' ' ' GLN . 27.4 m80 -148.61 133.87 18.41 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.4 p -66.73 -36.26 82.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.762 0.315 . . . . 0.0 111.034 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.51 -19.24 76.13 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.492 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.604 ' OE1' ' HE3' ' A' ' 8' ' ' LYS . 34.7 tt0 -82.44 -23.19 34.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.897 0.379 . . . . 0.0 110.087 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.597 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 75.8 m -69.48 -18.92 63.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.327 0.584 . . . . 0.0 109.57 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' A' ' 24' ' ' PHE . 4.2 tp -75.54 -36.67 60.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.811 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 29.1 mmmt -54.1 -53.7 55.64 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.838 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 54.1 Cg_endo -78.38 -18.93 12.09 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.515 1.477 . . . . 0.0 111.921 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 11.7 t -65.39 -24.96 67.35 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.123 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 8.7 ptpp? -61.06 -30.44 70.33 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.818 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -90.15 -13.13 36.31 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.395 0.617 . . . . 0.0 109.737 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.67 56.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.46 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.09 29.9 66.1 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.145 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.583 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.4 mmt -107.23 -178.47 3.65 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.235 -175.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.452 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 20.9 ttp180 -89.64 -77.9 0.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.216 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.452 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -112.72 174.35 5.93 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.159 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -135.54 100.19 0.34 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -90.21 163.37 14.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.182 0.515 . . . . 0.0 110.342 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -87.24 122.21 30.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.904 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.533 HG22 ' HB2' ' A' ' 31' ' ' LYS . 1.0 OUTLIER -109.09 173.06 2.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 28' ' ' ILE . 42.3 m-80 -58.57 87.72 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.245 0.545 . . . . 0.0 111.422 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.09 -24.02 30.63 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.712 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HB2' HG22 ' A' ' 28' ' ' ILE . 47.6 mmtm -121.42 170.98 9.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.02 0.438 . . . . 0.0 111.266 -170.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.625 ' O ' HG12 ' A' ' 3' ' ' ILE . 85.7 m -98.19 120.35 38.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 168.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' HB3' HD13 ' A' ' 28' ' ' ILE . 22.7 t70 -109.42 124.16 50.55 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.843 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.496 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 80.8 m -92.46 151.63 20.11 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.158 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.448 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 91.3 m -97.63 118.45 64.16 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.181 175.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.66 144.37 31.47 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.103 1.869 . . . . 0.0 112.487 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp . . . . . 0 C--O 1.248 0.975 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.778 -178.696 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 36' ' ' PRO . 31.2 m . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.922 0.391 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.9 155.88 30.72 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.356 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.523 HD11 ' SG ' ' A' ' 13' ' ' CYS . 12.3 pt -114.85 162.39 12.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.944 0.402 . . . . 0.0 110.736 -176.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 13.8 p-10 -81.84 20.7 0.93 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.586 -175.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.98 133.61 29.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.998 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -74.6 134.94 42.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.938 0.399 . . . . 0.0 110.144 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 t -68.16 101.59 1.19 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.433 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -91.59 -47.67 7.27 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -149.12 132.82 16.88 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.4 p -71.1 114.45 9.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.063 0.459 . . . . 0.0 110.529 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.93 -27.43 9.67 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.531 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -73.37 -22.11 60.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.377 0.608 . . . . 0.0 110.135 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' HD11 ' A' ' 3' ' ' ILE . 22.6 t -80.78 8.41 8.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.731 -175.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.477 HD22 ' H ' ' A' ' 25' ' ' GLY . 2.4 mm? -70.01 -28.28 65.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.155 0.502 . . . . 0.0 110.748 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 34.8 mmtp -67.78 -57.13 10.33 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.402 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 57.7 Cg_endo -71.09 -18.46 30.86 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.58 1.52 . . . . 0.0 112.795 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 36.1 t -79.79 -36.23 37.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.35 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -68.91 -25.14 64.44 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.306 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -82.92 -17.8 42.39 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.974 0.893 . . . . 0.0 109.115 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.08 -8.6 58.43 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.109 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.94 5.06 81.45 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.084 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.52 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 23.0 mmt -94.95 177.45 5.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.641 0.257 . . . . 0.0 110.88 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 2.8 ttp180 -88.41 -73.41 0.5 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.292 -173.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -121.99 154.19 37.56 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.392 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.477 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -106.19 110.3 3.33 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.624 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -90.66 154.9 19.23 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.85 120.22 30.9 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.059 0.457 . . . . 0.0 110.818 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.2 tp -109.46 168.54 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' N ' HG23 ' A' ' 28' ' ' ILE . 1.3 t30 -44.23 98.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.832 0.825 . . . . 0.0 110.776 173.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.41 -27.11 2.15 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 114.797 -1.092 . . . . 0.0 114.031 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 28' ' ' ILE . 74.8 mmtt -120.85 -177.32 3.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.731 0.766 . . . . 0.0 111.038 -168.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.6 t -114.2 114.81 26.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.185 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' HB3' HD13 ' A' ' 28' ' ' ILE . 23.9 t70 -103.38 115.57 30.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.356 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -88.53 155.86 19.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.849 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 62.7 m -97.67 132.52 24.92 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.93 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HG3' HG11 ' A' ' 1' ' ' VAL . 6.7 Cg_exo -70.25 170.62 16.74 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.787 1.658 . . . . 0.0 112.378 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.582 176.452 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.422 HG11 ' HD3' ' A' ' 36' ' ' PRO . 28.0 m . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.0 140.67 5.74 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.843 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -116.39 163.26 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -76.77 33.54 0.14 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.281 0.562 . . . . 0.0 111.887 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.63 151.76 17.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.682 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 35.3 mtmm -109.52 145.23 36.63 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 t -69.17 95.13 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.697 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -92.43 -42.92 9.48 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 167.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -148.29 126.02 11.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.446 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 p -66.99 -21.87 65.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.081 0.467 . . . . 0.0 111.048 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.86 -35.67 44.4 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.413 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -71.0 -30.06 66.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.077 0.465 . . . . 0.0 110.213 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.9 t -62.04 -19.29 62.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.992 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.508 HD12 ' H ' ' A' ' 25' ' ' GLY . 6.8 mp -72.15 -31.94 66.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.343 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.538 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 29.6 mtpp -58.91 -56.58 34.62 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.078 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 72.8 Cg_endo -76.71 -17.17 16.12 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.336 1.358 . . . . 0.0 112.21 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 35.3 t -80.36 -34.74 36.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.279 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 64.8 pttt -67.83 -24.78 65.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.159 0.504 . . . . 0.0 109.921 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -83.11 -9.6 59.12 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.575 0.702 . . . . 0.0 109.35 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.44 -15.16 31.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.989 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.73 13.16 63.22 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.009 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.506 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.2 mmt -94.91 -178.13 4.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.613 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 7.1 ttp180 -90.26 -65.7 0.99 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.72 -176.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.613 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -129.59 166.91 18.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 109.966 175.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' H ' HD12 ' A' ' 14' ' ' LEU . . . -113.59 109.62 2.3 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -91.08 152.1 20.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.051 0.453 . . . . 0.0 110.162 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.7 m -82.94 114.72 21.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.724 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -107.21 176.18 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.766 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.555 ' N ' HG23 ' A' ' 28' ' ' ILE . 4.8 p30 -44.75 85.08 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.739 0.78 . . . . 0.0 112.684 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 82.38 -21.33 7.35 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.169 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 99.1 mttt -120.19 172.52 7.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.427 0.632 . . . . 0.0 112.359 -168.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.73 103.18 14.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.581 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -105.15 117.42 33.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.134 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.3 m -83.52 154.58 23.79 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.698 0.761 . . . . 0.0 112.617 -174.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.46 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 89.2 m -101.71 116.82 62.91 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.843 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD3' HG11 ' A' ' 1' ' ' VAL . 63.7 Cg_endo -69.67 152.71 69.82 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.332 2.021 . . . . 0.0 112.62 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.069 176.479 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.544 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 30.9 m . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.697 0.284 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.514 ' HA2' ' H ' ' A' ' 34' ' ' CYS . . . -94.09 -177.69 39.1 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.338 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 32' ' ' CYS . 12.7 pt -128.8 157.7 41.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.961 0.41 . . . . 0.0 110.184 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -72.38 11.11 0.65 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.264 -177.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.78 135.85 23.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 46.2 mtpt -86.97 133.71 33.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.2 t -72.12 104.31 3.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -39.15 13.12 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 172.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -148.29 138.54 22.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.916 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 p -62.95 -27.24 69.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.066 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.41 -32.66 41.87 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.816 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -69.2 -15.95 63.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.389 0.275 . . . . 0.0 111.594 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 77.5 m -77.39 -16.79 58.67 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -176.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.85 -37.48 58.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.766 0.317 . . . . 0.0 111.594 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -53.02 -55.37 34.27 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.687 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 73.9 Cg_endo -77.66 -16.61 14.72 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.439 1.426 . . . . 0.0 112.197 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 38.5 t -75.4 -37.4 60.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.322 -175.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.454 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.76 -18.15 64.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.127 0.489 . . . . 0.0 110.13 178.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 16' ' ' PRO . 8.0 mtmp? -85.86 -14.29 45.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.634 0.731 . . . . 0.0 109.196 177.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.79 -7.62 57.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.336 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.58 16.86 69.79 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.028 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.541 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 25.2 mmt -97.85 179.64 4.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.659 0.266 . . . . 0.0 110.47 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 4.5 ttp180 -90.74 -69.83 0.71 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.535 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.472 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.63 169.5 11.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.83 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -125.29 109.4 1.19 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 19.4 ptmt -90.25 156.78 18.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.5 t -83.66 114.61 21.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.074 0.464 . . . . 0.0 110.242 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.606 HG22 ' H ' ' A' ' 31' ' ' LYS . 1.0 OUTLIER -103.33 170.71 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.396 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.467 ' N ' HG23 ' A' ' 28' ' ' ILE . 10.9 m-20 -38.41 -43.94 0.87 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -167.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.17 -0.48 1.65 Allowed Glycine 0 C--N 1.318 -0.419 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.596 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.606 ' H ' HG22 ' A' ' 28' ' ' ILE . 96.2 mttt -123.79 166.91 14.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.762 -172.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.452 ' O ' HG12 ' A' ' 3' ' ' ILE . 98.3 m -90.97 100.71 13.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 169.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.633 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 18.5 t70 -95.06 118.9 32.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.694 -177.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 1' ' ' VAL . 69.6 m -88.5 153.41 21.17 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.638 0.732 . . . . 0.0 112.611 -172.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.449 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 52.6 m -109.34 118.4 50.94 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.946 171.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 18.0 Cg_exo -69.35 -177.74 1.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.884 2.389 . . . . 0.0 112.317 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.245 0.839 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.205 177.877 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.762 0.315 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.43 162.47 9.25 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.87 153.03 18.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 117.217 0.509 . . . . 0.0 110.55 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -77.39 71.0 3.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.421 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 17.0 t -146.38 136.09 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -88.47 134.41 33.86 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.3 t -73.08 91.03 1.57 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.131 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -82.68 -34.02 27.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 28.6 m80 -147.5 148.59 31.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.983 177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 p -67.17 -34.4 77.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.183 0.516 . . . . 0.0 110.129 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.94 -12.63 81.14 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.623 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 9' ' ' HIS . 20.6 tt0 -84.1 -15.74 46.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.653 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 62.7 m -90.54 -17.33 27.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.022 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.666 HD23 ' H ' ' A' ' 25' ' ' GLY . 87.9 mt -74.18 -51.51 15.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.178 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 58.5 mttp -52.52 -53.51 52.78 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.847 -175.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 49.1 Cg_endo -73.39 -15.9 24.84 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.525 1.483 . . . . 0.0 112.88 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.653 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 14.4 t -78.69 -36.35 43.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.946 0.403 . . . . 0.0 111.234 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -69.79 -21.52 63.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.24 0.543 . . . . 0.0 109.932 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -83.84 -11.93 56.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.712 0.768 . . . . 0.0 109.044 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.87 -14.59 27.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.068 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.07 17.74 64.44 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.063 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.578 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 23.8 mmt -96.64 170.72 9.01 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.985 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 4.7 ttp180 -76.2 -68.46 0.58 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.602 -173.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.525 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -128.18 154.07 46.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 174.465 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.666 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -109.95 97.25 1.0 Allowed Glycine 0 C--N 1.309 -0.927 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -90.33 160.59 16.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.147 0.498 . . . . 0.0 110.694 -175.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.3 t -83.85 118.28 23.86 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.031 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.6 tp -110.46 -178.02 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.504 ' N ' HG23 ' A' ' 28' ' ' ILE . 43.9 m-80 -48.93 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.143 0.497 . . . . 0.0 111.901 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.04 -10.95 2.88 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.77 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 28' ' ' ILE . 30.4 ttpt -123.18 161.96 23.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.192 0.496 . . . . 0.0 111.584 -168.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.531 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 68.1 m -91.57 102.15 14.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.44 0.638 . . . . 0.0 110.45 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -99.81 127.29 45.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.505 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.0 m -96.88 149.34 21.98 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.448 0.642 . . . . 0.0 111.653 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.472 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 57.2 m -102.28 116.96 62.21 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.521 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.62 167.14 27.3 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.346 2.031 . . . . 0.0 111.43 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.4 mttp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.096 178.42 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.035 0.445 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.74 145.3 17.64 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.567 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.428 HD13 ' SG ' ' A' ' 34' ' ' CYS . 18.0 pt -118.51 164.08 15.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.172 0.51 . . . . 0.0 110.627 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -74.47 13.3 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.847 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.4 t -95.05 133.86 34.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.559 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.29 149.38 26.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 t -73.2 81.22 1.31 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.055 0.455 . . . . 0.0 110.211 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.43 -40.38 26.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.321 0.581 . . . . 0.0 110.11 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.679 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 6.9 p-80 -169.61 123.85 0.79 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.251 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.2 p -63.27 99.87 0.21 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.692 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.23 -30.01 1.34 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.679 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 24.8 tt0 -60.84 -34.5 74.67 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.943 0.402 . . . . 0.0 111.702 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 97.4 m -69.59 -9.5 54.32 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -168.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.51 -38.99 75.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.037 0.446 . . . . 0.0 110.667 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.516 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 75.0 mmtt -70.22 -56.25 7.17 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.207 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 50.8 Cg_endo -71.02 -29.28 18.11 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.585 1.523 . . . . 0.0 113.414 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 43.2 t -75.09 -36.12 61.74 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.319 -0.238 . . . . 0.0 111.546 -174.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 60.5 pttt -63.98 -23.17 67.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 109.903 175.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -83.09 -14.52 53.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.344 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.85 -12.34 48.16 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.844 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.73 19.55 53.7 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.474 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.636 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 43.8 mtt -116.17 173.63 6.48 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.3 ttp180 -84.28 -76.06 0.32 Allowed 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.538 -170.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.519 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -123.12 178.21 5.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.681 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -133.33 115.12 1.48 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 12.6 ptmm? -91.22 166.88 12.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.975 0.417 . . . . 0.0 110.047 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.55 135.4 35.58 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 31' ' ' LYS . 1.3 tp -123.26 173.23 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.451 ' N ' HG23 ' A' ' 28' ' ' ILE . 10.0 p30 -36.91 -44.58 0.51 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -166.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.19 -6.31 1.23 Allowed Glycine 0 C--N 1.317 -0.509 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.824 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' H ' HG22 ' A' ' 28' ' ' ILE . 34.3 mmtp -122.37 -165.86 1.34 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.947 0.403 . . . . 0.0 110.386 -168.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.3 t -118.27 125.92 51.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.953 175.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.459 ' HB3' HD13 ' A' ' 28' ' ' ILE . 22.0 t70 -111.51 123.98 51.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.197 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.539 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 21.7 m -87.66 155.88 19.73 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.642 0.734 . . . . 0.0 112.717 -173.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.467 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 89.4 m -107.27 128.69 25.52 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.712 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.33 -176.07 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.234 1.956 . . . . 0.0 112.03 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.4 pttm . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.834 -179.26 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.731 0.301 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.57 ' HA2' ' H ' ' A' ' 34' ' ' CYS . . . -83.83 -176.57 51.3 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.075 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.04 163.07 32.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.817 0.341 . . . . 0.0 110.277 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -70.24 4.18 2.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.105 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 14.1 t -84.93 138.18 19.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.17 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -90.18 139.26 30.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.27 104.83 4.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.576 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 62.8 mttp -91.73 -43.83 9.34 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 167.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -144.51 152.79 41.09 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.447 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 3.2 p -60.99 -50.73 72.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.996 0.362 . . . . 0.0 111.817 -175.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.47 -13.72 65.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.476 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 23.5 tt0 -70.69 -31.01 67.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.353 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 81.9 m -78.81 -21.31 47.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.604 -175.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.529 HD22 ' H ' ' A' ' 25' ' ' GLY . 1.3 mm? -64.94 -35.37 80.96 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.98 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 60.8 mtpt -60.21 -60.76 9.58 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.345 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 50.9 Cg_endo -71.44 -16.99 30.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.075 1.85 . . . . 0.0 112.678 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 15.4 t -70.75 -34.08 71.47 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.374 -174.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 23.5 pttm -63.82 -25.95 68.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.398 . . . . 0.0 110.48 176.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -88.69 -14.34 37.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.338 0.59 . . . . 0.0 109.543 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.21 45.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.2 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.91 15.46 48.84 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.66 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.518 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.3 mmt -99.67 -179.39 4.17 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.623 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.486 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 5.8 ttp180 -90.26 -65.78 0.99 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.496 -175.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.27 162.4 23.8 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 174.375 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -126.71 94.95 0.43 Allowed Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HZ3' HD11 ' A' ' 28' ' ' ILE . 21.1 pttp -90.87 159.35 16.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.366 0.603 . . . . 0.0 110.99 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -83.64 113.73 21.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.423 -177.193 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -106.36 169.94 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.748 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' N ' HG23 ' A' ' 28' ' ' ILE . 4.7 p30 -43.3 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.934 0.873 . . . . 0.0 113.173 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 80.06 -14.32 21.44 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.566 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -121.64 144.94 48.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.517 0.659 . . . . 0.0 111.541 -171.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.448 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 62.2 m -79.42 99.34 7.14 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.367 173.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' HB3' HD13 ' A' ' 28' ' ' ILE . 24.7 t70 -99.49 118.19 35.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.4 0.619 . . . . 0.0 110.75 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.57 ' H ' ' HA2' ' A' ' 2' ' ' GLY . 62.1 m -93.08 149.93 20.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.684 -176.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.474 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 98.7 m -111.56 126.14 29.11 Favored Pre-proline 0 N--CA 1.439 -0.985 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.225 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.71 -168.03 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.398 2.065 . . . . 0.0 112.26 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.7 mttp . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.627 -0.702 . . . . 0.0 109.898 179.75 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.82 126.6 9.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.411 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -105.24 -179.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.055 0.455 . . . . 0.0 110.836 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -83.56 42.68 0.85 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.624 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.64 152.38 36.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.248 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -95.65 147.54 23.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.79 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 41.8 t -78.3 57.23 1.85 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.854 -174.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -93.4 104.88 17.0 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.7 m80 67.9 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.762 0.664 . . . . 0.0 110.73 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 p -60.74 -28.16 68.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.07 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.4 -20.52 76.96 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.523 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -76.98 -33.12 57.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.573 0.225 . . . . 0.0 110.831 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 74.7 m -65.78 -18.22 65.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.579 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 25' ' ' GLY . 1.1 mm? -64.84 -36.41 84.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.682 0.277 . . . . 0.0 111.245 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 4.8 mptp? -65.76 -56.71 16.63 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.08 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 39.8 Cg_endo -71.01 -19.07 30.62 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.329 1.353 . . . . 0.0 112.701 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.5 m -76.38 -38.66 55.41 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.45 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 49.0 pttt -69.5 -26.75 64.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 95.3 mttt -75.67 -23.42 56.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.7 58.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.358 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.56 11.81 76.7 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.305 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.655 ' SD ' ' HA ' ' A' ' 36' ' ' PRO . 23.5 mmt -95.65 175.67 6.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.389 0.137 . . . . 0.0 111.117 -177.132 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 14.9 ttp180 -80.7 -71.49 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.24 -173.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.468 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -119.67 -176.88 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.169 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.459 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -136.17 102.81 0.42 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.388 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -85.26 156.31 21.0 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -96.16 109.71 22.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.407 HG23 ' N ' ' A' ' 29' ' ' ASN . 2.2 tp -104.3 177.98 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.665 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' N ' HG23 ' A' ' 28' ' ' ILE . 9.6 m-80 -53.2 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.001 0.52 . . . . 0.0 111.63 -177.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.91 -18.06 28.56 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.162 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 66.3 mttm -122.94 179.47 4.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.09 0.445 . . . . 0.0 110.564 -172.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.3 m -107.0 120.27 41.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -103.31 107.87 18.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.687 0.756 . . . . 0.0 110.381 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.9 m -81.09 142.07 33.68 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.357 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 m -88.98 121.05 69.99 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.655 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 17.7 Cg_endo -75.04 120.56 6.1 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.998 1.799 . . . . 0.0 112.38 -175.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.602 ' OXT' ' HD2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.814 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.44 118.43 0.03 OUTLIER Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.086 -0.578 . . . . 0.0 113.434 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.577 HD13 ' SG ' ' A' ' 34' ' ' CYS . 33.9 pt -120.17 167.62 13.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.53 67.56 7.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.955 0.407 . . . . 0.0 109.92 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -148.36 135.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -86.9 138.47 31.52 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 t -67.69 101.96 1.12 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.343 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.66 -50.74 5.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -149.65 135.16 18.4 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.5 p -62.17 -33.62 74.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.35 -31.58 61.01 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.967 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -76.72 -20.31 56.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' HA3' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -69.0 -13.58 62.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.413 -177.125 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.79 -35.43 78.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.947 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 97.7 mttt -57.07 -54.16 57.58 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.526 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 46.7 Cg_endo -74.49 -25.43 13.0 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.034 1.156 . . . . 0.0 112.844 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 m -76.23 -31.56 58.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 19.6 ptpt -68.41 -25.42 65.03 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -85.91 -11.09 54.08 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.269 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.2 -1.41 56.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.088 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.17 74.35 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.197 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.404 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 25.3 mmt -110.05 178.32 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.858 -0.201 . . . . 0.0 110.946 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.49 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 19.8 ttp180 -81.87 -70.04 0.57 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.169 -173.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.49 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.99 -177.23 3.78 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' A' ' 13' ' ' CYS . . . -126.72 107.91 0.95 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.872 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -91.9 157.05 17.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 m -90.05 129.69 36.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.216 0.532 . . . . 0.0 110.655 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.3 tp -119.42 -179.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.113 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.518 ' N ' HG23 ' A' ' 28' ' ' ILE . 38.9 m-20 -47.68 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.396 0.678 . . . . 0.0 112.133 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.49 -15.36 4.64 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.183 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HB2' HG22 ' A' ' 28' ' ' ILE . 48.0 mtmt -120.76 -173.66 2.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.231 0.515 . . . . 0.0 110.825 -172.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.3 t -115.49 121.34 42.4 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.8 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -112.24 115.91 29.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.4 0.619 . . . . 0.0 110.338 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.577 ' SG ' HD13 ' A' ' 3' ' ' ILE . 36.5 m -79.85 143.87 33.96 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.633 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.9 m -82.52 120.02 75.88 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -79.73 131.75 9.4 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.122 1.881 . . . . 0.0 111.872 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.6 pttt . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.515 -178.919 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.43 HG11 ' HG3' ' A' ' 36' ' ' PRO . 29.6 m . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.795 0.331 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.44 157.3 7.1 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 16' ' ' PRO . 18.1 pt -130.7 171.54 17.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.471 0.653 . . . . 0.0 111.936 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.23 37.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.605 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.53 144.89 22.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.345 -177.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -91.24 141.58 28.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.046 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.9 t -72.26 94.1 1.54 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.33 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.14 -47.65 7.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 7.1 p-80 -166.17 147.33 6.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.636 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.7 p -51.01 -46.58 61.58 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -171.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.95 -19.66 56.69 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.447 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.545 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 26.1 tt0 -74.68 -43.87 53.05 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 66.4 m -68.93 -15.48 63.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.38 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.597 HD22 ' H ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -62.45 -41.0 98.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.001 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 67.7 mttm -68.34 -54.97 13.29 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -174.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 56.5 Cg_endo -71.12 -18.4 30.8 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.327 1.351 . . . . 0.0 112.815 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 m -80.26 -39.62 28.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.585 0.231 . . . . 0.0 111.329 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -72.15 -23.0 61.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.084 0.468 . . . . 0.0 110.039 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -89.22 -5.94 57.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.59 0.709 . . . . 0.0 109.421 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.2 -5.81 51.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.267 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.73 14.87 62.45 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.847 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.7 mmt -104.84 179.6 4.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 2.6 ttp180 -82.59 -74.6 0.34 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.994 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -122.63 -179.94 4.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.386 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.597 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -131.47 111.03 1.03 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.963 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -91.1 153.67 19.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.898 0.38 . . . . 0.0 110.014 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -91.26 111.63 23.2 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 28' ' ' ILE . 2.4 tp -115.57 -179.12 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.027 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' N ' HG23 ' A' ' 28' ' ' ILE . 21.6 m-80 -44.37 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.87 0.868 . . . . 0.0 112.621 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.94 -8.23 3.68 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.392 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' HG2' ' N ' ' A' ' 32' ' ' CYS . 36.9 ttmt -122.9 167.4 13.6 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 122.559 -0.377 . . . . 0.0 110.001 -173.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.483 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 91.1 m -100.66 112.63 25.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.023 0.439 . . . . 0.0 109.895 169.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -96.43 109.11 21.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.62 0.724 . . . . 0.0 110.065 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 32.1 m -80.54 143.22 33.42 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.539 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.6 m -88.16 132.41 39.71 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.43 ' HG3' HG11 ' A' ' 1' ' ' VAL . 3.0 Cg_exo -69.18 166.48 26.74 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.474 1.449 . . . . 0.0 110.828 176.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.489 -177.578 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.653 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 13.2 m . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.79 0.329 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.18 87.17 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.864 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 32' ' ' CYS . 28.5 pt -104.26 174.35 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.139 0.495 . . . . 0.0 110.606 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -76.23 7.91 3.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.302 -172.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.0 139.52 19.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.841 -173.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -83.32 142.98 30.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.517 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 5.7 t -79.18 101.55 8.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.777 -176.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -91.94 -57.07 2.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 168.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -147.01 156.45 43.05 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -62.46 -38.09 88.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.829 0.347 . . . . 0.0 110.752 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.79 -27.41 64.17 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.604 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -73.16 -44.97 59.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 0.0 110.243 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.96 -16.3 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.41 -172.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.696 HD23 ' H ' ' A' ' 25' ' ' GLY . 82.5 mt -56.94 -49.74 74.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.424 0.631 . . . . 0.0 111.3 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 22.3 ttmm -60.17 -54.8 51.68 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.317 -172.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 52.1 Cg_endo -73.96 -20.79 19.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.148 1.232 . . . . 0.0 113.077 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 m -77.6 -34.35 53.47 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 64.2 pttt -68.6 -25.59 64.95 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -86.05 -6.34 59.05 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.498 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.0 4.86 50.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.322 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.96 22.67 71.05 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.105 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 34' ' ' CYS . 46.1 mtt -116.61 175.82 5.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.169 -176.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 8.1 ttp180 -75.41 -72.36 0.31 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.139 0.274 . . . . 0.0 111.653 -170.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.547 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.3 -176.61 3.63 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.09 0.471 . . . . 0.0 110.137 177.125 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.696 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -123.58 115.58 2.66 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.708 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -90.95 156.85 17.66 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.76 109.9 22.03 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.905 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.685 HG22 ' H ' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -95.01 164.33 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.166 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -39.06 -36.96 0.34 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.25 -14.79 1.05 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.025 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.685 ' H ' HG22 ' A' ' 28' ' ' ILE . 68.2 mttm -123.81 167.31 14.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.781 0.324 . . . . 0.0 111.277 -169.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.405 ' O ' HG12 ' A' ' 3' ' ' ILE . 99.6 m -91.16 111.91 23.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.429 0.633 . . . . 0.0 110.525 173.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 1' ' ' VAL . 8.0 t70 -85.53 158.52 20.13 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.573 ' HB2' ' SD ' ' A' ' 22' ' ' MET . 16.5 m -131.98 137.52 47.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.427 ' HB ' ' CD1' ' A' ' 24' ' ' PHE . 28.8 m -88.0 123.01 69.68 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.37 176.58 9.06 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.714 1.609 . . . . 0.0 111.498 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.004 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.406 HG21 ' HD3' ' A' ' 36' ' ' PRO . 20.2 m . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 121.102 0.477 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -57.91 141.37 45.13 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.575 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.44 HD11 ' SG ' ' A' ' 32' ' ' CYS . 21.3 pt -110.02 171.61 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -81.28 45.18 0.83 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.986 0.422 . . . . 0.0 111.729 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.95 144.29 36.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.992 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -92.97 146.55 23.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.678 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 46.0 t -77.02 78.29 3.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.14 0.495 . . . . 0.0 111.276 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 52.7 mtpt -91.35 -50.21 5.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -143.9 136.6 27.15 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.0 p -66.69 -34.96 79.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.353 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.78 -18.2 79.48 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.586 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.455 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 61.1 tt0 -82.78 -31.14 28.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -19.64 65.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.474 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 25' ' ' GLY . 81.2 mt -61.14 -48.68 80.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.437 0.637 . . . . 0.0 110.737 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 56.3 mtpt -53.18 -56.71 21.29 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.322 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 57.9 Cg_endo -72.32 -28.93 14.58 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.304 1.336 . . . . 0.0 112.867 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.0 m -72.06 -36.87 69.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -176.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 65.1 pttt -67.45 -26.06 66.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.029 0.443 . . . . 0.0 109.867 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -79.88 -18.52 50.48 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.495 0.664 . . . . 0.0 109.327 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.06 9.16 23.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.068 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.94 19.25 80.03 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.008 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.1 mmt -97.89 175.34 6.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.75 0.309 . . . . 0.0 111.47 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 3.5 ttp180 -81.82 -66.06 0.94 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.164 -176.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.532 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -131.01 -177.51 4.41 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.642 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -125.14 116.65 2.76 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -91.91 146.46 23.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.249 0.547 . . . . 0.0 110.174 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.73 111.9 23.68 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 28' ' ' ILE . 2.2 tp -108.55 178.71 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.089 -171.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.404 ' N ' HG23 ' A' ' 28' ' ' ILE . 30.7 m-80 -49.63 87.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.065 0.546 . . . . 0.0 111.891 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.18 -15.93 8.1 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.254 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 74.9 mmtt -121.92 174.07 7.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.059 0.43 . . . . 0.0 110.988 -171.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.44 ' SG ' HD11 ' A' ' 3' ' ' ILE . 14.2 t -111.35 112.09 23.6 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -115.7 118.98 34.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.413 0.625 . . . . 0.0 109.845 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 27.8 m -79.44 165.84 22.63 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.168 -172.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.452 ' HB ' ' CD1' ' A' ' 24' ' ' PHE . 10.6 m -105.37 109.5 63.28 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.406 ' HD3' HG21 ' A' ' 1' ' ' VAL . 31.8 Cg_endo -66.5 153.21 78.83 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.6 1.533 . . . . 0.0 111.137 173.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.902 177.205 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.405 HG21 ' HG3' ' A' ' 36' ' ' PRO . 13.3 m . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 121.048 0.451 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.48 164.85 19.05 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 16' ' ' PRO . 16.3 pt -122.89 176.07 5.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.145 0.497 . . . . 0.0 111.235 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -87.46 35.12 0.71 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.812 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 22.0 t -115.04 132.88 62.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-O 120.872 0.367 . . . . 0.0 110.279 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -80.69 126.81 31.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.994 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 t -67.35 93.8 0.35 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.272 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.29 -41.25 11.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.155 0.503 . . . . 0.0 110.371 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -144.12 135.86 26.06 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -174.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.463 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . 37.2 p -70.81 94.22 1.03 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.626 0.727 . . . . 0.0 110.282 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.64 -25.76 2.27 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -67.24 -25.44 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.299 0.571 . . . . 0.0 110.118 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.6 m -84.02 -9.26 58.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.453 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 25' ' ' GLY . 94.4 mt -61.47 -54.16 46.96 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 111.362 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.636 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 55.8 mtmt -59.57 -53.98 60.42 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.755 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HB2' HD12 ' A' ' 3' ' ' ILE . 20.1 Cg_endo -63.88 -24.45 67.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.214 1.276 . . . . 0.0 112.755 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -78.94 -37.92 38.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 13.8 ptmm? -71.11 -26.13 62.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.093 0.473 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 9.0 mtmp? -85.36 -5.2 59.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.703 0.763 . . . . 0.0 109.15 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.31 0.55 57.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.083 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 37' ' ' LYS . . . 80.65 19.13 68.96 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.014 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mmt -102.74 -175.8 2.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.46 0.171 . . . . 0.0 110.66 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 16.1 ttp180 -84.93 -71.23 0.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.678 0.275 . . . . 0.0 110.588 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -128.07 -179.37 4.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.192 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.701 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -131.49 104.54 0.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.605 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -91.35 158.81 16.33 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -92.15 114.75 27.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.037 0.446 . . . . 0.0 110.146 178.587 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.46 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.0 OUTLIER -99.81 162.86 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.089 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -58.33 87.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.397 0.618 . . . . 0.0 111.07 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.48 -31.85 8.17 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.02 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.421 ' H ' HG22 ' A' ' 28' ' ' ILE . 49.8 mtmt -121.8 147.6 45.74 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.362 -0.493 . . . . 0.0 111.882 -168.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 41.0 m -80.13 102.98 9.7 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 168.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.46 ' HB3' HD13 ' A' ' 28' ' ' ILE . 34.1 t70 -102.83 129.86 49.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.647 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.7 m -98.62 145.03 27.27 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.095 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 m -85.74 125.68 68.29 Favored Pre-proline 0 N--CA 1.446 -0.641 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HG3' HG21 ' A' ' 1' ' ' VAL . 3.9 Cg_exo -71.89 141.64 37.4 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.815 1.677 . . . . 0.0 111.264 177.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 21' ' ' GLY . 52.5 pttt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.496 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.755 0 CA-C-O 121.03 0.239 . . . . 0.0 113.023 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 pt -125.05 160.85 29.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -80.49 63.64 5.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.668 0.747 . . . . 0.0 109.965 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 22.0 t -140.08 160.81 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.671 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.45 ' N ' HG12 ' A' ' 5' ' ' VAL . 98.4 mttt -113.43 128.73 56.55 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.943 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.8 t -66.2 97.0 0.36 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.063 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 75.3 mmtt -90.39 -34.4 15.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 171.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -148.89 134.55 18.75 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.457 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 25.6 p -72.71 86.97 1.24 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.789 0.804 . . . . 0.0 110.692 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.1 -25.43 1.43 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.211 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.41 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 34.2 tt0 -67.62 -29.91 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.16 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 60.8 m -63.37 -12.74 32.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.414 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.441 HD22 ' H ' ' A' ' 25' ' ' GLY . 3.9 mm? -67.17 -37.51 83.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.931 0.396 . . . . 0.0 110.938 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 95.5 mttt -59.8 -51.67 79.21 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.004 -175.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 73.9 Cg_endo -78.62 -14.6 14.15 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.539 1.492 . . . . 0.0 112.494 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 11.0 t -75.44 -33.41 60.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.033 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 6.5 ptpp? -66.61 -20.67 66.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.947 0.403 . . . . 0.0 109.971 175.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -84.4 -19.64 33.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.04 -27.06 33.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.966 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.06 17.06 48.81 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.963 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.498 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 25.4 mmt -98.66 177.21 5.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.393 0.14 . . . . 0.0 111.119 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.511 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 6.3 ttp180 -78.21 -71.55 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.991 -173.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.511 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.62 173.52 8.46 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 175.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -133.12 103.26 0.5 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 62.7 pttt -90.81 164.06 14.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.115 0.483 . . . . 0.0 110.419 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 10' ' ' SER . 1.5 m -85.67 129.06 34.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.36 0.6 . . . . 0.0 111.184 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -118.15 179.0 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.589 177.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.552 ' N ' HG23 ' A' ' 28' ' ' ILE . 6.6 p30 -45.46 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.014 0.911 . . . . 0.0 112.844 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.46 -11.25 5.55 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.406 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HB2' HG22 ' A' ' 28' ' ' ILE . 97.4 mttt -121.24 177.49 5.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.307 0.554 . . . . 0.0 111.328 -172.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.578 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 62.9 m -107.31 119.04 38.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.28 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 20.0 t70 -113.0 127.91 56.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.786 175.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 63.7 m -91.76 155.35 18.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.327 0.584 . . . . 0.0 111.733 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.488 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 58.0 m -105.05 124.74 35.63 Favored Pre-proline 0 N--CA 1.44 -0.95 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.011 173.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.28 176.97 8.22 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.035 1.823 . . . . 0.0 111.328 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 pttm . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.599 176.579 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.764 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.3 pt -111.91 153.77 13.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.107 0.479 . . . . 0.0 110.637 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.27 64.64 4.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.303 -177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 46.1 t -130.94 138.02 54.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.578 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 9.9 mtmp? -77.46 111.55 13.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 26.1 t -73.64 106.3 5.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.473 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -88.76 -34.46 17.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -149.89 146.72 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.584 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.1 p -62.47 -39.37 93.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.96 0.409 . . . . 0.0 110.391 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.37 -23.92 68.75 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.397 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -70.53 -40.26 73.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 0.0 109.836 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 81.8 m -69.56 -16.81 63.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.89 -174.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -66.35 -34.1 77.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.032 0.444 . . . . 0.0 110.826 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 92.8 mttt -61.3 -53.16 65.3 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.791 -174.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 72.5 Cg_endo -79.2 -17.14 11.91 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.62 1.547 . . . . 0.0 112.39 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.8 t -71.57 -29.97 65.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.278 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 23.1 pttm -65.4 -23.95 67.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 110.532 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -90.1 -13.09 36.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.535 0.684 . . . . 0.0 109.731 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.41 -10.55 56.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.063 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.08 23.79 73.38 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.998 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.59 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.3 mmt -104.71 177.87 4.72 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.247 -177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.2 ttp180 -84.21 -72.74 0.45 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.077 -174.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.86 -179.16 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -129.58 110.98 1.12 Allowed Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.491 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -90.21 154.72 19.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.8 t -95.89 105.18 17.17 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.282 0.563 . . . . 0.0 111.037 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.4 mp -102.17 153.78 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -46.24 90.75 0.0 OUTLIER 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.891 0.744 . . . . 0.0 112.467 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 86.16 -9.66 68.95 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.373 -0.831 . . . . 0.0 113.458 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -121.02 135.42 55.21 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 117.726 0.763 . . . . 0.0 111.72 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.506 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 29.7 m -79.33 90.75 4.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.559 172.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.524 ' HB3' HD13 ' A' ' 28' ' ' ILE . 24.9 t70 -90.45 107.35 19.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.697 0.76 . . . . 0.0 110.901 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.6 m -81.47 149.98 28.51 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.532 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 26.3 m -92.07 128.63 44.67 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.141 174.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 5.1 Cg_exo -75.48 -173.04 1.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.817 1.678 . . . . 0.0 112.063 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.915 -177.631 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.9 pt -126.27 153.21 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.034 0.445 . . . . 0.0 110.851 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -80.73 42.05 0.6 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.615 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.7 t -110.59 146.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.072 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -81.66 138.92 35.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.234 0.54 . . . . 0.0 111.578 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 16.1 t -73.09 79.02 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.957 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -91.29 -47.92 7.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 172.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -150.74 142.8 24.03 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -66.21 -37.44 85.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.76 0.314 . . . . 0.0 110.985 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.1 -17.54 75.78 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.717 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.86 -41.09 26.99 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 75.2 m -62.83 -24.53 67.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.674 -176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.29 -35.66 80.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 0.0 111.565 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 61.8 mttp -64.51 -50.85 63.62 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -172.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 73.8 Cg_endo -78.53 -17.21 12.91 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.396 1.398 . . . . 0.0 112.355 176.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 39.6 t -73.58 -38.21 65.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.147 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 54.6 pttt -65.66 -21.85 66.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.312 0.577 . . . . 0.0 110.317 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -82.55 -16.74 47.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.672 0.748 . . . . 0.0 109.177 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.33 -11.11 53.02 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.18 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.546 ' O ' ' HE3' ' A' ' 37' ' ' LYS . . . 83.05 22.96 56.58 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.805 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.493 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.4 mmt -103.02 177.33 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.518 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.4 ttp180 -89.49 -68.23 0.79 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.02 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.518 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.35 172.91 9.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -139.85 107.22 0.53 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -86.89 154.35 20.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.191 0.52 . . . . 0.0 110.144 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.15 106.88 15.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.28 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 28' ' ' ILE . 2.3 tp -106.87 177.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.04 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -47.95 90.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.094 0.557 . . . . 0.0 111.499 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.41 -20.67 4.85 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.555 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 32.9 mmtp -123.47 178.78 5.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.363 0.582 . . . . 0.0 111.282 -170.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 80.2 m -108.48 113.57 26.71 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.28 117.3 32.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.999 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 65.3 m -91.02 150.69 21.34 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.501 0.667 . . . . 0.0 112.331 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.422 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 33.9 m -100.94 125.54 38.05 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.413 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 3.9 Cg_exo -72.47 145.37 42.4 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.148 1.899 . . . . 0.0 112.024 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HE3' ' O ' ' A' ' 21' ' ' GLY . 18.5 pttp . . . . . 0 C--O 1.249 1.042 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.246 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 N-CA-C 112.768 -0.133 . . . . 0.0 112.768 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.446 HD11 ' SG ' ' A' ' 32' ' ' CYS . 28.5 pt -112.39 -178.89 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.774 0.321 . . . . 0.0 110.327 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -81.48 41.21 0.61 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.916 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.33 148.05 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.25 157.34 16.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.968 0.413 . . . . 0.0 110.906 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.9 t -77.92 77.49 4.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.326 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -90.59 -52.59 4.82 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.789 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 19.2 m80 -147.24 137.13 23.08 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.8 p -64.38 -39.11 93.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.878 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.75 -19.96 79.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.894 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 9' ' ' HIS . 17.4 tt0 -70.13 -26.31 63.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.225 0.536 . . . . 0.0 110.07 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.48 -11.17 59.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.394 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.0 mt -59.89 -48.97 79.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.931 0.396 . . . . 0.0 111.614 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 52.2 mttm -67.38 -57.59 10.28 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -175.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 27.4 Cg_endo -62.41 -25.63 76.27 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 121.918 1.745 . . . . 0.0 112.781 -174.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' HA3' ' A' ' 25' ' ' GLY . 97.7 m -76.58 -38.51 54.76 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.1 0.476 . . . . 0.0 110.668 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -65.4 -36.8 85.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.169 0.509 . . . . 0.0 110.701 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 33.9 mmtp -76.2 -7.75 55.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.718 0.77 . . . . 0.0 109.541 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.3 5.27 50.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.378 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.99 26.81 54.9 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.731 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' A' ' 34' ' ' CYS . 37.4 mtt -123.65 175.71 6.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -88.17 -81.86 0.24 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.59 -174.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -110.88 -179.41 3.73 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -140.22 114.51 0.98 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.003 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -91.89 155.16 18.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.089 0.471 . . . . 0.0 109.968 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.22 105.68 17.97 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.6 tp -100.59 179.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -172.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.512 ' N ' HG23 ' A' ' 28' ' ' ILE . 38.0 m-20 -51.44 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.523 0.729 . . . . 0.0 112.21 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.422 ' C ' ' HD2' ' A' ' 31' ' ' LYS . . . 83.01 -17.51 21.96 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.023 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 30' ' ' GLY . 1.3 mptm? -121.22 -177.17 3.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.297 0.57 . . . . 0.0 111.217 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 3' ' ' ILE . 37.0 t -111.67 111.67 22.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.818 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -103.38 113.88 27.72 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.454 0.645 . . . . 0.0 110.476 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 24.0 m -93.1 151.66 19.73 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.978 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.8 m -96.43 108.26 41.02 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.36 152.68 15.85 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.04 1.827 . . . . 0.0 111.479 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.133 176.685 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 111.964 -0.454 . . . . 0.0 111.964 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -126.99 160.44 35.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.021 0.439 . . . . 0.0 110.686 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.69 42.75 0.63 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.838 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.7 142.94 40.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 51.3 pttt -91.05 138.31 31.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.6 t -72.28 111.8 7.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.162 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HD2' HE22 ' A' ' 12' ' ' GLN . 96.4 mttt -91.53 -33.87 15.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 54.6 m80 -150.01 143.68 25.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p -75.71 76.98 2.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.833 0.825 . . . . 0.0 110.901 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.83 -28.16 0.59 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.815 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.582 HE22 ' HD2' ' A' ' 8' ' ' LYS . 13.6 tt0 -62.69 -28.4 69.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.325 0.583 . . . . 0.0 109.76 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 70.3 m -63.78 -9.27 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.934 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.453 HD22 ' H ' ' A' ' 25' ' ' GLY . 3.4 mm? -65.88 -37.04 85.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.864 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.495 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 98.6 mttt -60.05 -54.01 59.51 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.117 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 51.5 Cg_endo -74.3 -24.37 14.48 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.41 1.407 . . . . 0.0 112.386 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 20.7 t -73.38 -39.22 65.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.332 -175.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -69.88 -21.51 63.32 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.022 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -88.17 -0.84 57.56 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.637 0.732 . . . . 0.0 109.18 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.23 -16.52 19.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.936 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.0 7.97 60.73 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.994 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.488 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.0 mmt -96.79 178.53 5.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.375 -0.13 . . . . 0.0 110.678 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.477 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 20.8 ttp180 -87.61 -69.14 0.71 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.853 -174.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.497 ' HD1' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -124.68 167.75 14.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -131.8 107.71 0.75 Allowed Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.14 168.2 12.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.167 0.508 . . . . 0.0 110.5 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 t -84.75 122.14 28.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.889 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.2 tp -118.65 178.68 2.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.549 ' N ' HG23 ' A' ' 28' ' ' ILE . 5.5 m120 -48.85 86.35 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.979 0.799 . . . . 0.0 111.747 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.23 -18.07 4.53 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.436 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 34.1 mmtp -121.55 173.41 7.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.602 0.701 . . . . 0.0 111.838 -170.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 90.2 m -98.06 116.86 31.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.081 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -106.74 122.92 47.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.31 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 58.2 m -90.76 152.32 20.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.44 0.638 . . . . 0.0 112.138 -175.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.497 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 95.9 m -112.64 122.41 36.32 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.556 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.06 169.81 21.34 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.106 1.87 . . . . 0.0 112.058 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.9 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.581 HD11 ' SG ' ' A' ' 32' ' ' CYS . 17.2 pt -115.21 162.44 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.198 0.523 . . . . 0.0 110.662 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -75.31 11.3 1.25 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.059 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.455 HG11 ' HG3' ' A' ' 16' ' ' PRO . 22.1 t -91.6 140.48 16.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -86.5 131.56 34.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.929 0.395 . . . . 0.0 110.11 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 49.5 t -91.04 115.49 28.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.925 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -91.54 -35.95 13.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 171.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -145.1 151.76 39.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.552 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -61.84 -43.16 99.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.804 0.335 . . . . 0.0 111.342 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.34 -24.68 67.72 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.033 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.85 -28.19 50.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.975 0.417 . . . . 0.0 110.206 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 7' ' ' CYS . 43.0 t -73.22 -25.65 60.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.617 0.722 . . . . 0.0 109.401 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -67.93 -29.55 68.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.464 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 47.7 mmtm -66.3 -53.84 28.99 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 86.3 Cg_endo -81.08 -17.64 9.21 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.338 1.359 . . . . 0.0 111.839 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 48.6 t -75.46 -39.33 58.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.294 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.58 -32.19 73.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.801 0.334 . . . . 0.0 110.631 -179.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 19.6 pttp -86.11 -13.99 45.56 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.839 0.828 . . . . 0.0 109.186 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.14 -14.19 60.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.199 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.69 9.79 64.0 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.956 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.414 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.5 mmt -94.5 -178.11 4.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.442 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 6.4 ttp180 -90.19 -73.12 0.53 Allowed 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.87 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.543 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -123.93 172.6 8.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.413 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -136.9 112.92 0.98 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -91.82 155.93 17.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.04 109.64 17.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.157 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -96.71 165.64 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.402 ' N ' HG23 ' A' ' 28' ' ' ILE . 24.5 m-80 -59.29 83.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.548 0.53 . . . . 0.0 111.394 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.35 -25.67 27.32 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.011 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.47 ' H ' HG22 ' A' ' 28' ' ' ILE . 14.3 mmmm -122.57 159.24 28.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.62 0.71 . . . . 0.0 112.326 -169.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 3' ' ' ILE . 42.0 t -90.24 105.45 17.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.144 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -101.82 125.39 48.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.714 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.5 m -97.51 154.54 17.44 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.418 0.628 . . . . 0.0 112.182 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.463 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 33.9 m -105.4 131.07 22.09 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.772 172.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -81.53 159.65 19.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.201 1.934 . . . . 0.0 111.617 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.191 179.658 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.54 0 N-CA-C 111.879 -0.489 . . . . 0.0 111.879 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 pt -125.44 157.63 34.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.23 0.538 . . . . 0.0 110.705 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -79.55 48.32 0.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.759 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -130.45 139.91 50.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.072 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.78 132.64 34.54 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.35 85.57 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.128 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 32.0 mtmm -92.17 105.63 17.81 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.2 m80 70.12 119.1 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.599 0.562 . . . . 0.0 109.823 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 p -70.79 77.54 0.62 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.785 0.802 . . . . 0.0 110.606 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.37 -23.33 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.625 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 54.2 tt0 -74.62 -26.39 59.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.854 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 59.6 m -69.66 -11.39 60.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.399 -172.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.3 mt -65.95 -49.2 68.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.637 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 64.1 mttp -54.36 -58.97 11.46 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.472 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 45.6 Cg_endo -69.2 -19.84 38.24 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.565 1.51 . . . . 0.0 112.414 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 34.6 t -74.38 -29.99 61.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -63.36 -37.66 88.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.477 175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -76.71 1.82 16.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.641 0.734 . . . . 0.0 109.89 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.23 -7.7 17.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.104 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.02 22.31 78.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.308 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.642 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 22.4 mmt -98.12 -177.31 3.69 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.445 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 4.8 ttp180 -90.26 -73.25 0.53 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.709 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.531 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.15 174.63 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -127.33 104.27 0.69 Allowed Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 20.5 ptmt -89.03 153.35 21.07 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.955 0.407 . . . . 0.0 109.951 -177.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 t -80.28 118.18 21.71 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.292 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -106.28 164.34 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 173.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.411 ' N ' HG23 ' A' ' 28' ' ' ILE . 8.0 m120 -57.2 85.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.41 0.624 . . . . 0.0 111.659 -176.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 -23.12 37.48 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.829 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -122.33 151.19 41.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.282 0.541 . . . . 0.0 110.996 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 88.1 m -85.75 113.47 21.95 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 172.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.59 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 27.8 t70 -109.35 123.09 48.75 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.447 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 75.9 m -89.6 154.37 20.03 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.574 0.702 . . . . 0.0 112.226 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 31.3 m -98.18 130.24 28.94 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.884 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 7.2 Cg_exo -69.07 152.75 72.84 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.719 1.613 . . . . 0.0 111.224 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.775 -0.631 . . . . 0.0 110.023 178.08 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.473 0 N-CA-C 113.849 0.299 . . . . 0.0 113.849 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 32' ' ' CYS . 33.2 pt -86.06 175.04 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 109.962 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -86.91 44.07 1.14 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.363 0.601 . . . . 0.0 111.003 -175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -131.58 149.98 33.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.524 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -99.74 138.19 37.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.24 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -70.11 86.38 0.56 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.951 0.405 . . . . 0.0 111.105 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HE3' ' OE1' ' A' ' 12' ' ' GLN . 56.6 mtmt -91.83 -41.24 10.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 167.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 12' ' ' GLN . 27.4 m80 -148.61 133.87 18.41 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.4 p -66.73 -36.26 82.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.762 0.315 . . . . 0.0 111.034 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.51 -19.24 76.13 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.492 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.604 ' OE1' ' HE3' ' A' ' 8' ' ' LYS . 34.7 tt0 -82.44 -23.19 34.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.897 0.379 . . . . 0.0 110.087 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.597 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 75.8 m -69.48 -18.92 63.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.327 0.584 . . . . 0.0 109.57 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' A' ' 24' ' ' PHE . 4.2 tp -75.54 -36.67 60.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.811 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 29.1 mmmt -54.1 -53.7 55.64 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.838 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 54.1 Cg_endo -78.38 -18.93 12.09 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.515 1.477 . . . . 0.0 111.921 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 11.7 t -65.39 -24.96 67.35 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.123 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 8.7 ptpp? -61.06 -30.44 70.33 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.818 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -90.15 -13.13 36.31 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.395 0.617 . . . . 0.0 109.737 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.67 56.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.46 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.09 29.9 66.1 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.145 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.583 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.4 mmt -107.23 -178.47 3.65 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.235 -175.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.452 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 20.9 ttp180 -89.64 -77.9 0.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.216 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.452 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -112.72 174.35 5.93 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.159 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -135.54 100.19 0.34 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -90.21 163.37 14.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.182 0.515 . . . . 0.0 110.342 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -87.24 122.21 30.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.904 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.533 HG22 ' HB2' ' A' ' 31' ' ' LYS . 1.0 OUTLIER -109.09 173.06 2.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 28' ' ' ILE . 42.3 m-80 -58.57 87.72 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.245 0.545 . . . . 0.0 111.422 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.09 -24.02 30.63 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.712 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HB2' HG22 ' A' ' 28' ' ' ILE . 47.6 mmtm -121.42 170.98 9.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.02 0.438 . . . . 0.0 111.266 -170.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.625 ' O ' HG12 ' A' ' 3' ' ' ILE . 85.7 m -98.19 120.35 38.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 168.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' HB3' HD13 ' A' ' 28' ' ' ILE . 22.7 t70 -109.42 124.16 50.55 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.843 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.496 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 80.8 m -92.46 151.63 20.11 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.158 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.448 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 91.3 m -97.63 118.45 64.16 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.181 175.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.66 144.37 31.47 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.103 1.869 . . . . 0.0 112.487 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp . . . . . 0 C--O 1.248 0.975 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.778 -178.696 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.668 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.523 HD11 ' SG ' ' A' ' 13' ' ' CYS . 12.3 pt -114.85 162.39 12.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.944 0.402 . . . . 0.0 110.736 -176.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.84 20.7 0.93 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.586 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.98 133.61 29.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.998 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -74.6 134.94 42.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.938 0.399 . . . . 0.0 110.144 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 t -68.16 101.59 1.19 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.433 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -91.59 -47.67 7.27 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -149.12 132.82 16.88 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.4 p -71.1 114.45 9.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.063 0.459 . . . . 0.0 110.529 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.93 -27.43 9.67 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.531 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -73.37 -22.11 60.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.377 0.608 . . . . 0.0 110.135 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' HD11 ' A' ' 3' ' ' ILE . 22.6 t -80.78 8.41 8.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.731 -175.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.477 HD22 ' H ' ' A' ' 25' ' ' GLY . 2.4 mm? -70.01 -28.28 65.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.155 0.502 . . . . 0.0 110.748 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.511 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 34.8 mmtp -67.78 -57.13 10.33 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.402 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 57.7 Cg_endo -71.09 -18.46 30.86 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.58 1.52 . . . . 0.0 112.795 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 36.1 t -79.79 -36.23 37.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.35 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -68.91 -25.14 64.44 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.306 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -82.92 -17.8 42.39 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.974 0.893 . . . . 0.0 109.115 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.08 -8.6 58.43 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.109 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.94 5.06 81.45 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.084 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.52 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 23.0 mmt -94.95 177.45 5.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.641 0.257 . . . . 0.0 110.88 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 2.8 ttp180 -88.41 -73.41 0.5 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.292 -173.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -121.99 154.19 37.56 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.477 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -106.19 110.3 3.33 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.624 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -90.66 154.9 19.23 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.85 120.22 30.9 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.059 0.457 . . . . 0.0 110.818 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.2 tp -109.46 168.54 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.422 ' N ' HG23 ' A' ' 28' ' ' ILE . 1.3 t30 -44.23 98.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.832 0.825 . . . . 0.0 110.776 173.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.41 -27.11 2.15 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 114.797 -1.092 . . . . 0.0 114.031 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 28' ' ' ILE . 74.8 mmtt -120.85 -177.32 3.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.731 0.766 . . . . 0.0 111.038 -168.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.6 t -114.2 114.81 26.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.185 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.457 ' HB3' HD13 ' A' ' 28' ' ' ILE . 23.9 t70 -103.38 115.57 30.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.356 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -88.53 155.86 19.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.849 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 62.7 m -97.67 132.52 24.92 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.93 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -70.25 170.62 16.74 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.787 1.658 . . . . 0.0 112.378 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.582 176.452 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -116.39 163.26 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.77 33.54 0.14 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.281 0.562 . . . . 0.0 111.887 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.63 151.76 17.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.682 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 35.3 mtmm -109.52 145.23 36.63 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 t -69.17 95.13 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.697 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -92.43 -42.92 9.48 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 167.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -148.29 126.02 11.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.446 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 p -66.99 -21.87 65.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.081 0.467 . . . . 0.0 111.048 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.86 -35.67 44.4 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.413 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -71.0 -30.06 66.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.077 0.465 . . . . 0.0 110.213 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.9 t -62.04 -19.29 62.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.992 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.508 HD12 ' H ' ' A' ' 25' ' ' GLY . 6.8 mp -72.15 -31.94 66.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.343 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.538 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 29.6 mtpp -58.91 -56.58 34.62 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.078 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 72.8 Cg_endo -76.71 -17.17 16.12 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.336 1.358 . . . . 0.0 112.21 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 35.3 t -80.36 -34.74 36.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.279 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 64.8 pttt -67.83 -24.78 65.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.159 0.504 . . . . 0.0 109.921 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -83.11 -9.6 59.12 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.575 0.702 . . . . 0.0 109.35 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.44 -15.16 31.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.989 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.73 13.16 63.22 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.009 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.506 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.2 mmt -94.91 -178.13 4.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.613 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 7.1 ttp180 -90.26 -65.7 0.99 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.72 -176.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.613 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -129.59 166.91 18.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 109.966 175.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.508 ' H ' HD12 ' A' ' 14' ' ' LEU . . . -113.59 109.62 2.3 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -91.08 152.1 20.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.051 0.453 . . . . 0.0 110.162 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.7 m -82.94 114.72 21.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.724 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -107.21 176.18 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.766 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.555 ' N ' HG23 ' A' ' 28' ' ' ILE . 4.8 p30 -44.75 85.08 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.739 0.78 . . . . 0.0 112.684 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 82.38 -21.33 7.35 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.169 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 99.1 mttt -120.19 172.52 7.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.427 0.632 . . . . 0.0 112.359 -168.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.73 103.18 14.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.581 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -105.15 117.42 33.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.134 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.3 m -83.52 154.58 23.79 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.698 0.761 . . . . 0.0 112.617 -174.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.46 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 89.2 m -101.71 116.82 62.91 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.843 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -69.67 152.71 69.82 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.332 2.021 . . . . 0.0 112.62 -177.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.069 176.479 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.514 ' HA2' ' H ' ' A' ' 34' ' ' CYS . . . . . . . . 0 N--CA 1.446 -0.699 0 N-CA-C 112.338 -0.305 . . . . 0.0 112.338 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 32' ' ' CYS . 12.7 pt -128.8 157.7 41.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.961 0.41 . . . . 0.0 110.184 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.409 ' N ' HD22 ' A' ' 4' ' ' ASN . 0.1 OUTLIER -72.38 11.11 0.65 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.264 -177.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.78 135.85 23.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 46.2 mtpt -86.97 133.71 33.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.2 t -72.12 104.31 3.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -39.15 13.12 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 172.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -148.29 138.54 22.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.916 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 p -62.95 -27.24 69.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.066 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.41 -32.66 41.87 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.816 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -69.2 -15.95 63.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.389 0.275 . . . . 0.0 111.594 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 77.5 m -77.39 -16.79 58.67 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -176.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.85 -37.48 58.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.766 0.317 . . . . 0.0 111.594 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -53.02 -55.37 34.27 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.687 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 73.9 Cg_endo -77.66 -16.61 14.72 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.439 1.426 . . . . 0.0 112.197 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 38.5 t -75.4 -37.4 60.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.322 -175.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.454 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.76 -18.15 64.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.127 0.489 . . . . 0.0 110.13 178.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 16' ' ' PRO . 8.0 mtmp? -85.86 -14.29 45.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.634 0.731 . . . . 0.0 109.196 177.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.79 -7.62 57.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.336 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.58 16.86 69.79 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.028 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.541 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 25.2 mmt -97.85 179.64 4.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.659 0.266 . . . . 0.0 110.47 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 4.5 ttp180 -90.74 -69.83 0.71 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.535 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.472 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.63 169.5 11.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -125.29 109.4 1.19 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 19.4 ptmt -90.25 156.78 18.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.5 t -83.66 114.61 21.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.074 0.464 . . . . 0.0 110.242 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.606 HG22 ' H ' ' A' ' 31' ' ' LYS . 1.0 OUTLIER -103.33 170.71 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.396 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.467 ' N ' HG23 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -38.41 -43.94 0.87 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -167.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.17 -0.48 1.65 Allowed Glycine 0 C--N 1.318 -0.419 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.596 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.606 ' H ' HG22 ' A' ' 28' ' ' ILE . 96.2 mttt -123.79 166.91 14.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.762 -172.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.452 ' O ' HG12 ' A' ' 3' ' ' ILE . 98.3 m -90.97 100.71 13.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 169.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.633 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 18.5 t70 -95.06 118.9 32.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.694 -177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.514 ' H ' ' HA2' ' A' ' 2' ' ' GLY . 69.6 m -88.5 153.41 21.17 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.638 0.732 . . . . 0.0 112.611 -172.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.449 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 52.6 m -109.34 118.4 50.94 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.946 171.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 18.0 Cg_exo -69.35 -177.74 1.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.884 2.389 . . . . 0.0 112.317 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.245 0.839 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.205 177.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.626 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.87 153.03 18.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 117.217 0.509 . . . . 0.0 110.55 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . 0.54 ' C ' HD22 ' A' ' 4' ' ' ASN . 0.1 OUTLIER -77.39 71.0 3.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.421 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 17.0 t -146.38 136.09 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -88.47 134.41 33.86 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.3 t -73.08 91.03 1.57 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.131 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -82.68 -34.02 27.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 28.6 m80 -147.5 148.59 31.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.983 177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 p -67.17 -34.4 77.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.183 0.516 . . . . 0.0 110.129 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.94 -12.63 81.14 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.623 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 9' ' ' HIS . 20.6 tt0 -84.1 -15.74 46.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.653 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 62.7 m -90.54 -17.33 27.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.022 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.666 HD23 ' H ' ' A' ' 25' ' ' GLY . 87.9 mt -74.18 -51.51 15.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.178 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 58.5 mttp -52.52 -53.51 52.78 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.847 -175.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 49.1 Cg_endo -73.39 -15.9 24.84 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.525 1.483 . . . . 0.0 112.88 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.653 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 14.4 t -78.69 -36.35 43.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.946 0.403 . . . . 0.0 111.234 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -69.79 -21.52 63.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.24 0.543 . . . . 0.0 109.932 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -83.84 -11.93 56.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.712 0.768 . . . . 0.0 109.044 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.87 -14.59 27.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.068 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.07 17.74 64.44 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.063 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.578 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 23.8 mmt -96.64 170.72 9.01 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.985 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 4.7 ttp180 -76.2 -68.46 0.58 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.602 -173.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.525 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -128.18 154.07 46.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 174.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.666 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -109.95 97.25 1.0 Allowed Glycine 0 C--N 1.309 -0.927 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -90.33 160.59 16.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.147 0.498 . . . . 0.0 110.694 -175.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.3 t -83.85 118.28 23.86 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.031 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.6 tp -110.46 -178.02 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.504 ' N ' HG23 ' A' ' 28' ' ' ILE . 43.9 m-80 -48.93 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.143 0.497 . . . . 0.0 111.901 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.04 -10.95 2.88 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.77 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 28' ' ' ILE . 30.4 ttpt -123.18 161.96 23.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.192 0.496 . . . . 0.0 111.584 -168.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.531 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 68.1 m -91.57 102.15 14.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.44 0.638 . . . . 0.0 110.45 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -99.81 127.29 45.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.505 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.0 m -96.88 149.34 21.98 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.448 0.642 . . . . 0.0 111.653 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.472 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 57.2 m -102.28 116.96 62.21 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.521 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.62 167.14 27.3 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.346 2.031 . . . . 0.0 111.43 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.4 mttp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.096 178.42 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.428 HD13 ' SG ' ' A' ' 34' ' ' CYS . 18.0 pt -118.51 164.08 15.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.172 0.51 . . . . 0.0 110.627 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -74.47 13.3 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.847 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.4 t -95.05 133.86 34.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.559 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.29 149.38 26.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 t -73.2 81.22 1.31 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.055 0.455 . . . . 0.0 110.211 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.43 -40.38 26.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.321 0.581 . . . . 0.0 110.11 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.679 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 6.9 p-80 -169.61 123.85 0.79 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.251 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.2 p -63.27 99.87 0.21 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.692 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.23 -30.01 1.34 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.679 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 24.8 tt0 -60.84 -34.5 74.67 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.943 0.402 . . . . 0.0 111.702 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 97.4 m -69.59 -9.5 54.32 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -168.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.51 -38.99 75.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.037 0.446 . . . . 0.0 110.667 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.516 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 75.0 mmtt -70.22 -56.25 7.17 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.207 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 50.8 Cg_endo -71.02 -29.28 18.11 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.585 1.523 . . . . 0.0 113.414 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 43.2 t -75.09 -36.12 61.74 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.319 -0.238 . . . . 0.0 111.546 -174.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 60.5 pttt -63.98 -23.17 67.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 109.903 175.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -83.09 -14.52 53.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.344 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.85 -12.34 48.16 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.844 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.73 19.55 53.7 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.474 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.636 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 43.8 mtt -116.17 173.63 6.48 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.3 ttp180 -84.28 -76.06 0.32 Allowed 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.538 -170.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.519 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -123.12 178.21 5.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -133.33 115.12 1.48 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 12.6 ptmm? -91.22 166.88 12.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.975 0.417 . . . . 0.0 110.047 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.55 135.4 35.58 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 31' ' ' LYS . 1.3 tp -123.26 173.23 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.451 ' N ' HG23 ' A' ' 28' ' ' ILE . 10.0 p30 -36.91 -44.58 0.51 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -166.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.19 -6.31 1.23 Allowed Glycine 0 C--N 1.317 -0.509 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.824 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.474 ' H ' HG22 ' A' ' 28' ' ' ILE . 34.3 mmtp -122.37 -165.86 1.34 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.947 0.403 . . . . 0.0 110.386 -168.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.3 t -118.27 125.92 51.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.953 175.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.459 ' HB3' HD13 ' A' ' 28' ' ' ILE . 22.0 t70 -111.51 123.98 51.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.197 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.539 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 21.7 m -87.66 155.88 19.73 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.642 0.734 . . . . 0.0 112.717 -173.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.467 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 89.4 m -107.27 128.69 25.52 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.712 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.33 -176.07 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.234 1.956 . . . . 0.0 112.03 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.4 pttm . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.834 -179.26 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.57 ' HA2' ' H ' ' A' ' 34' ' ' CYS . . . . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.04 163.07 32.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.817 0.341 . . . . 0.0 110.277 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -70.24 4.18 2.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.105 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 14.1 t -84.93 138.18 19.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.17 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -90.18 139.26 30.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.27 104.83 4.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.576 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 62.8 mttp -91.73 -43.83 9.34 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 167.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -144.51 152.79 41.09 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.447 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 3.2 p -60.99 -50.73 72.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.996 0.362 . . . . 0.0 111.817 -175.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.47 -13.72 65.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.476 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 23.5 tt0 -70.69 -31.01 67.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.353 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 81.9 m -78.81 -21.31 47.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.604 -175.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.529 HD22 ' H ' ' A' ' 25' ' ' GLY . 1.3 mm? -64.94 -35.37 80.96 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.98 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 60.8 mtpt -60.21 -60.76 9.58 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.345 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 50.9 Cg_endo -71.44 -16.99 30.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.075 1.85 . . . . 0.0 112.678 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 15.4 t -70.75 -34.08 71.47 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.374 -174.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 23.5 pttm -63.82 -25.95 68.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.398 . . . . 0.0 110.48 176.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -88.69 -14.34 37.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.338 0.59 . . . . 0.0 109.543 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.21 45.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.2 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.91 15.46 48.84 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.66 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.518 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.3 mmt -99.67 -179.39 4.17 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.623 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.486 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 5.8 ttp180 -90.26 -65.78 0.99 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.496 -175.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.27 162.4 23.8 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 174.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -126.71 94.95 0.43 Allowed Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HZ3' HD11 ' A' ' 28' ' ' ILE . 21.1 pttp -90.87 159.35 16.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.366 0.603 . . . . 0.0 110.99 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -83.64 113.73 21.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.423 -177.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -106.36 169.94 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.465 ' N ' HG23 ' A' ' 28' ' ' ILE . 4.7 p30 -43.3 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.934 0.873 . . . . 0.0 113.173 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 80.06 -14.32 21.44 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.566 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -121.64 144.94 48.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.517 0.659 . . . . 0.0 111.541 -171.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.448 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 62.2 m -79.42 99.34 7.14 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.367 173.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.439 ' HB3' HD13 ' A' ' 28' ' ' ILE . 24.7 t70 -99.49 118.19 35.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.4 0.619 . . . . 0.0 110.75 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.57 ' H ' ' HA2' ' A' ' 2' ' ' GLY . 62.1 m -93.08 149.93 20.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.684 -176.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.474 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 98.7 m -111.56 126.14 29.11 Favored Pre-proline 0 N--CA 1.439 -0.985 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.225 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.71 -168.03 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.398 2.065 . . . . 0.0 112.26 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.7 mttp . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.627 -0.702 . . . . 0.0 109.898 179.75 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.411 -0.276 . . . . 0.0 112.411 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -105.24 -179.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.055 0.455 . . . . 0.0 110.836 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -83.56 42.68 0.85 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.624 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.64 152.38 36.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.248 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -95.65 147.54 23.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.79 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 41.8 t -78.3 57.23 1.85 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.854 -174.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -93.4 104.88 17.0 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.7 m80 67.9 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.762 0.664 . . . . 0.0 110.73 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 p -60.74 -28.16 68.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.07 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.4 -20.52 76.96 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.523 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -76.98 -33.12 57.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.573 0.225 . . . . 0.0 110.831 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 74.7 m -65.78 -18.22 65.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.579 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 25' ' ' GLY . 1.1 mm? -64.84 -36.41 84.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.682 0.277 . . . . 0.0 111.245 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 4.8 mptp? -65.76 -56.71 16.63 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.08 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 39.8 Cg_endo -71.01 -19.07 30.62 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.329 1.353 . . . . 0.0 112.701 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.5 m -76.38 -38.66 55.41 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.45 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 49.0 pttt -69.5 -26.75 64.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 95.3 mttt -75.67 -23.42 56.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.7 58.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.358 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.56 11.81 76.7 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.305 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.655 ' SD ' ' HA ' ' A' ' 36' ' ' PRO . 23.5 mmt -95.65 175.67 6.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.389 0.137 . . . . 0.0 111.117 -177.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 14.9 ttp180 -80.7 -71.49 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.24 -173.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.468 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -119.67 -176.88 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.169 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.459 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -136.17 102.81 0.42 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.388 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -85.26 156.31 21.0 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -96.16 109.71 22.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.407 HG23 ' N ' ' A' ' 29' ' ' ASN . 2.2 tp -104.3 177.98 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.665 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.407 ' N ' HG23 ' A' ' 28' ' ' ILE . 9.6 m-80 -53.2 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.001 0.52 . . . . 0.0 111.63 -177.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.91 -18.06 28.56 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.162 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 66.3 mttm -122.94 179.47 4.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.09 0.445 . . . . 0.0 110.564 -172.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.3 m -107.0 120.27 41.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -103.31 107.87 18.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.687 0.756 . . . . 0.0 110.381 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.9 m -81.09 142.07 33.68 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.357 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 m -88.98 121.05 69.99 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.655 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 17.7 Cg_endo -75.04 120.56 6.1 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.998 1.799 . . . . 0.0 112.38 -175.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.602 ' OXT' ' HD2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.814 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.396 0 CA-C-O 120.939 0.188 . . . . 0.0 113.434 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.577 HD13 ' SG ' ' A' ' 34' ' ' CYS . 33.9 pt -120.17 167.62 13.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.53 67.56 7.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.955 0.407 . . . . 0.0 109.92 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -148.36 135.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -86.9 138.47 31.52 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 t -67.69 101.96 1.12 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.343 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.66 -50.74 5.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -149.65 135.16 18.4 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.5 p -62.17 -33.62 74.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.35 -31.58 61.01 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.967 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -76.72 -20.31 56.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' HA3' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -69.0 -13.58 62.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.413 -177.125 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.79 -35.43 78.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.947 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 97.7 mttt -57.07 -54.16 57.58 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.526 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 46.7 Cg_endo -74.49 -25.43 13.0 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.034 1.156 . . . . 0.0 112.844 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 m -76.23 -31.56 58.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 19.6 ptpt -68.41 -25.42 65.03 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -85.91 -11.09 54.08 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.269 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.2 -1.41 56.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.088 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.17 74.35 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.197 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.404 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 25.3 mmt -110.05 178.32 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.858 -0.201 . . . . 0.0 110.946 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.49 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 19.8 ttp180 -81.87 -70.04 0.57 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.169 -173.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.49 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.99 -177.23 3.78 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' A' ' 13' ' ' CYS . . . -126.72 107.91 0.95 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.872 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -91.9 157.05 17.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 m -90.05 129.69 36.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.216 0.532 . . . . 0.0 110.655 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.3 tp -119.42 -179.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.113 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.518 ' N ' HG23 ' A' ' 28' ' ' ILE . 38.9 m-20 -47.68 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.396 0.678 . . . . 0.0 112.133 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.49 -15.36 4.64 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.183 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HB2' HG22 ' A' ' 28' ' ' ILE . 48.0 mtmt -120.76 -173.66 2.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.231 0.515 . . . . 0.0 110.825 -172.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.3 t -115.49 121.34 42.4 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.8 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -112.24 115.91 29.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.4 0.619 . . . . 0.0 110.338 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.577 ' SG ' HD13 ' A' ' 3' ' ' ILE . 36.5 m -79.85 143.87 33.96 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.633 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.9 m -82.52 120.02 75.88 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -79.73 131.75 9.4 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.122 1.881 . . . . 0.0 111.872 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.6 pttt . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.515 -178.919 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.414 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 16' ' ' PRO . 18.1 pt -130.7 171.54 17.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.471 0.653 . . . . 0.0 111.936 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.23 37.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.605 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.53 144.89 22.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.345 -177.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -91.24 141.58 28.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.046 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.9 t -72.26 94.1 1.54 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.33 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.14 -47.65 7.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 7.1 p-80 -166.17 147.33 6.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.636 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.7 p -51.01 -46.58 61.58 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -171.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.95 -19.66 56.69 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.447 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.545 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 26.1 tt0 -74.68 -43.87 53.05 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 66.4 m -68.93 -15.48 63.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.38 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.597 HD22 ' H ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -62.45 -41.0 98.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.001 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 67.7 mttm -68.34 -54.97 13.29 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -174.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 56.5 Cg_endo -71.12 -18.4 30.8 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.327 1.351 . . . . 0.0 112.815 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 m -80.26 -39.62 28.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.585 0.231 . . . . 0.0 111.329 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -72.15 -23.0 61.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.084 0.468 . . . . 0.0 110.039 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -89.22 -5.94 57.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.59 0.709 . . . . 0.0 109.421 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.2 -5.81 51.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.267 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.73 14.87 62.45 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.847 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.7 mmt -104.84 179.6 4.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 2.6 ttp180 -82.59 -74.6 0.34 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.994 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -122.63 -179.94 4.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.597 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -131.47 111.03 1.03 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.963 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -91.1 153.67 19.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.898 0.38 . . . . 0.0 110.014 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -91.26 111.63 23.2 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 28' ' ' ILE . 2.4 tp -115.57 -179.12 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.027 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.424 ' N ' HG23 ' A' ' 28' ' ' ILE . 21.6 m-80 -44.37 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.87 0.868 . . . . 0.0 112.621 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.94 -8.23 3.68 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.392 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.483 ' HG2' ' N ' ' A' ' 32' ' ' CYS . 36.9 ttmt -122.9 167.4 13.6 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 122.559 -0.377 . . . . 0.0 110.001 -173.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.483 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 91.1 m -100.66 112.63 25.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.023 0.439 . . . . 0.0 109.895 169.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -96.43 109.11 21.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.62 0.724 . . . . 0.0 110.065 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 32.1 m -80.54 143.22 33.42 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.539 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.6 m -88.16 132.41 39.71 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -69.18 166.48 26.74 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.474 1.449 . . . . 0.0 110.828 176.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.489 -177.578 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.458 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 32' ' ' CYS . 28.5 pt -104.26 174.35 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.139 0.495 . . . . 0.0 110.606 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -76.23 7.91 3.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.302 -172.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.0 139.52 19.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.841 -173.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -83.32 142.98 30.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.517 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 5.7 t -79.18 101.55 8.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.777 -176.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -91.94 -57.07 2.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 168.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -147.01 156.45 43.05 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -62.46 -38.09 88.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.829 0.347 . . . . 0.0 110.752 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.79 -27.41 64.17 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.604 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -73.16 -44.97 59.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 0.0 110.243 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.96 -16.3 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.41 -172.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.696 HD23 ' H ' ' A' ' 25' ' ' GLY . 82.5 mt -56.94 -49.74 74.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.424 0.631 . . . . 0.0 111.3 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 22.3 ttmm -60.17 -54.8 51.68 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.317 -172.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 52.1 Cg_endo -73.96 -20.79 19.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.148 1.232 . . . . 0.0 113.077 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 m -77.6 -34.35 53.47 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 64.2 pttt -68.6 -25.59 64.95 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -86.05 -6.34 59.05 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.498 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.0 4.86 50.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.322 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.96 22.67 71.05 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.105 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 34' ' ' CYS . 46.1 mtt -116.61 175.82 5.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.169 -176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 8.1 ttp180 -75.41 -72.36 0.31 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.139 0.274 . . . . 0.0 111.653 -170.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.547 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.3 -176.61 3.63 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.09 0.471 . . . . 0.0 110.137 177.125 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.696 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -123.58 115.58 2.66 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.708 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -90.95 156.85 17.66 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.76 109.9 22.03 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.905 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.685 HG22 ' H ' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -95.01 164.33 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -39.06 -36.96 0.34 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.25 -14.79 1.05 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.025 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.685 ' H ' HG22 ' A' ' 28' ' ' ILE . 68.2 mttm -123.81 167.31 14.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.781 0.324 . . . . 0.0 111.277 -169.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.405 ' O ' HG12 ' A' ' 3' ' ' ILE . 99.6 m -91.16 111.91 23.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.429 0.633 . . . . 0.0 110.525 173.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -85.53 158.52 20.13 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.573 ' HB2' ' SD ' ' A' ' 22' ' ' MET . 16.5 m -131.98 137.52 47.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.427 ' HB ' ' CD1' ' A' ' 24' ' ' PHE . 28.8 m -88.0 123.01 69.68 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.37 176.58 9.06 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.714 1.609 . . . . 0.0 111.498 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.413 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.004 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.526 0 CA-C-O 121.019 0.233 . . . . 0.0 113.575 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.44 HD11 ' SG ' ' A' ' 32' ' ' CYS . 21.3 pt -110.02 171.61 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -81.28 45.18 0.83 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.986 0.422 . . . . 0.0 111.729 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.95 144.29 36.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.992 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -92.97 146.55 23.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.678 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 46.0 t -77.02 78.29 3.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.14 0.495 . . . . 0.0 111.276 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 52.7 mtpt -91.35 -50.21 5.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -143.9 136.6 27.15 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.0 p -66.69 -34.96 79.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.353 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.78 -18.2 79.48 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.586 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.455 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 61.1 tt0 -82.78 -31.14 28.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -19.64 65.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.474 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 25' ' ' GLY . 81.2 mt -61.14 -48.68 80.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.437 0.637 . . . . 0.0 110.737 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 56.3 mtpt -53.18 -56.71 21.29 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.322 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 57.9 Cg_endo -72.32 -28.93 14.58 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.304 1.336 . . . . 0.0 112.867 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.0 m -72.06 -36.87 69.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 65.1 pttt -67.45 -26.06 66.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.029 0.443 . . . . 0.0 109.867 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -79.88 -18.52 50.48 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.495 0.664 . . . . 0.0 109.327 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.06 9.16 23.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.068 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.94 19.25 80.03 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.008 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.1 mmt -97.89 175.34 6.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.75 0.309 . . . . 0.0 111.47 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 3.5 ttp180 -81.82 -66.06 0.94 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.164 -176.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.532 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -131.01 -177.51 4.41 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.642 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -125.14 116.65 2.76 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -91.91 146.46 23.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.249 0.547 . . . . 0.0 110.174 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.73 111.9 23.68 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 28' ' ' ILE . 2.2 tp -108.55 178.71 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.089 -171.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.404 ' N ' HG23 ' A' ' 28' ' ' ILE . 30.7 m-80 -49.63 87.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.065 0.546 . . . . 0.0 111.891 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.18 -15.93 8.1 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.254 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 74.9 mmtt -121.92 174.07 7.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.059 0.43 . . . . 0.0 110.988 -171.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.44 ' SG ' HD11 ' A' ' 3' ' ' ILE . 14.2 t -111.35 112.09 23.6 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -115.7 118.98 34.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.413 0.625 . . . . 0.0 109.845 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 27.8 m -79.44 165.84 22.63 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.168 -172.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.452 ' HB ' ' CD1' ' A' ' 24' ' ' PHE . 10.6 m -105.37 109.5 63.28 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -66.5 153.21 78.83 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.6 1.533 . . . . 0.0 111.137 173.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.902 177.205 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 16' ' ' PRO . 16.3 pt -122.89 176.07 5.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.145 0.497 . . . . 0.0 111.235 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -87.46 35.12 0.71 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.812 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 22.0 t -115.04 132.88 62.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-O 120.872 0.367 . . . . 0.0 110.279 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -80.69 126.81 31.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.994 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 t -67.35 93.8 0.35 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.272 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.29 -41.25 11.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.155 0.503 . . . . 0.0 110.371 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -144.12 135.86 26.06 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -174.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.463 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . 37.2 p -70.81 94.22 1.03 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.626 0.727 . . . . 0.0 110.282 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.64 -25.76 2.27 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -67.24 -25.44 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.299 0.571 . . . . 0.0 110.118 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.6 m -84.02 -9.26 58.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.453 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 25' ' ' GLY . 94.4 mt -61.47 -54.16 46.96 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 111.362 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.636 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 55.8 mtmt -59.57 -53.98 60.42 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.755 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HB2' HD12 ' A' ' 3' ' ' ILE . 20.1 Cg_endo -63.88 -24.45 67.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.214 1.276 . . . . 0.0 112.755 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -78.94 -37.92 38.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 13.8 ptmm? -71.11 -26.13 62.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.093 0.473 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 9.0 mtmp? -85.36 -5.2 59.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.703 0.763 . . . . 0.0 109.15 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.31 0.55 57.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.083 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 37' ' ' LYS . . . 80.65 19.13 68.96 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.014 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mmt -102.74 -175.8 2.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.46 0.171 . . . . 0.0 110.66 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 16.1 ttp180 -84.93 -71.23 0.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.678 0.275 . . . . 0.0 110.588 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -128.07 -179.37 4.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.701 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -131.49 104.54 0.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.605 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -91.35 158.81 16.33 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -92.15 114.75 27.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.037 0.446 . . . . 0.0 110.146 178.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.46 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.0 OUTLIER -99.81 162.86 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -58.33 87.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.397 0.618 . . . . 0.0 111.07 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.48 -31.85 8.17 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.02 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.421 ' H ' HG22 ' A' ' 28' ' ' ILE . 49.8 mtmt -121.8 147.6 45.74 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.362 -0.493 . . . . 0.0 111.882 -168.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 41.0 m -80.13 102.98 9.7 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 168.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.46 ' HB3' HD13 ' A' ' 28' ' ' ILE . 34.1 t70 -102.83 129.86 49.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.647 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.7 m -98.62 145.03 27.27 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.095 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 m -85.74 125.68 68.29 Favored Pre-proline 0 N--CA 1.446 -0.641 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -71.89 141.64 37.4 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.815 1.677 . . . . 0.0 111.264 177.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 21' ' ' GLY . 52.5 pttt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.496 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 77.6 t . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.567 0.222 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.35 124.39 0.26 Allowed Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.953 -0.642 . . . . 0.0 113.023 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 19.2 pt -125.05 160.85 29.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -80.49 63.64 5.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.668 0.747 . . . . 0.0 109.965 -176.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.578 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 22.0 t -140.08 160.81 26.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.671 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.45 ' N ' HG12 ' A' ' 5' ' ' VAL . 98.4 mttt -113.43 128.73 56.55 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.943 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.8 t -66.2 97.0 0.36 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.063 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.41 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 75.3 mmtt -90.39 -34.4 15.67 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 171.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -148.89 134.55 18.75 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.457 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 25.6 p -72.71 86.97 1.24 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.789 0.804 . . . . 0.0 110.692 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.1 -25.43 1.43 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.211 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.41 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 34.2 tt0 -67.62 -29.91 69.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.214 -0.493 . . . . 0.0 110.16 176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.612 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 60.8 m -63.37 -12.74 32.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.414 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.441 HD22 ' H ' ' A' ' 25' ' ' GLY . 3.9 mm? -67.17 -37.51 83.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.931 0.396 . . . . 0.0 110.938 177.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 95.5 mttt -59.8 -51.67 79.21 Favored Pre-proline 0 CA--C 1.535 0.397 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.004 -175.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 73.9 Cg_endo -78.62 -14.6 14.15 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 121.539 1.492 . . . . 0.0 112.494 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 11.0 t -75.44 -33.41 60.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.033 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 6.5 ptpp? -66.61 -20.67 66.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.947 0.403 . . . . 0.0 109.971 175.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -84.4 -19.64 33.21 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.04 -27.06 33.24 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.625 -1.171 . . . . 0.0 109.966 176.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 92.06 17.06 48.81 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.963 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.498 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 25.4 mmt -98.66 177.21 5.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.393 0.14 . . . . 0.0 111.119 -177.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.511 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 6.3 ttp180 -78.21 -71.55 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.991 -173.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.511 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.62 173.52 8.46 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 175.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -133.12 103.26 0.5 Allowed Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 62.7 pttt -90.81 164.06 14.21 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.115 0.483 . . . . 0.0 110.419 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 10' ' ' SER . 1.5 m -85.67 129.06 34.92 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.36 0.6 . . . . 0.0 111.184 177.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.552 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -118.15 179.0 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.064 -0.971 . . . . 0.0 108.589 177.838 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.552 ' N ' HG23 ' A' ' 28' ' ' ILE . 6.6 p30 -45.46 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 122.014 0.911 . . . . 0.0 112.844 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 73.46 -11.25 5.55 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.615 -0.721 . . . . 0.0 113.406 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.458 ' HB2' HG22 ' A' ' 28' ' ' ILE . 97.4 mttt -121.24 177.49 5.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.307 0.554 . . . . 0.0 111.328 -172.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.578 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 62.9 m -107.31 119.04 38.3 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.591 -0.732 . . . . 0.0 110.28 177.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 20.0 t70 -113.0 127.91 56.36 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.786 175.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 63.7 m -91.76 155.35 18.32 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.327 0.584 . . . . 0.0 111.733 -177.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.488 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 58.0 m -105.05 124.74 35.63 Favored Pre-proline 0 N--CA 1.44 -0.95 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.011 173.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -81.28 176.97 8.22 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.035 1.823 . . . . 0.0 111.328 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 23.5 pttm . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.49 -0.767 . . . . 0.0 109.599 176.579 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.408 HG11 ' HG3' ' A' ' 36' ' ' PRO . 34.4 m . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.602 0.239 . . . . 0.0 110.542 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 127.04 147.76 6.79 Favored Glycine 0 N--CA 1.445 -0.764 0 N-CA-C 111.446 -0.662 . . . . 0.0 111.446 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 15.3 pt -111.91 153.77 13.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.107 0.479 . . . . 0.0 110.637 -177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -79.27 64.64 4.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.303 -177.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.506 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 46.1 t -130.94 138.02 54.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.578 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.589 ' HA ' ' O ' ' A' ' 30' ' ' GLY . 9.9 mtmp? -77.46 111.55 13.29 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.428 ' SG ' ' SG ' ' A' ' 13' ' ' CYS . 26.1 t -73.64 106.3 5.34 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.473 -176.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.5 mtpp -88.76 -34.46 17.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -149.89 146.72 27.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.124 -0.943 . . . . 0.0 108.584 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.1 p -62.47 -39.37 93.22 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.96 0.409 . . . . 0.0 110.391 178.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.37 -23.92 68.75 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.397 178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -70.53 -40.26 73.57 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 0.0 109.836 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 81.8 m -69.56 -16.81 63.49 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.89 -174.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -66.35 -34.1 77.22 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.032 0.444 . . . . 0.0 110.826 177.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.534 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 92.8 mttt -61.3 -53.16 65.3 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.791 -174.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 72.5 Cg_endo -79.2 -17.14 11.91 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.62 1.547 . . . . 0.0 112.39 176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 8.8 t -71.57 -29.97 65.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.278 -174.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 23.1 pttm -65.4 -23.95 67.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.95 0.405 . . . . 0.0 110.532 177.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -90.1 -13.09 36.54 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-O 121.535 0.684 . . . . 0.0 109.731 178.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.41 -10.55 56.07 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.063 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.08 23.79 73.38 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.998 179.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.59 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.3 mmt -104.71 177.87 4.72 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.78 -0.368 . . . . 0.0 111.247 -177.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.504 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.2 ttp180 -84.21 -72.74 0.45 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.077 -174.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.504 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.86 -179.16 4.55 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -129.58 110.98 1.12 Allowed Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.491 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -90.21 154.72 19.53 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 3.8 t -95.89 105.18 17.17 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.282 0.563 . . . . 0.0 111.037 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.524 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.4 mp -102.17 153.78 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 175.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -46.24 90.75 0.0 OUTLIER 'General case' 0 C--O 1.233 0.212 0 O-C-N 123.891 0.744 . . . . 0.0 112.467 -176.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.589 ' O ' ' HA ' ' A' ' 6' ' ' LYS . . . 86.16 -9.66 68.95 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.373 -0.831 . . . . 0.0 113.458 176.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 29.8 mtpp -121.02 135.42 55.21 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 117.726 0.763 . . . . 0.0 111.72 -175.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.506 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 29.7 m -79.33 90.75 4.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.559 172.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.524 ' HB3' HD13 ' A' ' 28' ' ' ILE . 24.9 t70 -90.45 107.35 19.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.697 0.76 . . . . 0.0 110.901 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.425 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 56.6 m -81.47 149.98 28.51 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.532 -177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 26.3 m -92.07 128.63 44.67 Favored Pre-proline 0 C--N 1.314 -0.937 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.141 174.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 5.1 Cg_exo -75.48 -173.04 1.47 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 121.817 1.678 . . . . 0.0 112.063 178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.596 -0.716 . . . . 0.0 109.915 -177.631 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.484 HG11 ' HG3' ' A' ' 36' ' ' PRO . 30.6 m . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.66 0.267 . . . . 0.0 110.687 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 144.93 160.42 8.53 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.622 -178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.9 pt -126.27 153.21 34.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.034 0.445 . . . . 0.0 110.851 -178.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -80.73 42.05 0.6 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.615 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.7 t -110.59 146.11 16.15 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.072 -177.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.8 mmmm -81.66 138.92 35.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.234 0.54 . . . . 0.0 111.578 -176.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.545 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 16.1 t -73.09 79.02 1.22 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.957 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -91.29 -47.92 7.21 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 172.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -150.74 142.8 24.03 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.3 p -66.21 -37.44 85.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.76 0.314 . . . . 0.0 110.985 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.1 -17.54 75.78 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.964 -0.636 . . . . 0.0 111.717 176.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -79.86 -41.09 26.99 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 176.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 75.2 m -62.83 -24.53 67.81 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.674 -176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -66.29 -35.66 80.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 0.0 111.565 -178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 61.8 mttp -64.51 -50.85 63.62 Favored Pre-proline 0 CA--C 1.539 0.535 0 N-CA-C 112.616 0.598 . . . . 0.0 112.616 -172.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.453 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 73.8 Cg_endo -78.53 -17.21 12.91 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.396 1.398 . . . . 0.0 112.355 176.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 39.6 t -73.58 -38.21 65.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.147 -176.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 54.6 pttt -65.66 -21.85 66.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.312 0.577 . . . . 0.0 110.317 177.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -82.55 -16.74 47.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.672 0.748 . . . . 0.0 109.177 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.33 -11.11 53.02 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.791 -1.095 . . . . 0.0 110.18 178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.546 ' O ' ' HE3' ' A' ' 37' ' ' LYS . . . 83.05 22.96 56.58 Favored Glycine 0 N--CA 1.443 -0.851 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.805 -177.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.493 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.4 mmt -103.02 177.33 4.87 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.209 -0.293 . . . . 0.0 110.209 178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.518 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.4 ttp180 -89.49 -68.23 0.79 Allowed 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.02 -173.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.518 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.35 172.91 9.22 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 175.341 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.505 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -139.85 107.22 0.53 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 21.8 ptmt -86.89 154.35 20.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.191 0.52 . . . . 0.0 110.144 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.15 106.88 15.3 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.28 -176.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.427 HD12 ' HA ' ' A' ' 28' ' ' ILE . 2.3 tp -106.87 177.86 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.04 -172.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -47.95 90.5 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 123.094 0.557 . . . . 0.0 111.499 -179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.41 -20.67 4.85 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.555 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.545 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 32.9 mmtp -123.47 178.78 5.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 117.363 0.582 . . . . 0.0 111.282 -170.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 80.2 m -108.48 113.57 26.71 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 173.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -98.28 117.3 32.37 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.999 -176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.505 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 65.3 m -91.02 150.69 21.34 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.501 0.667 . . . . 0.0 112.331 -174.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.422 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 33.9 m -100.94 125.54 38.05 Favored Pre-proline 0 C--N 1.319 -0.754 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.413 174.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HG3' HG11 ' A' ' 1' ' ' VAL . 3.9 Cg_exo -72.47 145.37 42.4 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.148 1.899 . . . . 0.0 112.024 -179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.546 ' HE3' ' O ' ' A' ' 21' ' ' GLY . 18.5 pttp . . . . . 0 C--O 1.249 1.042 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.246 176.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.4 m . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.727 0.298 . . . . 0.0 110.429 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -95.52 135.98 12.65 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.768 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.446 HD11 ' SG ' ' A' ' 32' ' ' CYS . 28.5 pt -112.39 -178.89 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.774 0.321 . . . . 0.0 110.327 177.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -81.48 41.21 0.61 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.916 -177.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.3 t -129.33 148.05 33.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -101.25 157.34 16.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.968 0.413 . . . . 0.0 110.906 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.9 t -77.92 77.49 4.43 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.326 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -90.59 -52.59 4.82 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.789 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.517 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 19.2 m80 -147.24 137.13 23.08 Favored 'General case' 0 N--CA 1.463 0.2 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 51.8 p -64.38 -39.11 93.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.878 -175.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.75 -19.96 79.69 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.456 -0.878 . . . . 0.0 111.894 178.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.517 ' HB2' ' HB2' ' A' ' 9' ' ' HIS . 17.4 tt0 -70.13 -26.31 63.89 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.225 0.536 . . . . 0.0 110.07 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.3 m -78.48 -11.17 59.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.518 -0.765 . . . . 0.0 112.394 -176.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.0 mt -59.89 -48.97 79.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.931 0.396 . . . . 0.0 111.614 -177.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 52.2 mttm -67.38 -57.59 10.28 Favored Pre-proline 0 CA--C 1.54 0.582 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -175.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.421 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 27.4 Cg_endo -62.41 -25.63 76.27 Favored 'Trans proline' 0 C--N 1.359 1.123 0 C-N-CA 121.918 1.745 . . . . 0.0 112.781 -174.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.438 ' SG ' ' HA3' ' A' ' 25' ' ' GLY . 97.7 m -76.58 -38.51 54.76 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.1 0.476 . . . . 0.0 110.668 177.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -65.4 -36.8 85.05 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.169 0.509 . . . . 0.0 110.701 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 33.9 mmtp -76.2 -7.75 55.52 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.718 0.77 . . . . 0.0 109.541 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -97.3 5.27 50.22 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.378 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 79.99 26.81 54.9 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.988 -0.625 . . . . 0.0 111.731 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.498 ' SD ' ' HB2' ' A' ' 34' ' ' CYS . 37.4 mtt -123.65 175.71 6.67 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -177.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.574 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 0.6 OUTLIER -88.17 -81.86 0.24 Allowed 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.453 -0.499 . . . . 0.0 111.59 -174.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.574 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -110.88 -179.41 3.73 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -140.22 114.51 0.98 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.003 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 56.6 tttm -91.89 155.16 18.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.089 0.471 . . . . 0.0 109.968 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -90.22 105.68 17.97 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.512 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.6 tp -100.59 179.82 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 110.113 -0.328 . . . . 0.0 110.113 -172.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.512 ' N ' HG23 ' A' ' 28' ' ' ILE . 38.0 m-20 -51.44 83.13 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 123.523 0.729 . . . . 0.0 112.21 -177.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.422 ' C ' ' HD2' ' A' ' 31' ' ' LYS . . . 83.01 -17.51 21.96 Favored Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 116.175 -0.466 . . . . 0.0 113.023 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HD2' ' C ' ' A' ' 30' ' ' GLY . 1.3 mptm? -121.22 -177.17 3.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.297 0.57 . . . . 0.0 111.217 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.446 ' SG ' HD11 ' A' ' 3' ' ' ILE . 37.0 t -111.67 111.67 22.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.818 176.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -103.38 113.88 27.72 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.454 0.645 . . . . 0.0 110.476 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.531 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 24.0 m -93.1 151.66 19.73 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.978 -174.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 24.8 m -96.43 108.26 41.02 Favored Pre-proline 0 N--CA 1.446 -0.667 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -82.36 152.68 15.85 Favored 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.04 1.827 . . . . 0.0 111.479 178.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 19.1 ptmt . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.265 -0.874 . . . . 0.0 110.133 176.685 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 121.047 0.451 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -101.98 175.23 24.98 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.533 -0.841 . . . . 0.0 111.964 -178.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.6 pt -126.99 160.44 35.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.021 0.439 . . . . 0.0 110.686 178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -80.69 42.75 0.63 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.838 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.5 t -125.7 142.94 40.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 51.3 pttt -91.05 138.31 31.7 Favored 'General case' 0 N--CA 1.448 -0.527 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 177.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 31.6 t -72.28 111.8 7.8 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.162 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.582 ' HD2' HE22 ' A' ' 12' ' ' GLN . 96.4 mttt -91.53 -33.87 15.0 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 172.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.418 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 54.6 m80 -150.01 143.68 25.32 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -178.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.1 p -75.71 76.98 2.68 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.833 0.825 . . . . 0.0 110.901 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 155.83 -28.16 0.59 Allowed Glycine 0 N--CA 1.445 -0.74 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.815 -177.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.582 HE22 ' HD2' ' A' ' 8' ' ' LYS . 13.6 tt0 -62.69 -28.4 69.91 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.325 0.583 . . . . 0.0 109.76 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 70.3 m -63.78 -9.27 13.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.934 -177.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.453 HD22 ' H ' ' A' ' 25' ' ' GLY . 3.4 mm? -65.88 -37.04 85.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.864 178.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.495 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 98.6 mttt -60.05 -54.01 59.51 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.117 -177.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 51.5 Cg_endo -74.3 -24.37 14.48 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 121.41 1.407 . . . . 0.0 112.386 177.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 20.7 t -73.38 -39.22 65.28 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.332 -175.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -69.88 -21.51 63.32 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.669 -0.412 . . . . 0.0 110.022 177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 36.1 mtmm -88.17 -0.84 57.56 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.637 0.732 . . . . 0.0 109.18 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.23 -16.52 19.4 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.933 -1.03 . . . . 0.0 109.936 177.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 94.0 7.97 60.73 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.994 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.488 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.0 mmt -96.79 178.53 5.28 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.375 -0.13 . . . . 0.0 110.678 -179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.477 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 20.8 ttp180 -87.61 -69.14 0.71 Allowed 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.586 -0.446 . . . . 0.0 110.853 -174.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.497 ' HD1' ' HB ' ' A' ' 35' ' ' THR . 0.0 OUTLIER -124.68 167.75 14.11 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 175.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.483 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -131.8 107.71 0.75 Allowed Glycine 0 N--CA 1.444 -0.796 0 N-CA-C 111.139 -0.784 . . . . 0.0 111.139 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.14 168.2 12.15 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.167 0.508 . . . . 0.0 110.5 -177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 11.5 t -84.75 122.14 28.69 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.889 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.549 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.2 tp -118.65 178.68 2.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.549 ' N ' HG23 ' A' ' 28' ' ' ILE . 5.5 m120 -48.85 86.35 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.979 0.799 . . . . 0.0 111.747 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.23 -18.07 4.53 Favored Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.436 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 34.1 mmtp -121.55 173.41 7.43 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.602 0.701 . . . . 0.0 111.838 -170.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 90.2 m -98.06 116.86 31.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.081 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -106.74 122.92 47.32 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.31 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.483 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 58.2 m -90.76 152.32 20.85 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.44 0.638 . . . . 0.0 112.138 -175.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.497 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 95.9 m -112.64 122.41 36.32 Favored Pre-proline 0 N--CA 1.441 -0.91 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.556 174.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.06 169.81 21.34 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.106 1.87 . . . . 0.0 112.058 178.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.471 -0.776 . . . . 0.0 110.9 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.8 m . . . . . 0 N--CA 1.482 1.136 0 CA-C-O 121.004 0.431 . . . . 0.0 111.538 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -105.5 164.83 14.02 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 111.106 -0.797 . . . . 0.0 111.106 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.581 HD11 ' SG ' ' A' ' 32' ' ' CYS . 17.2 pt -115.21 162.44 13.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.198 0.523 . . . . 0.0 110.662 -179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -75.31 11.3 1.25 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.059 -174.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.455 HG11 ' HG3' ' A' ' 16' ' ' PRO . 22.1 t -91.6 140.48 16.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -178.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -86.5 131.56 34.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.929 0.395 . . . . 0.0 110.11 177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' SG ' ' HB2' ' A' ' 13' ' ' CYS . 49.5 t -91.04 115.49 28.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.925 -177.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp -91.54 -35.95 13.99 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 171.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -145.1 151.76 39.0 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.552 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.9 p -61.84 -43.16 99.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.804 0.335 . . . . 0.0 111.342 -176.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.34 -24.68 67.72 Favored Glycine 0 C--N 1.331 0.253 0 C-N-CA 121.029 -0.605 . . . . 0.0 112.033 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -77.85 -28.19 50.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.975 0.417 . . . . 0.0 110.206 177.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.409 ' HB2' ' SG ' ' A' ' 7' ' ' CYS . 43.0 t -73.22 -25.65 60.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.617 0.722 . . . . 0.0 109.401 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.413 HD22 ' H ' ' A' ' 25' ' ' GLY . 0.9 OUTLIER -67.93 -29.55 68.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.464 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 47.7 mmtm -66.3 -53.84 28.99 Favored Pre-proline 0 CA--C 1.538 0.483 0 N-CA-C 112.47 0.545 . . . . 0.0 112.47 -172.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 86.3 Cg_endo -81.08 -17.64 9.21 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 121.338 1.359 . . . . 0.0 111.839 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 48.6 t -75.46 -39.33 58.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.294 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -64.58 -32.19 73.74 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.801 0.334 . . . . 0.0 110.631 -179.437 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 19.6 pttp -86.11 -13.99 45.56 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 121.839 0.828 . . . . 0.0 109.186 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -74.14 -14.19 60.93 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.261 -1.336 . . . . 0.0 110.199 174.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 90.69 9.79 64.0 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.956 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.414 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.5 mmt -94.5 -178.11 4.46 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 121.056 -0.258 . . . . 0.0 110.442 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.543 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 6.4 ttp180 -90.19 -73.12 0.53 Allowed 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.87 -175.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.543 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -123.93 172.6 8.81 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.311 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.413 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -136.9 112.92 0.98 Allowed Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -91.82 155.93 17.88 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.04 109.64 17.29 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.157 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.47 HG22 ' H ' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -96.71 165.64 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' N ' HG23 ' A' ' 28' ' ' ILE . 24.5 m-80 -59.29 83.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.548 0.53 . . . . 0.0 111.394 -176.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.35 -25.67 27.32 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.011 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.47 ' H ' HG22 ' A' ' 28' ' ' ILE . 14.3 mmmm -122.57 159.24 28.19 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 117.62 0.71 . . . . 0.0 112.326 -169.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.581 ' SG ' HD11 ' A' ' 3' ' ' ILE . 42.0 t -90.24 105.45 17.82 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.144 175.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -101.82 125.39 48.48 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.714 -177.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 89.5 m -97.51 154.54 17.44 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.418 0.628 . . . . 0.0 112.182 -175.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.463 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 33.9 m -105.4 131.07 22.09 Favored Pre-proline 0 N--CA 1.444 -0.747 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.772 172.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -81.53 159.65 19.47 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.201 1.934 . . . . 0.0 111.617 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.881 -0.58 . . . . 0.0 110.191 179.658 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 17.4 m . . . . . 0 N--CA 1.481 1.097 0 CA-C-O 120.85 0.357 . . . . 0.0 111.399 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -90.89 169.61 33.92 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.879 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.7 pt -125.44 157.63 34.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.23 0.538 . . . . 0.0 110.705 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -79.55 48.32 0.91 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.759 -176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.4 t -130.45 139.91 50.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.072 -178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -88.78 132.64 34.54 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 40.6 t -70.35 85.57 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 0.0 112.128 -174.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 32.0 mtmm -92.17 105.63 17.81 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 167.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 6.2 m80 70.12 119.1 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.641 0 O-C-N 123.599 0.562 . . . . 0.0 109.823 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.9 p -70.79 77.54 0.62 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.785 0.802 . . . . 0.0 110.606 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 177.37 -23.33 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.625 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.403 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 54.2 tt0 -74.62 -26.39 59.87 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.844 0.354 . . . . 0.0 110.854 179.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 32' ' ' CYS . 59.6 m -69.66 -11.39 60.8 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.399 -172.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.3 mt -65.95 -49.2 68.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.637 -177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.481 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 64.1 mttp -54.36 -58.97 11.46 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.472 -177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 45.6 Cg_endo -69.2 -19.84 38.24 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.565 1.51 . . . . 0.0 112.414 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.642 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 34.6 t -74.38 -29.99 61.78 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.333 0.587 . . . . 0.0 110.401 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 81.4 tttt -63.36 -37.66 88.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.477 175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.1 mmtm -76.71 1.82 16.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.641 0.734 . . . . 0.0 109.89 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.23 -7.7 17.7 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.692 -1.14 . . . . 0.0 110.104 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.02 22.31 78.07 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.364 -0.835 . . . . 0.0 112.308 -179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.642 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 22.4 mmt -98.12 -177.31 3.69 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 121.039 -0.264 . . . . 0.0 110.445 -178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.531 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 4.8 ttp180 -90.26 -73.25 0.53 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.709 -177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.531 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.15 174.63 7.94 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 175.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -127.33 104.27 0.69 Allowed Glycine 0 N--CA 1.446 -0.633 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 20.5 ptmt -89.03 153.35 21.07 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.955 0.407 . . . . 0.0 109.951 -177.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.2 t -80.28 118.18 21.71 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.292 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.411 HG23 ' N ' ' A' ' 29' ' ' ASN . 0.8 OUTLIER -106.28 164.34 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 173.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.411 ' N ' HG23 ' A' ' 28' ' ' ILE . 8.0 m120 -57.2 85.0 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.41 0.624 . . . . 0.0 111.659 -176.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.27 -23.12 37.48 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.829 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.8 tptm -122.33 151.19 41.41 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.282 0.541 . . . . 0.0 110.996 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 13' ' ' CYS . 88.1 m -85.75 113.47 21.95 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 172.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.59 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 27.8 t70 -109.35 123.09 48.75 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -178.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 1' ' ' VAL . 75.9 m -89.6 154.37 20.03 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.574 0.702 . . . . 0.0 112.226 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 36' ' ' PRO . 31.3 m -98.18 130.24 28.94 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.884 172.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 7.2 Cg_exo -69.07 152.75 72.84 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.719 1.613 . . . . 0.0 111.224 177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 98.1 mttt . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.775 -0.631 . . . . 0.0 110.023 178.08 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.442 HG21 ' HB2' ' A' ' 34' ' ' CYS . 7.9 m . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 119.787 -0.149 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 52.6 91.32 0.01 OUTLIER Glycine 0 C--N 1.34 0.767 0 O-C-N 123.197 0.31 . . . . 0.0 113.849 178.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 32' ' ' CYS . 33.2 pt -86.06 175.04 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.034 0.445 . . . . 0.0 109.962 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 30.7 p-10 -86.91 44.07 1.14 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.363 0.601 . . . . 0.0 111.003 -175.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 97.1 t -131.58 149.98 33.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.524 -175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -99.74 138.19 37.16 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.24 -178.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.3 t -70.11 86.38 0.56 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.951 0.405 . . . . 0.0 111.105 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.604 ' HE3' ' OE1' ' A' ' 12' ' ' GLN . 56.6 mtmt -91.83 -41.24 10.75 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 167.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.402 ' HB2' ' CB ' ' A' ' 12' ' ' GLN . 27.4 m80 -148.61 133.87 18.41 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 178.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.4 p -66.73 -36.26 82.06 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.762 0.315 . . . . 0.0 111.034 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.51 -19.24 76.13 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.666 -0.778 . . . . 0.0 111.492 176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.604 ' OE1' ' HE3' ' A' ' 8' ' ' LYS . 34.7 tt0 -82.44 -23.19 34.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.897 0.379 . . . . 0.0 110.087 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.597 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 75.8 m -69.48 -18.92 63.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.327 0.584 . . . . 0.0 109.57 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.447 HD11 ' HA ' ' A' ' 24' ' ' PHE . 4.2 tp -75.54 -36.67 60.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.811 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.559 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 29.1 mmmt -54.1 -53.7 55.64 Favored Pre-proline 0 CA--C 1.54 0.578 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.838 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.559 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 54.1 Cg_endo -78.38 -18.93 12.09 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 121.515 1.477 . . . . 0.0 111.921 176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.597 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 11.7 t -65.39 -24.96 67.35 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.123 -175.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 8.7 ptpp? -61.06 -30.44 70.33 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.818 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -90.15 -13.13 36.31 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.395 0.617 . . . . 0.0 109.737 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -81.39 -14.67 56.92 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.46 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 72.09 29.9 66.1 Favored Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.145 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.583 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.4 mmt -107.23 -178.47 3.65 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 121.08 -0.248 . . . . 0.0 111.235 -175.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.452 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 20.9 ttp180 -89.64 -77.9 0.38 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.216 -176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.452 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -112.72 174.35 5.93 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.159 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.496 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -135.54 100.19 0.34 Allowed Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.3 ptpp? -90.21 163.37 14.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.182 0.515 . . . . 0.0 110.342 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -87.24 122.21 30.72 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.904 178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.533 HG22 ' HB2' ' A' ' 31' ' ' LYS . 1.0 OUTLIER -109.09 173.06 2.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.481 ' N ' HG23 ' A' ' 28' ' ' ILE . 42.3 m-80 -58.57 87.72 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 121.245 0.545 . . . . 0.0 111.422 -177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.09 -24.02 30.63 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.712 178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.533 ' HB2' HG22 ' A' ' 28' ' ' ILE . 47.6 mmtm -121.42 170.98 9.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.02 0.438 . . . . 0.0 111.266 -170.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.625 ' O ' HG12 ' A' ' 3' ' ' ILE . 85.7 m -98.19 120.35 38.44 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 168.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' HB3' HD13 ' A' ' 28' ' ' ILE . 22.7 t70 -109.42 124.16 50.55 Favored 'General case' 0 C--N 1.317 -0.825 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.843 176.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.496 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 80.8 m -92.46 151.63 20.11 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.158 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.448 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 91.3 m -97.63 118.45 64.16 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.181 175.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.66 144.37 31.47 Favored 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 122.103 1.869 . . . . 0.0 112.487 -177.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp . . . . . 0 C--O 1.248 0.975 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.778 -178.696 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.42 HG11 ' HG3' ' A' ' 36' ' ' PRO . 31.2 m . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.922 0.391 . . . . 0.0 111.351 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.9 155.88 30.72 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.665 -0.779 . . . . 0.0 111.356 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.523 HD11 ' SG ' ' A' ' 13' ' ' CYS . 12.3 pt -114.85 162.39 12.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 120.944 0.402 . . . . 0.0 110.736 -176.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.84 20.7 0.93 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.586 -175.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.98 133.61 29.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.998 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -74.6 134.94 42.04 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.938 0.399 . . . . 0.0 110.144 177.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 t -68.16 101.59 1.19 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.433 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 61.9 mttm -91.59 -47.67 7.27 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 173.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.1 m80 -149.12 132.82 16.88 Favored 'General case' 0 CA--C 1.517 -0.325 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.4 p -71.1 114.45 9.17 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.063 0.459 . . . . 0.0 110.529 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 112.93 -27.43 9.67 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.531 -175.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 tt0 -73.37 -22.11 60.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.377 0.608 . . . . 0.0 110.135 179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.523 ' SG ' HD11 ' A' ' 3' ' ' ILE . 22.6 t -80.78 8.41 8.2 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.731 -175.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.477 HD22 ' H ' ' A' ' 25' ' ' GLY . 2.4 mm? -70.01 -28.28 65.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.155 0.502 . . . . 0.0 110.748 177.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.511 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 34.8 mmtp -67.78 -57.13 10.33 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.402 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 57.7 Cg_endo -71.09 -18.46 30.86 Favored 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.58 1.52 . . . . 0.0 112.795 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 36.1 t -79.79 -36.23 37.35 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.661 -0.245 . . . . 0.0 111.35 -176.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.7 ptpp? -68.91 -25.14 64.44 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.726 -0.389 . . . . 0.0 111.306 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 16' ' ' PRO . 0.3 OUTLIER -82.92 -17.8 42.39 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 121.974 0.893 . . . . 0.0 109.115 179.48 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.08 -8.6 58.43 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.109 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 86.94 5.06 81.45 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.67 -0.695 . . . . 0.0 112.084 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.52 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 23.0 mmt -94.95 177.45 5.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.641 0.257 . . . . 0.0 110.88 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 2.8 ttp180 -88.41 -73.41 0.5 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.292 -173.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -121.99 154.19 37.56 Favored 'General case' 0 C--O 1.223 -0.337 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 177.392 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.477 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -106.19 110.3 3.33 Favored Glycine 0 C--N 1.313 -0.706 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.624 178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -90.66 154.9 19.23 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.85 120.22 30.9 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.059 0.457 . . . . 0.0 110.818 177.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.457 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.2 tp -109.46 168.54 3.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 177.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' N ' HG23 ' A' ' 28' ' ' ILE . 1.3 t30 -44.23 98.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.832 0.825 . . . . 0.0 110.776 173.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.41 -27.11 2.15 Favored Glycine 0 CA--C 1.523 0.545 0 CA-C-N 114.797 -1.092 . . . . 0.0 114.031 176.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 28' ' ' ILE . 74.8 mmtt -120.85 -177.32 3.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.731 0.766 . . . . 0.0 111.038 -168.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.6 t -114.2 114.81 26.51 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.185 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.457 ' HB3' HD13 ' A' ' 28' ' ' ILE . 23.9 t70 -103.38 115.57 30.8 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.356 177.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 31.5 m -88.53 155.86 19.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.849 -175.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 62.7 m -97.67 132.52 24.92 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.93 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.42 ' HG3' HG11 ' A' ' 1' ' ' VAL . 6.7 Cg_exo -70.25 170.62 16.74 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.787 1.658 . . . . 0.0 112.378 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp . . . . . 0 C--O 1.25 1.099 0 CA-C-N 115.102 -0.954 . . . . 0.0 109.582 176.452 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.422 HG11 ' HD3' ' A' ' 36' ' ' PRO . 28.0 m . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.0 140.67 5.74 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.728 -0.749 . . . . 0.0 111.843 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 10.5 pt -116.39 163.26 13.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -76.77 33.54 0.14 Allowed 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.281 0.562 . . . . 0.0 111.887 -176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.63 151.76 17.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.682 -176.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 35.3 mtmm -109.52 145.23 36.63 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 175.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 t -69.17 95.13 0.73 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.697 -174.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -92.43 -42.92 9.48 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 167.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -148.29 126.02 11.85 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 114.883 -1.053 . . . . 0.0 108.446 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 14.7 p -66.99 -21.87 65.94 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.081 0.467 . . . . 0.0 111.048 -177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -75.86 -35.67 44.4 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.724 -0.75 . . . . 0.0 111.413 173.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -71.0 -30.06 66.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.077 0.465 . . . . 0.0 110.213 178.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 11.9 t -62.04 -19.29 62.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.992 -175.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.508 HD12 ' H ' ' A' ' 25' ' ' GLY . 6.8 mp -72.15 -31.94 66.44 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.343 -179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.538 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 29.6 mtpp -58.91 -56.58 34.62 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.187 -0.46 . . . . 0.0 112.078 -177.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.538 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 72.8 Cg_endo -76.71 -17.17 16.12 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.336 1.358 . . . . 0.0 112.21 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 35.3 t -80.36 -34.74 36.27 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.279 -176.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 64.8 pttt -67.83 -24.78 65.32 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.159 0.504 . . . . 0.0 109.921 177.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -83.11 -9.6 59.12 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.575 0.702 . . . . 0.0 109.35 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -90.44 -15.16 31.42 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.989 178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 88.73 13.16 63.22 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.009 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.506 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 24.2 mmt -94.91 -178.13 4.4 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.613 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 7.1 ttp180 -90.26 -65.7 0.99 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.72 -176.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.613 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -129.59 166.91 18.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.908 0.385 . . . . 0.0 109.966 175.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.508 ' H ' HD12 ' A' ' 14' ' ' LEU . . . -113.59 109.62 2.3 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.607 -0.997 . . . . 0.0 110.607 175.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -91.08 152.1 20.76 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.051 0.453 . . . . 0.0 110.162 -177.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.7 m -82.94 114.72 21.41 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.724 176.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.555 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -107.21 176.18 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.766 178.496 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.555 ' N ' HG23 ' A' ' 28' ' ' ILE . 4.8 p30 -44.75 85.08 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 121.739 0.78 . . . . 0.0 112.684 177.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 82.38 -21.33 7.35 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.559 -0.746 . . . . 0.0 113.169 177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.492 ' HA ' ' HA ' ' A' ' 6' ' ' LYS . 99.1 mttt -120.19 172.52 7.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.427 0.632 . . . . 0.0 112.359 -168.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.73 103.18 14.41 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.581 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -105.15 117.42 33.95 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.134 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.42 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 59.3 m -83.52 154.58 23.79 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.698 0.761 . . . . 0.0 112.617 -174.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.46 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 89.2 m -101.71 116.82 62.91 Favored Pre-proline 0 N--CA 1.44 -0.967 0 CA-C-N 114.951 -1.022 . . . . 0.0 108.843 172.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD3' HG11 ' A' ' 1' ' ' VAL . 63.7 Cg_endo -69.67 152.71 69.82 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.332 2.021 . . . . 0.0 112.62 -177.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? . . . . . 0 C--O 1.25 1.13 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.069 176.479 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.544 ' O ' ' HB2' ' A' ' 34' ' ' CYS . 30.9 m . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 120.697 0.284 . . . . 0.0 111.25 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.514 ' HA2' ' H ' ' A' ' 34' ' ' CYS . . . -94.09 -177.69 39.1 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.338 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 32' ' ' CYS . 12.7 pt -128.8 157.7 41.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 120.961 0.41 . . . . 0.0 110.184 -179.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.409 ' N ' HD22 ' A' ' 4' ' ' ASN . 0.1 OUTLIER -72.38 11.11 0.65 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 115.76 -0.655 . . . . 0.0 112.264 -177.08 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.78 135.85 23.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 31' ' ' LYS . 46.2 mtpt -86.97 133.71 33.56 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.657 -0.498 . . . . 0.0 109.657 178.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 53.2 t -72.12 104.31 3.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.816 0.341 . . . . 0.0 111.037 -176.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -90.03 -39.15 13.12 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 172.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -148.29 138.54 22.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.854 -1.066 . . . . 0.0 108.916 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 5.3 p -62.95 -27.24 69.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.998 -0.547 . . . . 0.0 112.066 -174.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.41 -32.66 41.87 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.701 -0.761 . . . . 0.0 111.816 176.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.3 mt-30 -69.2 -15.95 63.51 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.389 0.275 . . . . 0.0 111.594 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 77.5 m -77.39 -16.79 58.67 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 -176.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 mp -75.85 -37.48 58.93 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.766 0.317 . . . . 0.0 111.594 -179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.8 mptp? -53.02 -55.37 34.27 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.687 -177.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.435 ' HA ' ' HE3' ' A' ' 19' ' ' LYS . 73.9 Cg_endo -77.66 -16.61 14.72 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 121.439 1.426 . . . . 0.0 112.197 177.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 38.5 t -75.4 -37.4 60.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.322 -175.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.454 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -68.76 -18.15 64.16 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.127 0.489 . . . . 0.0 110.13 178.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.435 ' HE3' ' HA ' ' A' ' 16' ' ' PRO . 8.0 mtmp? -85.86 -14.29 45.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.634 0.731 . . . . 0.0 109.196 177.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -87.79 -7.62 57.04 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.336 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 82.58 16.86 69.79 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.028 -178.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.541 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 25.2 mmt -97.85 179.64 4.74 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.659 0.266 . . . . 0.0 110.47 -179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 4.5 ttp180 -90.74 -69.83 0.71 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.535 -176.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.472 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.63 169.5 11.88 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 175.83 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -125.29 109.4 1.19 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 111.25 -0.74 . . . . 0.0 111.25 177.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 19.4 ptmt -90.25 156.78 18.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -178.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 10.5 t -83.66 114.61 21.68 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.074 0.464 . . . . 0.0 110.242 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.606 HG22 ' H ' ' A' ' 31' ' ' LYS . 1.0 OUTLIER -103.33 170.71 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 178.396 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.467 ' N ' HG23 ' A' ' 28' ' ' ILE . 1.0 OUTLIER -38.41 -43.94 0.87 Allowed 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -167.462 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.17 -0.48 1.65 Allowed Glycine 0 C--N 1.318 -0.419 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.596 174.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.606 ' H ' HG22 ' A' ' 28' ' ' ILE . 96.2 mttt -123.79 166.91 14.79 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.154 0.502 . . . . 0.0 111.762 -172.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.452 ' O ' HG12 ' A' ' 3' ' ' ILE . 98.3 m -90.97 100.71 13.53 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 169.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.633 ' O ' ' HG2' ' A' ' 26' ' ' LYS . 18.5 t70 -95.06 118.9 32.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.694 -177.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 1' ' ' VAL . 69.6 m -88.5 153.41 21.17 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.638 0.732 . . . . 0.0 112.611 -172.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.449 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 52.6 m -109.34 118.4 50.94 Favored Pre-proline 0 N--CA 1.442 -0.866 0 CA-C-N 114.999 -1.0 . . . . 0.0 108.946 171.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 35' ' ' THR . 18.0 Cg_exo -69.35 -177.74 1.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 122.884 2.389 . . . . 0.0 112.317 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 68.6 mttm . . . . . 0 C--O 1.245 0.839 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.205 177.877 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.479 1.005 0 CA-C-O 120.762 0.315 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.43 162.47 9.25 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 18.0 pt -116.87 153.03 18.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 117.217 0.509 . . . . 0.0 110.55 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . 0.54 ' C ' HD22 ' A' ' 4' ' ' ASN . 0.1 OUTLIER -77.39 71.0 3.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.421 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 17.0 t -146.38 136.09 17.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 28.5 mtpp -88.47 134.41 33.86 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 174.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.3 t -73.08 91.03 1.57 Allowed 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.711 -0.396 . . . . 0.0 111.131 -175.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -82.68 -34.02 27.52 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 170.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.402 ' HB2' ' HB2' ' A' ' 12' ' ' GLN . 28.6 m80 -147.5 148.59 31.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.648 -1.16 . . . . 0.0 107.983 177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 15.2 p -67.17 -34.4 77.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.183 0.516 . . . . 0.0 110.129 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.94 -12.63 81.14 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.623 175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.402 ' HB2' ' HB2' ' A' ' 9' ' ' HIS . 20.6 tt0 -84.1 -15.74 46.25 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 177.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.653 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 62.7 m -90.54 -17.33 27.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.022 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.666 HD23 ' H ' ' A' ' 25' ' ' GLY . 87.9 mt -74.18 -51.51 15.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.178 -179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 58.5 mttp -52.52 -53.51 52.78 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.382 -0.826 . . . . 0.0 112.847 -175.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.468 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 49.1 Cg_endo -73.39 -15.9 24.84 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 121.525 1.483 . . . . 0.0 112.88 177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.653 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 14.4 t -78.69 -36.35 43.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.946 0.403 . . . . 0.0 111.234 -175.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 60.5 pttt -69.79 -21.52 63.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.24 0.543 . . . . 0.0 109.932 176.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -83.84 -11.93 56.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.712 0.768 . . . . 0.0 109.044 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.87 -14.59 27.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.068 177.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.07 17.74 64.44 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.461 -0.79 . . . . 0.0 112.063 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.578 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 23.8 mmt -96.64 170.72 9.01 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.985 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.525 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 4.7 ttp180 -76.2 -68.46 0.58 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.577 -0.283 . . . . 0.0 110.602 -173.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.525 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -128.18 154.07 46.2 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 174.465 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.666 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -109.95 97.25 1.0 Allowed Glycine 0 C--N 1.309 -0.927 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 173.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -90.33 160.59 16.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.147 0.498 . . . . 0.0 110.694 -175.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 18.3 t -83.85 118.28 23.86 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.031 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.504 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.6 tp -110.46 -178.02 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.504 ' N ' HG23 ' A' ' 28' ' ' ILE . 43.9 m-80 -48.93 88.8 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.143 0.497 . . . . 0.0 111.901 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 71.04 -10.95 2.88 Favored Glycine 0 CA--C 1.524 0.625 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.77 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 28' ' ' ILE . 30.4 ttpt -123.18 161.96 23.47 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.192 0.496 . . . . 0.0 111.584 -168.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.531 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 68.1 m -91.57 102.15 14.8 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.44 0.638 . . . . 0.0 110.45 175.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -99.81 127.29 45.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.505 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 57.0 m -96.88 149.34 21.98 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.448 0.642 . . . . 0.0 111.653 -178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.472 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 57.2 m -102.28 116.96 62.21 Favored Pre-proline 0 C--N 1.314 -0.973 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.521 175.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -71.62 167.14 27.3 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.346 2.031 . . . . 0.0 111.43 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 61.4 mttp . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.096 178.42 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 10.2 m . . . . . 0 N--CA 1.481 1.121 0 CA-C-O 121.035 0.445 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.74 145.3 17.64 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.567 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.428 HD13 ' SG ' ' A' ' 34' ' ' CYS . 18.0 pt -118.51 164.08 15.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.172 0.51 . . . . 0.0 110.627 179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.4 p-10 -74.47 13.3 0.62 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.847 -176.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 30.4 t -95.05 133.86 34.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.559 -176.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.29 149.38 26.8 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 38.1 t -73.2 81.22 1.31 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.055 0.455 . . . . 0.0 110.211 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -80.43 -40.38 26.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.321 0.581 . . . . 0.0 110.11 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.679 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 6.9 p-80 -169.61 123.85 0.79 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.251 178.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.2 p -63.27 99.87 0.21 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.692 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 148.23 -30.01 1.34 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 110.527 -1.029 . . . . 0.0 110.527 -174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.679 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 24.8 tt0 -60.84 -34.5 74.67 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.943 0.402 . . . . 0.0 111.702 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.409 ' C ' ' HD2' ' A' ' 16' ' ' PRO . 97.4 m -69.59 -9.5 54.32 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -168.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -57.51 -38.99 75.53 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.037 0.446 . . . . 0.0 110.667 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.516 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 75.0 mmtt -70.22 -56.25 7.17 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.207 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 50.8 Cg_endo -71.02 -29.28 18.11 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 121.585 1.523 . . . . 0.0 113.414 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.636 ' SG ' ' HB2' ' A' ' 22' ' ' MET . 43.2 t -75.09 -36.12 61.74 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 122.319 -0.238 . . . . 0.0 111.546 -174.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.424 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 60.5 pttt -63.98 -23.17 67.23 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.144 0.497 . . . . 0.0 109.903 175.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -83.09 -14.52 53.56 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.344 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -86.85 -12.34 48.16 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.101 -0.954 . . . . 0.0 109.844 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.73 19.55 53.7 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.474 -177.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.636 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 43.8 mtt -116.17 173.63 6.48 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 3.3 ttp180 -84.28 -76.06 0.32 Allowed 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.797 -0.361 . . . . 0.0 111.538 -170.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.519 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -123.12 178.21 5.2 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 177.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -133.33 115.12 1.48 Allowed Glycine 0 N--CA 1.446 -0.636 0 N-CA-C 111.811 -0.516 . . . . 0.0 111.811 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 33' ' ' ASP . 12.6 ptmm? -91.22 166.88 12.71 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.975 0.417 . . . . 0.0 110.047 179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.4 t -81.55 135.4 35.58 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 177.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.474 HG22 ' H ' ' A' ' 31' ' ' LYS . 1.3 tp -123.26 173.23 9.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.451 ' N ' HG23 ' A' ' 28' ' ' ILE . 10.0 p30 -36.91 -44.58 0.51 Allowed 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -166.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -139.19 -6.31 1.23 Allowed Glycine 0 C--N 1.317 -0.509 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.824 172.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' H ' HG22 ' A' ' 28' ' ' ILE . 34.3 mmtp -122.37 -165.86 1.34 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.947 0.403 . . . . 0.0 110.386 -168.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 19.3 t -118.27 125.92 51.09 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.953 175.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.459 ' HB3' HD13 ' A' ' 28' ' ' ILE . 22.0 t70 -111.51 123.98 51.34 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.197 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.539 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 21.7 m -87.66 155.88 19.73 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-O 121.642 0.734 . . . . 0.0 112.717 -173.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.467 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 89.4 m -107.27 128.69 25.52 Favored Pre-proline 0 N--CA 1.439 -0.988 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.712 176.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -76.33 -176.07 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.234 1.956 . . . . 0.0 112.03 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 18.4 pttm . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.233 -0.889 . . . . 0.0 110.834 -179.26 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.483 1.191 0 CA-C-O 120.731 0.301 . . . . 0.0 111.673 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.57 ' HA2' ' H ' ' A' ' 34' ' ' CYS . . . -83.83 -176.57 51.3 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.793 -0.717 . . . . 0.0 112.075 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.4 pt -128.04 163.07 32.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.817 0.341 . . . . 0.0 110.277 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -70.24 4.18 2.39 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.105 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 14.1 t -84.93 138.18 19.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.17 -176.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -90.18 139.26 30.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 t -73.27 104.83 4.44 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.576 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 62.8 mttp -91.73 -43.83 9.34 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 167.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -144.51 152.79 41.09 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.447 ' HA ' ' SG ' ' A' ' 27' ' ' CYS . 3.2 p -60.99 -50.73 72.2 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.996 0.362 . . . . 0.0 111.817 -175.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.47 -13.72 65.81 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.062 -0.589 . . . . 0.0 112.476 -178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.429 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 23.5 tt0 -70.69 -31.01 67.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.817 0.341 . . . . 0.0 110.353 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.544 ' O ' ' HB2' ' A' ' 17' ' ' CYS . 81.9 m -78.81 -21.31 47.91 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.604 -175.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.529 HD22 ' H ' ' A' ' 25' ' ' GLY . 1.3 mm? -64.94 -35.37 80.96 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.98 177.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 60.8 mtpt -60.21 -60.76 9.58 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.345 -172.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 50.9 Cg_endo -71.44 -16.99 30.77 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.075 1.85 . . . . 0.0 112.678 177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 13' ' ' CYS . 15.4 t -70.75 -34.08 71.47 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.374 -174.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.589 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 23.5 pttm -63.82 -25.95 68.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.937 0.398 . . . . 0.0 110.48 176.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -88.69 -14.34 37.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.338 0.59 . . . . 0.0 109.543 -179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.73 -23.21 45.59 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.2 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 93.91 15.46 48.84 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.66 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.518 ' HB2' ' SG ' ' A' ' 17' ' ' CYS . 26.3 mmt -99.67 -179.39 4.17 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.623 -178.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.486 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 5.8 ttp180 -90.26 -65.78 0.99 Allowed 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.904 -0.318 . . . . 0.0 110.496 -175.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.486 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.27 162.4 23.8 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 174.375 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.534 ' HA2' ' HA ' ' A' ' 34' ' ' CYS . . . -126.71 94.95 0.43 Allowed Glycine 0 C--N 1.312 -0.754 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 177.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.403 ' HZ3' HD11 ' A' ' 28' ' ' ILE . 21.1 pttp -90.87 159.35 16.28 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.366 0.603 . . . . 0.0 110.99 -174.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 10' ' ' SER . 0.8 OUTLIER -83.64 113.73 21.05 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.423 -177.193 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.465 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.0 OUTLIER -106.36 169.94 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 176.748 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.465 ' N ' HG23 ' A' ' 28' ' ' ILE . 4.7 p30 -43.3 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 121.934 0.873 . . . . 0.0 113.173 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 28' ' ' ILE . . . 80.06 -14.32 21.44 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.341 -0.845 . . . . 0.0 113.566 178.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -121.64 144.94 48.47 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 117.517 0.659 . . . . 0.0 111.541 -171.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.448 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 62.2 m -79.42 99.34 7.14 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.367 173.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.439 ' HB3' HD13 ' A' ' 28' ' ' ILE . 24.7 t70 -99.49 118.19 35.53 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.4 0.619 . . . . 0.0 110.75 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.57 ' H ' ' HA2' ' A' ' 2' ' ' GLY . 62.1 m -93.08 149.93 20.88 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.684 -176.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.474 ' HB ' ' HD1' ' A' ' 24' ' ' PHE . 98.7 m -111.56 126.14 29.11 Favored Pre-proline 0 N--CA 1.439 -0.985 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.225 177.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -74.71 -168.03 0.46 Allowed 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.398 2.065 . . . . 0.0 112.26 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.7 mttp . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.627 -0.702 . . . . 0.0 109.898 179.75 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.478 0.93 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -73.82 126.6 9.81 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.886 -0.674 . . . . 0.0 112.411 -177.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 24.1 pt -105.24 -179.59 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.055 0.455 . . . . 0.0 110.836 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -83.56 42.68 0.85 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.624 -176.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 64.5 t -128.64 152.38 36.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.248 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -95.65 147.54 23.49 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.79 -177.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.503 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 41.8 t -78.3 57.23 1.85 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.854 -174.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 45.6 mmtm -93.4 104.88 17.0 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 168.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 3.7 m80 67.9 116.7 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 O-C-N 123.762 0.664 . . . . 0.0 110.73 178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.1 p -60.74 -28.16 68.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.07 -176.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.4 -20.52 76.96 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.523 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -76.98 -33.12 57.64 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.573 0.225 . . . . 0.0 110.831 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 74.7 m -65.78 -18.22 65.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.579 -175.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 25' ' ' GLY . 1.1 mm? -64.84 -36.41 84.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.682 0.277 . . . . 0.0 111.245 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.465 ' O ' ' HG3' ' A' ' 19' ' ' LYS . 4.8 mptp? -65.76 -56.71 16.63 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.08 -175.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 39.8 Cg_endo -71.01 -19.07 30.62 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 121.329 1.353 . . . . 0.0 112.701 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.5 m -76.38 -38.66 55.41 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.45 179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 49.0 pttt -69.5 -26.75 64.7 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 177.218 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 95.3 mttt -75.67 -23.42 56.23 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.62 -4.7 58.12 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.358 178.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 84.56 11.81 76.7 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.305 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.655 ' SD ' ' HA ' ' A' ' 36' ' ' PRO . 23.5 mmt -95.65 175.67 6.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.389 0.137 . . . . 0.0 111.117 -177.132 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 14.9 ttp180 -80.7 -71.49 0.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 120.933 -0.307 . . . . 0.0 111.24 -173.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.468 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -119.67 -176.88 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 177.169 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.459 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -136.17 102.81 0.42 Allowed Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.388 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -85.26 156.31 21.0 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -96.16 109.71 22.11 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.407 HG23 ' N ' ' A' ' 29' ' ' ASN . 2.2 tp -104.3 177.98 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.665 -172.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.407 ' N ' HG23 ' A' ' 28' ' ' ILE . 9.6 m-80 -53.2 86.88 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 C-N-CA 123.001 0.52 . . . . 0.0 111.63 -177.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.91 -18.06 28.56 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.965 -0.561 . . . . 0.0 113.162 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.503 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 66.3 mttm -122.94 179.47 4.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.09 0.445 . . . . 0.0 110.564 -172.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 97.3 m -107.0 120.27 41.62 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 171.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -103.31 107.87 18.87 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.687 0.756 . . . . 0.0 110.381 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 22.9 m -81.09 142.07 33.68 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.357 -177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 m -88.98 121.05 69.99 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 177.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.655 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 17.7 Cg_endo -75.04 120.56 6.1 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.998 1.799 . . . . 0.0 112.38 -175.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.602 ' OXT' ' HD2' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.965 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.814 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.636 -0.135 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.44 118.43 0.03 OUTLIER Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.086 -0.578 . . . . 0.0 113.434 179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.577 HD13 ' SG ' ' A' ' 34' ' ' CYS . 33.9 pt -120.17 167.62 13.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.53 67.56 7.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.955 0.407 . . . . 0.0 109.92 178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.9 t -148.36 135.15 13.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.9 mttp -86.9 138.47 31.52 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 t -67.69 101.96 1.12 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.343 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -91.66 -50.74 5.6 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 169.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -149.65 135.16 18.4 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 16.5 p -62.17 -33.62 74.87 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.197 -177.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.35 -31.58 61.01 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.967 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -76.72 -20.31 56.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.04 0.448 . . . . 0.0 110.079 -178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.46 ' HB3' ' HA3' ' A' ' 25' ' ' GLY . 0.5 OUTLIER -69.0 -13.58 62.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.413 -177.125 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.0 mp -67.79 -35.43 78.65 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.902 0.382 . . . . 0.0 110.947 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.531 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 97.7 mttt -57.07 -54.16 57.58 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.526 -179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.45 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 46.7 Cg_endo -74.49 -25.43 13.0 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 121.034 1.156 . . . . 0.0 112.844 177.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 46.0 m -76.23 -31.56 58.43 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 19.6 ptpt -68.41 -25.42 65.03 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 175.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -85.91 -11.09 54.08 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.269 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.2 -1.41 56.27 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.088 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.35 23.17 74.35 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.197 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.404 ' HG3' ' HB2' ' A' ' 34' ' ' CYS . 25.3 mmt -110.05 178.32 4.44 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.858 -0.201 . . . . 0.0 110.946 -177.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.49 ' HG2' ' CE2' ' A' ' 24' ' ' PHE . 19.8 ttp180 -81.87 -70.04 0.57 Allowed 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 121.007 -0.277 . . . . 0.0 111.169 -173.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.49 ' CE2' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -124.99 -177.23 3.78 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 175.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.46 ' HA3' ' HB3' ' A' ' 13' ' ' CYS . . . -126.72 107.91 0.95 Allowed Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 121.112 -0.566 . . . . 0.0 111.872 178.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.1 tttp -91.9 157.05 17.06 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.5 m -90.05 129.69 36.32 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 121.216 0.532 . . . . 0.0 110.655 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.518 HG23 ' N ' ' A' ' 29' ' ' ASN . 1.3 tp -119.42 -179.98 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.113 -178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.518 ' N ' HG23 ' A' ' 28' ' ' ILE . 38.9 m-20 -47.68 87.14 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.396 0.678 . . . . 0.0 112.133 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 75.49 -15.36 4.64 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 116.095 -0.502 . . . . 0.0 113.183 179.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HB2' HG22 ' A' ' 28' ' ' ILE . 48.0 mtmt -120.76 -173.66 2.64 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 117.231 0.515 . . . . 0.0 110.825 -172.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 30.3 t -115.49 121.34 42.4 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.8 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -112.24 115.91 29.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.4 0.619 . . . . 0.0 110.338 175.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.577 ' SG ' HD13 ' A' ' 3' ' ' ILE . 36.5 m -79.85 143.87 33.96 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.633 -177.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 12.9 m -82.52 120.02 75.88 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 177.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -79.73 131.75 9.4 Favored 'Trans proline' 0 N--CA 1.448 -1.197 0 C-N-CA 122.122 1.881 . . . . 0.0 111.872 -177.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 48.6 pttt . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.515 -178.919 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.43 HG11 ' HG3' ' A' ' 36' ' ' PRO . 29.6 m . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 120.795 0.331 . . . . 0.0 110.626 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 142.44 157.3 7.1 Favored Glycine 0 N--CA 1.45 -0.414 0 N-CA-C 111.13 -0.788 . . . . 0.0 111.13 -177.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.406 HD12 ' HB2' ' A' ' 16' ' ' PRO . 18.1 pt -130.7 171.54 17.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.471 0.653 . . . . 0.0 111.936 -176.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -86.23 37.05 0.71 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.605 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.8 t -115.53 144.89 22.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.656 -0.247 . . . . 0.0 110.345 -177.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -91.24 141.58 28.64 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.046 -176.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.9 t -72.26 94.1 1.54 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.33 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -91.14 -47.65 7.41 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 171.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' A' ' 12' ' ' GLN . 7.1 p-80 -166.17 147.33 6.63 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.636 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 37.7 p -51.01 -46.58 61.58 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -171.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -60.95 -19.66 56.69 Favored Glycine 0 N--CA 1.453 -0.197 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.447 -178.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.545 ' HB2' ' CD2' ' A' ' 9' ' ' HIS . 26.1 tt0 -74.68 -43.87 53.05 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 66.4 m -68.93 -15.48 63.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.38 -173.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.597 HD22 ' H ' ' A' ' 25' ' ' GLY . 0.6 OUTLIER -62.45 -41.0 98.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.001 179.527 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.428 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 67.7 mttm -68.34 -54.97 13.29 Favored Pre-proline 0 CA--C 1.537 0.476 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -174.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.428 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 56.5 Cg_endo -71.12 -18.4 30.8 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.327 1.351 . . . . 0.0 112.815 -178.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 42.2 m -80.26 -39.62 28.58 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 120.585 0.231 . . . . 0.0 111.329 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -72.15 -23.0 61.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.084 0.468 . . . . 0.0 110.039 177.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -89.22 -5.94 57.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.59 0.709 . . . . 0.0 109.421 176.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.2 -5.81 51.81 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.267 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 87.73 14.87 62.45 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.847 -177.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 25.7 mmt -104.84 179.6 4.22 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 179.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 2.6 ttp180 -82.59 -74.6 0.34 Allowed 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.962 -0.295 . . . . 0.0 110.994 -174.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.52 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -122.63 -179.94 4.39 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.386 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.597 ' H ' HD22 ' A' ' 14' ' ' LEU . . . -131.47 111.03 1.03 Allowed Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 121.24 -0.505 . . . . 0.0 111.963 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 22.4 ttmm -91.1 153.67 19.92 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.898 0.38 . . . . 0.0 110.014 -179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -91.26 111.63 23.2 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 28' ' ' ILE . 2.4 tp -115.57 -179.12 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.027 -173.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' N ' HG23 ' A' ' 28' ' ' ILE . 21.6 m-80 -44.37 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.87 0.868 . . . . 0.0 112.621 -178.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 69.94 -8.23 3.68 Favored Glycine 0 CA--C 1.524 0.635 0 CA-C-N 116.156 -0.475 . . . . 0.0 113.392 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' HG2' ' N ' ' A' ' 32' ' ' CYS . 36.9 ttmt -122.9 167.4 13.6 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 122.559 -0.377 . . . . 0.0 110.001 -173.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.483 ' N ' ' HG2' ' A' ' 31' ' ' LYS . 91.1 m -100.66 112.63 25.06 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.023 0.439 . . . . 0.0 109.895 169.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -96.43 109.11 21.72 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.62 0.724 . . . . 0.0 110.065 179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 32.1 m -80.54 143.22 33.42 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.539 -176.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 26.6 m -88.16 132.41 39.71 Favored Pre-proline 0 N--CA 1.444 -0.772 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.43 ' HG3' HG11 ' A' ' 1' ' ' VAL . 3.0 Cg_exo -69.18 166.48 26.74 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 121.474 1.449 . . . . 0.0 110.828 176.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.62 -0.705 . . . . 0.0 110.489 -177.578 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.653 ' HA ' ' OD1' ' A' ' 33' ' ' ASP . 13.2 m . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 120.79 0.329 . . . . 0.0 111.296 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 153.18 87.17 0.06 OUTLIER Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.864 178.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 32' ' ' CYS . 28.5 pt -104.26 174.35 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.139 0.495 . . . . 0.0 110.606 -178.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -76.23 7.91 3.81 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.626 -0.715 . . . . 0.0 112.302 -172.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.6 t -97.0 139.52 19.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.632 -0.258 . . . . 0.0 110.841 -173.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -83.32 142.98 30.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.517 -179.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 5.7 t -79.18 101.55 8.01 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.777 -176.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -91.94 -57.07 2.85 Favored 'General case' 0 N--CA 1.445 -0.691 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 168.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 8.9 m80 -147.01 156.45 43.05 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 26.3 p -62.46 -38.09 88.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.829 0.347 . . . . 0.0 110.752 -179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.79 -27.41 64.17 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.604 177.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -73.16 -44.97 59.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 0.0 110.243 177.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 71.2 m -69.96 -16.3 63.18 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.41 -172.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.696 HD23 ' H ' ' A' ' 25' ' ' GLY . 82.5 mt -56.94 -49.74 74.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.424 0.631 . . . . 0.0 111.3 177.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 22.3 ttmm -60.17 -54.8 51.68 Favored Pre-proline 0 CA--C 1.54 0.577 0 CA-C-N 114.853 -1.067 . . . . 0.0 113.317 -172.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.436 ' HD3' ' HB3' ' A' ' 15' ' ' LYS . 52.1 Cg_endo -73.96 -20.79 19.1 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 121.148 1.232 . . . . 0.0 113.077 -178.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.9 m -77.6 -34.35 53.47 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 64.2 pttt -68.6 -25.59 64.95 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.1 mtpp -86.05 -6.34 59.05 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.498 179.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -91.0 4.86 50.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.322 174.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 76.96 22.67 71.05 Favored Glycine 0 N--CA 1.445 -0.716 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.105 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.573 ' SD ' ' HB2' ' A' ' 34' ' ' CYS . 46.1 mtt -116.61 175.82 5.39 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 121.025 -0.27 . . . . 0.0 111.169 -176.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.547 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 8.1 ttp180 -75.41 -72.36 0.31 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.139 0.274 . . . . 0.0 111.653 -170.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.547 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -125.3 -176.61 3.63 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 121.09 0.471 . . . . 0.0 110.137 177.125 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.696 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -123.58 115.58 2.66 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.708 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -90.95 156.85 17.66 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -104.76 109.9 22.03 Favored 'General case' 0 C--N 1.313 -1.016 0 C-N-CA 120.57 -0.452 . . . . 0.0 109.905 177.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.685 HG22 ' H ' ' A' ' 31' ' ' LYS . 0.7 OUTLIER -95.01 164.33 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -39.06 -36.96 0.34 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -168.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -135.25 -14.79 1.05 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.177 -1.011 . . . . 0.0 113.025 175.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.685 ' H ' HG22 ' A' ' 28' ' ' ILE . 68.2 mttm -123.81 167.31 14.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.781 0.324 . . . . 0.0 111.277 -169.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.405 ' O ' HG12 ' A' ' 3' ' ' ILE . 99.6 m -91.16 111.91 23.58 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.429 0.633 . . . . 0.0 110.525 173.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.653 ' OD1' ' HA ' ' A' ' 1' ' ' VAL . 8.0 t70 -85.53 158.52 20.13 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 172.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.573 ' HB2' ' SD ' ' A' ' 22' ' ' MET . 16.5 m -131.98 137.52 47.93 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.427 ' HB ' ' CD1' ' A' ' 24' ' ' PHE . 28.8 m -88.0 123.01 69.68 Favored Pre-proline 0 N--CA 1.439 -1.009 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -80.37 176.58 9.06 Favored 'Trans proline' 0 N--CA 1.444 -1.422 0 C-N-CA 121.714 1.609 . . . . 0.0 111.498 178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.413 ' N ' ' HD3' ' A' ' 37' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.994 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.004 -178.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.406 HG21 ' HD3' ' A' ' 36' ' ' PRO . 20.2 m . . . . . 0 N--CA 1.482 1.151 0 CA-C-O 121.102 0.477 . . . . 0.0 110.713 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -57.91 141.37 45.13 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.544 -0.753 . . . . 0.0 113.575 -175.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.44 HD11 ' SG ' ' A' ' 32' ' ' CYS . 21.3 pt -110.02 171.61 2.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -81.28 45.18 0.83 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.986 0.422 . . . . 0.0 111.729 -177.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.1 t -125.95 144.29 36.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.125 -0.489 . . . . 0.0 109.992 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.8 tttp -92.97 146.55 23.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.678 -175.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 31' ' ' LYS . 46.0 t -77.02 78.29 3.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.14 0.495 . . . . 0.0 111.276 -177.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.455 ' HB2' ' OE1' ' A' ' 12' ' ' GLN . 52.7 mtpt -91.35 -50.21 5.93 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 174.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 22.8 m80 -143.9 136.6 27.15 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 6.0 p -66.69 -34.96 79.02 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.353 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.78 -18.2 79.48 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.906 -0.664 . . . . 0.0 111.586 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.455 ' OE1' ' HB2' ' A' ' 8' ' ' LYS . 61.1 tt0 -82.78 -31.14 28.42 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -67.32 -19.64 65.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.474 179.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.642 HD23 ' H ' ' A' ' 25' ' ' GLY . 81.2 mt -61.14 -48.68 80.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.437 0.637 . . . . 0.0 110.737 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.496 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 56.3 mtpt -53.18 -56.71 21.29 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 114.565 -1.198 . . . . 0.0 113.322 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 15' ' ' LYS . 57.9 Cg_endo -72.32 -28.93 14.58 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 121.304 1.336 . . . . 0.0 112.867 -178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.0 m -72.06 -36.87 69.7 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -176.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 65.1 pttt -67.45 -26.06 66.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.029 0.443 . . . . 0.0 109.867 177.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -79.88 -18.52 50.48 Favored 'General case' 0 CA--C 1.519 -0.24 0 CA-C-O 121.495 0.664 . . . . 0.0 109.327 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.06 9.16 23.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.892 -1.049 . . . . 0.0 110.068 178.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 74.94 19.25 80.03 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.008 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 24.1 mmt -97.89 175.34 6.18 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.75 0.309 . . . . 0.0 111.47 -176.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 3.5 ttp180 -81.82 -66.06 0.94 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.164 -176.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.532 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -131.01 -177.51 4.41 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 172.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.642 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -125.14 116.65 2.76 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.558 -0.617 . . . . 0.0 111.558 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -91.91 146.46 23.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.249 0.547 . . . . 0.0 110.174 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -93.73 111.9 23.68 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.451 HD12 ' HA ' ' A' ' 28' ' ' ILE . 2.2 tp -108.55 178.71 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 119.258 -0.401 . . . . 0.0 110.089 -171.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.404 ' N ' HG23 ' A' ' 28' ' ' ILE . 30.7 m-80 -49.63 87.83 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 123.065 0.546 . . . . 0.0 111.891 -178.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.18 -15.93 8.1 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.254 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' CYS . 74.9 mmtt -121.92 174.07 7.11 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.059 0.43 . . . . 0.0 110.988 -171.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.44 ' SG ' HD11 ' A' ' 3' ' ' ILE . 14.2 t -111.35 112.09 23.6 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -115.7 118.98 34.57 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-O 121.413 0.625 . . . . 0.0 109.845 176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.441 ' HA ' ' HA2' ' A' ' 25' ' ' GLY . 27.8 m -79.44 165.84 22.63 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.168 -172.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.452 ' HB ' ' CD1' ' A' ' 24' ' ' PHE . 10.6 m -105.37 109.5 63.28 Favored Pre-proline 0 N--CA 1.441 -0.925 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 173.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.406 ' HD3' HG21 ' A' ' 1' ' ' VAL . 31.8 Cg_endo -66.5 153.21 78.83 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 121.6 1.533 . . . . 0.0 111.137 173.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 10.8 ptpp? . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.854 -0.593 . . . . 0.0 109.902 177.205 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.405 HG21 ' HG3' ' A' ' 36' ' ' PRO . 13.3 m . . . . . 0 N--CA 1.484 1.27 0 CA-C-O 121.048 0.451 . . . . 0.0 111.497 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -100.48 164.85 19.05 Favored Glycine 0 N--CA 1.447 -0.596 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 177.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.517 HD12 ' HB2' ' A' ' 16' ' ' PRO . 16.3 pt -122.89 176.07 5.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.145 0.497 . . . . 0.0 111.235 -177.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -87.46 35.12 0.71 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.812 -176.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.424 ' HB ' ' HB2' ' A' ' 32' ' ' CYS . 22.0 t -115.04 132.88 62.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.891 0 CA-C-O 120.872 0.367 . . . . 0.0 110.279 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp -80.69 126.81 31.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.994 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 4.4 t -67.35 93.8 0.35 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.272 -179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -91.29 -41.25 11.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.155 0.503 . . . . 0.0 110.371 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -144.12 135.86 26.06 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -174.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.463 ' HA ' ' HB2' ' A' ' 27' ' ' CYS . 37.2 p -70.81 94.22 1.03 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.626 0.727 . . . . 0.0 110.282 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 142.64 -25.76 2.27 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -173.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -67.24 -25.44 66.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.299 0.571 . . . . 0.0 110.118 176.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 33.6 m -84.02 -9.26 58.79 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.453 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.701 HD23 ' H ' ' A' ' 25' ' ' GLY . 94.4 mt -61.47 -54.16 46.96 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.887 0.375 . . . . 0.0 111.362 -177.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.636 ' O ' ' HG2' ' A' ' 18' ' ' LYS . 55.8 mtmt -59.57 -53.98 60.42 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.755 -176.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.517 ' HB2' HD12 ' A' ' 3' ' ' ILE . 20.1 Cg_endo -63.88 -24.45 67.89 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 121.214 1.276 . . . . 0.0 112.755 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -78.94 -37.92 38.5 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 111.855 0.317 . . . . 0.0 111.855 -179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 15' ' ' LYS . 13.8 ptmm? -71.11 -26.13 62.9 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.093 0.473 . . . . 0.0 110.037 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 15' ' ' LYS . 9.0 mtmp? -85.36 -5.2 59.32 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.703 0.763 . . . . 0.0 109.15 177.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.31 0.55 57.01 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.083 176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.429 ' O ' ' HE2' ' A' ' 37' ' ' LYS . . . 80.65 19.13 68.96 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.014 -179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.5 mmt -102.74 -175.8 2.91 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.46 0.171 . . . . 0.0 110.66 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.528 ' HG2' ' CZ ' ' A' ' 24' ' ' PHE . 16.1 ttp180 -84.93 -71.23 0.53 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.678 0.275 . . . . 0.0 110.588 -177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.528 ' CZ ' ' HG2' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -128.07 -179.37 4.95 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 174.192 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.701 ' H ' HD23 ' A' ' 14' ' ' LEU . . . -131.49 104.54 0.58 Allowed Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.605 178.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 57.8 tttm -91.35 158.81 16.33 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.463 ' HB2' ' HA ' ' A' ' 10' ' ' SER . 0.1 OUTLIER -92.15 114.75 27.38 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.037 0.446 . . . . 0.0 110.146 178.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.46 HD13 ' HB3' ' A' ' 33' ' ' ASP . 1.0 OUTLIER -99.81 162.86 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -58.33 87.34 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.397 0.618 . . . . 0.0 111.07 -177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.48 -31.85 8.17 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.263 -0.88 . . . . 0.0 113.02 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.421 ' H ' HG22 ' A' ' 28' ' ' ILE . 49.8 mtmt -121.8 147.6 45.74 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 122.362 -0.493 . . . . 0.0 111.882 -168.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.424 ' HB2' ' HB ' ' A' ' 5' ' ' VAL . 41.0 m -80.13 102.98 9.7 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 168.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.46 ' HB3' HD13 ' A' ' 28' ' ' ILE . 34.1 t70 -102.83 129.86 49.65 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.718 -0.673 . . . . 0.0 109.647 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 29.7 m -98.62 145.03 27.27 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.095 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 15.3 m -85.74 125.68 68.29 Favored Pre-proline 0 N--CA 1.446 -0.641 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 176.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.405 ' HG3' HG21 ' A' ' 1' ' ' VAL . 3.9 Cg_exo -71.89 141.64 37.4 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.815 1.677 . . . . 0.0 111.264 177.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.429 ' HE2' ' O ' ' A' ' 21' ' ' GLY . 52.5 pttt . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.393 -0.813 . . . . 0.0 110.496 178.888 . . . . . . . . 1 1 . 1 stop_ save_